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Deoxysugars are indispensable structural components of many biologically active 
natural products and are essential for many significant cellular processes.  In this work, 
the biosynthetic pathway of TDP-forosamine, which is a 2,3,4,6-tetradeoxy sugar 
component of the potent, and environmentally benign insecticide spinosyn, has been 
established without ambiguity.  Five genes, spnO, spnN, spnQ, spnR, and spnS have been 
cloned from Saccharopolyspora spinosa chromosomal DNA and expressed in E. coli.  
The encoded proteins have been purified and characterized by in vitro assays.  The 
products of four reactions have been isolated and characterized with MS and/or NMR.  
SpnO was demonstrated to be a 2,3-dehydratase, while SpnN was shown to be a 3-
iv
ketoreductase, catalyzing equatorial hydroxyl formation at C-3.  Studies of the combined 
action of SpnO and SpnN reinforce the previous finding that C-2 deoxygenation is 
accomplished through a β-elimination/reduction type mechanism.  SpnQ is a homologue 
of the well-characterized CDP-6-deoxy-L-threo-D-glycero-4-hexulose-3-dehydrase (E1) 
which in combination with CDP-6-deoxy-4-keto-∆3,4-glucoseen reductase (E3) catalyzes 
the C-O bond cleavage at C-3 in the biosynthesis of CDP-ascarylose in Yersinia 
pseudotuberculosis.  In the biosynthesis of TDP-forosamine, SpnQ was shown to 
catalyze an analogous C-3 deoxygenation but instead using ferredoxin/ferredoxin 
reductase pair as the electron transfer media.  Additionally, in the absence of 
ferredoxin/ferredoxin reductase to allow C-3 deoxygenation, and in the presence of L-
glutamate as an amino donor, SpnQ was shown to act as a 4-aminotransferase, converting 
TDP-2,6-dideoxy-4-keto-D-glucose to TDP-4-amino-2,4,6-trideoxy-D-glucose.  Due to 
the instability of 2-deoxysugars, an analog of TDP-4-amino-2,3,4,6-tetradeoxy-glucose 
was used to characterize the late steps in the pathway.  SpnR was shown to be a 4-
aminotransferase which, interestingly, can recognize both the SpnQ product and the 
SpnN product as substrates.  SpnS was shown to be a 4-amino-N,N-dimethyltransferase.  
Mechanistic investigation revealed that both N-methyl groups of TDP-forosamine are 
installed by SpnS in a step-wise manner via a monomethylated intermediate.  Together, 
studies described in this thesis have extensively enriched our knowledge of the enzymes 
involved in deoxysugar biosynthesis.  The newly discovered substrate flexibility of TDP-
forosamine pathway enzymes will also be very useful in generating engineered sugar 
biosynthetic pathway for use in generating novel natural products.
v
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Chapter 1.  Background and Significance
1.  INTRODUCTION
Carbohydrates, proteins and nucleic acids are three important constituents of 
biological systems.  Although each has its respective role in providing energy for the 
living organism, catalyzing various types of biological reactions, and serving as the 
template for the reproduction and evolution of organisms, they also serve specific 
functions by acting in combination.1-7  For example, glycopeptides are indispensable 
components of cell wall structures.  It is also well known that the antigenic determinants 
of the ABO(H) blood group and the related lewis blood group are carbohydrates attached 
to a peptide.8,9  The ribosome that is essential in protein production by translating mRNA 
is an assortment of nucleic acids and proteins.  The universal presence of carbohydrates 
in living systems has inspired extensive research to explore their diverse functions in 
microorganisms, plants, and animals.10-16
Deoxysugars are an important class of carbohydrates that occur widely in nature.  
They are commonly defined as monosaccharides with one or more hydroxyl group(s) 
replaced by hydrogen(s).  However, since deoxysugars often contain functional groups 
other than hydrogens in place of the hydroxyls, they are more often defined as sugars in 
which one or more of the hydroxyl groups is replaced by a hydrogen (deoxysugars) or 
other heteroatom or heteroatomic group, such as sulfur (thiosugars), amino group 
(aminosugars) or nitro group (nitrosugar).  There is also a group of deoxysugars where an 
additional alkyl-branched chain is attached to a backbone carbon on the sugar ring.17-19
These are referred to as alkyl-branched chain deoxysugars.  Deoxysugars can be found as 
2
elements of lipopolysaccharides (LPS), glycoproteins, and a great variety of secondary 
metabolites with biological activities.  
LPS is a constituent of the gram-negative bacterial cell wall and is known to be 
responsible for the endotoxic effect of these bacteria on the host during infection.20-23
LPS has a common architecture consisting of a lipid to which a carbohydrate portion is 



























































Figure 1-1. (a) General tripartite structure of LPS. (b) LPS of Salmonella typhimurium. Abbreviations:
Abeq, abequose; Gal, galactose; GlcN, N-acetylglucosamine; Glu, gluocse; Hep, L-glycero-D-
mannoheptose; KDO, keto-deoxy-octanoate; Man, mannose.  Adapted from Nat. Prod. Rep. 1999, 16, 283-








unit with up to 15 monosaccharides called the core region, and a polysaccharide 
extension made of repeating units referred to as the O-chain.24,25,31  The structures of LPS 
are similar to some glycoproteins that also have a tripartite structural organization, where 
the usually conserved core regions serves as a linkage connecting a glycan chain to a 
polypeptide.26,27  Shown in Figure 1-2 are two structures of N-linked glycopeptides 
having the tripartite organization.  While the
Man ( 1 2 )α Man ( 1 2 )α Man ( 1 3 )α
Man ( 1 2 )α Man ( 1 3 )α
Man ( 1 2 )α Man ( 1 6 )α
Man ( 1 6 )α
Man ( 1 4 )GlcNAcβ GlcNAc( 1 4 ) Asnβ
Man ( 1 3 )α
Man ( 1 6 )α
Man ( 1 4 )GlcNAcβ GlcNAc( 1 4 ) Asnβ
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Figure 1-2.  Structures of N-linked oligosaccharides. (a) High-mannose chain. (b) Complex chain. Scrimgeour, 
M. Biochemistry; Prentice Hall:New Jersey, 1994.
core region of the LPS in most bacteria is very similar, the O-chains display a broad 
structural diversity among different organisms.24,34  It has been well documented that the 
O-chains of the LPS are rich in deoxysugars which are directly involved in host 
recognition, modulation of bacterial virulence, and cell-cell adhesion.21,28,29,32,35,36,37  In 
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addition, studies of the structure and function of LPS have shown that the 
immunospecificity of the pathogenic bacteria is in large part determined by the 
deoxysugar unit at the non-reducing end of the O-chain.2,30,38,39 
Deoxysugars are also found as structural components in naturally occurring 
antimicrobial agents and anticancer drugs.  For example, macrolide antibiotics are made 
up of a cyclic polyketide aglycone with one or more sugars that are linked to the 
aglycone.  Various deoxysugars have been found in macrolide antibiotic structures.  
Some of these sugars have further modifications, such as O-, N-, and C-methylations and 
acetylations.  Accumulated evidence showed that deoxysugars are essential for the 
biological activities and the specificities of antibiotics of which they are a part.12,39  High-
resolution X-ray crystal structures of the 50S ribosomal subunit of the eubacterium 
Deinococcus radiodurans complexed with erythromycin, clarithromycin and 
roxithromycin have unambiguously established the interactions between the deoxysugar 
portions of these compounds and the nucleotides of 23S ribosomal RNA.  These 
interactions inhibit the peptidyl transferase activity of the ribosome by interfering with 
the proper positioning and movement of tRNAs in the peptidyl transferase cavity.40,41
In light of the above structural as well as biochemical evidence, it is expected that 
the activity and specificity of these antibiotics could be fine-tuned by making changes to 
deoxysugar structures.  Much efforts have been devoted to prepare derivatives of known 
antibiotics carrying varied deoxysugar components in order to overcome the increasingly 
serious drug resistance problem.42,43,44  Although chemical synthesis has traditionally 
been the approach of choice, biosynthetic engineering has emerged as an alternative 
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means for generating structural variations in recent years.  This approach is made 
possible by the availability of the sequencing information of a large number of 
deoxysugar-containing secondary metabolite biosynthetic clusters.  In vivo and in vitro
studies have shown that many glycosyltransferases catalyzing the attachment of 
deoxysugars to acceptor substrates have some degree of substrate flexibility, and thus are 
capable of accepting some unnatural deoxysugars generated by reengineering the 
deoxysugar biosynthetic machineries.  It is encouraging that some of the resulting 
antibiotic analogs exhibit reasonable antibiotic activities.45-51  The success of such 
pathway reengineering strategy depends on a thorough understanding of the functions of 
the enzymes encoded by each individual genes in the deoxysugar biosynthetic clusters.  
The studies of our laboratory have provided much insight into the enzymatic logic behind 
TDP-deoxysugar formation.52,53,54  Detailed investigation of the enzymatic mechanism of 
the C-O bond cleavage in the biosynthesis of 3,6-dideoxyhexoses represents one of the 
first mechanistic studies of deoxysugar biosynthesis.55-68  Over the years, the enzymatic 
mechanisms of C-O bond cleavage at other positions of the hexose ring, and the 
mechanisms of the C-N as well as C-C bond formation involved in amino and branched-
chain sugar biosynthesis, have also been explored.71,72,73,80,81  These endeavors not only 
provide valuable information on the characteristics of the enzymes involved, but also set 
the stage for further development of creating deoxysugar-containing bio-active 
compounds either through in vivo engineering or in vitro enzymatic synthesis. 
2.  BIOSYNTHETIC PATHWAYS OF DEOXYSUGARS
6
Polyketide Synthase (PKS) 
Many natural products are polyketide derivatives, having a highly functionalized 
aglycone which is further modified at various positions by deoxysugars.  According to 
the structures of the polyketide aglycones, these natural products can be roughly divided 
into three families:82,83 the aromatic tetracyclic family,84,85 the macrocyclic lactone 
family,86 and the aminocoumarin family.89,90  The polyketide aglycones are synthesized 
by polyketide synthases, which are large multifunctional enzyme complexes.  There are 
two main types of polyketide synthases: modular polyketide synthase and iterative 
polyketide synthase.83,91  Modular polyketide synthases, also known as type-I PKS, are 
large multienzyme complexes that synthesize macrocyclic polyketides by successive 
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(a)
Figure 1-3  (a) Biosynthesis of 6-deoxyerythronolide B (6dEB) by deoxyerythronolide B synthase , a type I PKS.
Abbreviations: KS, -ketosynthase; AT, acyl transferase; ACP, acyl carrier protein; KR, keto reductase;
DH, dehydrase; ER, enoy reductase.
β
(b) Organisation of the gra polyketide synthase gene cluster, a type II PKS.
Abbreviations: KS, keto-acyl synthase; CLF, chain length factor; ACP, acyl carrier protein; ARO, aromatase;
KR, ketoreductase. Hans, M. et al. J. Am. Chem. Soc. 2003, 125, 5366.
KR KR KS CLF ACP ARO
(b)
regulation/export genes, sugar genes, tailoring genes
Adapted from  
7
condensation of acetate, propionate or butyrate units.  The extent of β-carbonyl-group 
reduction in each condensation cycle varies.  Iterative PKS, also known as type-II PKS, 
construct polyketides mainly from acetate units, and the carbonyl group formed after 
each condensation cycle are usually left unreduced.  The erythromycin PKS is an 
example of a type-I PKS, while the granaticin PKS is an example of a type-II PKS 













































nucleophile; (c) the acyl-S-Cys-KS donor; (d) the product, -keto-acyl-S-ACP.β
Figure 1-4.  Four stages to the C-C bond-forming chain elongation steps of  type I PKS  assemblies:




















the sequential catalysis of several modules, each of which is composed of several 
individual domains.  The start unit is first linked to the ACP of the loading domain 
(module).  By the catalysis of ketosynthase domain and acyl-transferase domain on the 
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following module, the unit is transferred to the ACP domain of the second module and 
the size of the chain increases by either a two or three-carbon unit, depending on the 
condensation unit used.  The polyketide chain can be further modified by the domain in 
the same module, such as ketoreductase domain, dehydratase domain and enoyl reductase 
domain before being transferred to the next module.  Each module in the type-I PKS has 
the basic duty of increasing the length of the polyketide chain, possibly reducing the most 
recently added unit, and finally passing it to the next module.  When the polyketide chain 
is loaded onto the last module, the linear chain is cyclized and released from the PKS.  As 
for type-II PKS (Figure 1-5), the domains are dispersed among the metabolite 
biosynthesis cluster.  The enzymatic function of each domain is used repeatedly until the 
final product is formed.  In each chain elongation cycle, malonyl or methylmalonyl unit is 
































Figure 1-5.  The iterative chain elongation cycles of tyep II PKS.  Adapted from Walsh, C. T. 
Antibiotics: Actions, Origins, Resistance; ASM press: Washington, D.C. 2003
9
domain.  The adjacently localized KSβ domain is supposed to control the length of the 
polyketide chain and the number of the elongation cycle.  Since the work in this 
dissertation is not related to polyketide synthesis, the PKS-catalyzed reactions are only 
briefly described here.  More detailed account on catalysis by each type of PKS can be 
found in many reviews.83,87,88,92,93
Genes in Deoxysugar Biosynthesis
The genes for the biosynthesis of deoxysugars that are attached to polyketide-
derived aglycone are usually located adjacent to the PKS genes responsible for the 
formation of the alycone to which the sugar(s) is attached.  When a sugar unit is not only 
a component of a secondary metabolite, but also of LPS of the producing organism, the 
sugar biosynthesis genes may be found outside the secondary metabolite gene cluster.94
To synthesize such secondary metabolites, the sugar unit probably is obtained from the 
cellular pool.  There are also cases where a sugar biosynthetic gene, whose encoded 
protein catalyzes a reaction common to several deoxysugar pathways that occur in the 
same organism, is present in only one copy.  The encoded enzyme is presumably used by 
all pathways for which it is needed.  For example, TylX3 is the dehydratase in the 
biosynthesis of three deoxysugars: mycaminose, mycarose, and deoxyallose, all of which 
are the sugar components of antibiotic tylosin.  In tylosin biosynthesis gene cluster, only 
one copy of tylX3 can be identified. Although the structures of the polyketides to which 
deoxysugars are attached and those of the O-chain of LPS which have deoxysugars as 
components are very different, so as the organization of the biosynthetic genes in each 
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pathway, the same sugar component of different natural products generally have the same
biosynthetic pathway.  In the following section, the biosynthetic pathways of 
deoxyhexoses will be illustrated.  The deoxyhexoses discussed are subdivided into 
following groups: 6-deoxysugars, 2,6-dideoxysugars, 3,6-dideoxysugars, 2,3,6-
trideoxysugars and 3,4,6-trideoxysugars.  The discussion is not intended to be a complete 
description of deoxysugar biosynthesis, but is instead an illustration of the diversity of 
deoxysugar structures found in nature and the presentation of several better-studied 
biosynthetic pathways.  The names of some enzymes are not given.  This is either 
because the enzyme has not been assigned a name, or because the deoxysugar is made by 
a few different organisms, each containing a biosynthetic machinery for that dexoysugar.  
In most cases, the names used by different research groups have not been standardized. 
Biosynthetic Pathways of 6-Deoxysugars (Scheme 1-1)
One of the best-known 6-deoxysugars, L-rhamnose, is found widely in bacteria 
and plants and is a common component of the cell wall and capsule of many pathogenic 
bacteria.  The cell wall and capsule of the pathogen interact with the host during infection 
and help the bacteria to survive.  L-Rhamnose is also a component of several secondary 
metabolites produced by microorganisms.94  The precursor of rhamnose is glucose with a 
nucleotide diphosphate group attached at C-1.  Having such a diphospho- linkage 
facilitates the bond formation between a nucleophile and the C-1 of the sugar since 
nucleotide diphosphate is a better leaving group than a hydroxyl group.  In fact, in all 
deoxysugar biosynthesis studied so far, the sugar unit is always activated to NDP-sugar.  
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in Salmonella enterica is RmlA, which is a α-D-glucose-1-phosphate 
thymidylyltransferase catalyzing the transfer of thymidylmonophosphate (TMP) from 
thymidyltriphosphate (TTP) to glucose-1-phosphate (1).  The second enzyme, RmlB, is a 
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TDP-glucose-4,6-dehydratase. The product formed, TDP-6-deoxy-4-keto-glucose (3) is 
an intermediate common to many deoxysugar biosynthetic pathways and is the branch 
point at which various pathway diverge.  The third enzyme, RmlC, catalyzes both the C-3 
and C-5 epimerization reactions.  Finally, RmlD reduces the 4-keto functional group to 
generate the final product, TDP-L-rhamnose (5).24,95
Another 6-deoxysugar, D-rhamnose, is primarily utilized in the cell wall synthesis 
by Pseudomonas aeruginosa.24,96  Unlike L-rhamnose, D-rhamnose is made from 
mannose-1-phosphate (11).  After guanidylylmonophosphate nucleotide transfer, GDP-
mannose (12) is formed.  A TDP-glucose-4,6-dehydratase homologue then catalyzes the 
formation of GDP-6-deoxy-4-keto-mannose (13).  Finally, a ketoreductase reduces the C-
4 position to complete the synthesis of GDP-D-rhamnose (14).  
L-Fucose is a sugar commonly found as component of LPS and surface antigen of 
E. coli.  The biosynthetic pathway of GDP-L-fucose (16) begins with mannose-1-
phosphate (11), which is converted to GDP-mannose (12), then GDP-6-deoxy-4-keto-
mannose (13) as in GDP-D-rhamnose biosynthesis.  Compound 13 is then epimerized at 
C-3 and C-5, and finally converted to GDP-L-fucose (16) by the reduction of the C-4 
ketone. 
6-Deoxy-D-gulose is another unusual 6-deoxysugar which is a component of LPS 
from several different Yersinia enterocolitica strains.  Based on sequence analysis, four 
genes are proposed to be involved in the biosynthesis of CDP-6-deoxy-D-gulose (22).  
The biosynthetic pathway is proposed to consist of the following reactions in sequence: 
activation of glucose-1-phosphate (1) to CDP-glucose (19), 4,6-dehydration to give CDP-
13
6-deoxy-4-keto-D-glucose (20), followed by 3-epimerization and 4-ketoreduction to give 
the final product.24,95
The aminocoumarin antibiotics coumermycin A1, clorobiocin, and novobiocin, 
are produced by various Streptomyces strains and have demonstrated strong antibiotic 
potency against Gram-positive pathogenic bacteria.  The three antibiotics have a common 
sugar unit, TDP-6-deoxy-5-methyl-L-lyxo-hexose (7).  In the biosynthesis of this TDP-6-
deoxysugar, the first two steps are glucose-1-phosphate (1) activation and TDP-glucose-
4,6-dehydration, common to all TDP-deoxysugar biosynthetic pathways.  Then the TDP-
6-deoxy-4-keto-glucose (3) undergoes 3,5-epimerization (4), C-5 methylation (6) and 4-
ketoreduction to form the final product, which is then transferred to the polyketide 
acceptor.97,98
Nogalose is a sugar unit attached to the polyketide portion of nogalamycin, an 
antitumor antibiotic produced by Streptomyces nogalater.  TDP-6-deoxy-4-keto-glucose 
(3) is formed by the sequential catalysis of SnogJ and SnogK from glucose-1-phosphate 
(1).  The next steps are a 3,5-epimerization (4) catalyzed by SnogF, C-3 methylation (8) 
catalyzed by SnogG2, and 4-ketoreduction (9) catalyzed by SnogC.99
D-Perosamine is often found as a component of the LPS of E. coli.  However, it 
has also been discovered to be a component of the structures of some polyene antibiotics.  
In the biosynthetic pathway of GDP-D-perosamine (17), after the formation of GDP-6-
deoxy-4-keto-mannose (13) by the identical route that has been described in the 
biosynthesis of GDP-L-fucose (16) and GDP-D-rhamnose (14), a transamination reaction 
at C-3 concludes the synthesis of GDP-D-perosamine (17).24
14















































































Scheme 1-2 .  2,6-Dideoxy hexose biosynthetic pathways.
2,6-dideoxysugars in which the hydroxyl groups at C-2 and C-6 have been 
replaced with either hydrogen or other non-oxygenated functional groups are often found 
as structural components of many secondary metabolites.  As more biosynthetic gene 
clusters of deoxysugars are sequenced, it has been shown that the first two steps in the 
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deoxysugar biosynthesis are always hexose-1-phosphate activation to form an NDP-
hexose and 4,6-dehydration to form NDP-6-deoxy-4-keto-hexose.  It can also be 
generalized that the biosynthesis of 2,6-dideoxysugars and 3,6-dideoxysugars, 2,3,6-
trideoxysugars and 3,4,6-trideoxysugars all have NDP-6-deoxy-4-keto-hexose as a 
common intermediate.  From this point, the various deoxysugar biosynthetic pathways 
diverge. 
Mithramycin, produced by Streptomyces argillaceus, has been used as an 
antitumor drug. As shown in Figure 1-6, the two sugar appendages that are attached to 
the aromatic polyketide of mithramycin include a disaccharide chain made up of two D-
olivoses attached to a phenolic oxygen, and a trisaccharide chain made up of D-olivose, 
D-oliose, and D-mycarose attached to a β-hydroxyl group.  The biosynthesis gene clusters 
of these three deoxysugars have been sequenced.  Based on sequence analysis, the 
biosynthetic pathway of TDP-D-oliose (27) has been suggested.  Following the formation 
of TDP-6-deoxy-4-keto-glucose (3), 2,3-dehydration and 3-ketoreduction lead to TDP-
2,6-dideoxy-4-keto-glucose (24).  A final 4-ketoreduction gives TDP-D-oliose (27).  It 
should be noted that the hydroxyl group formed by the 3-ketoreduction is equatorial.100
TDP-D-olivose differs from TDP-D-oliose only by the stereochemistry at C-4.  The two 
deoxysugars share the same biosynthetic pathway up to the final ketoreduction step; the 
TDP-D-olivose (29) pathway has a 4-ketoreductase with the opposite stereospecificity 
than that of the TDP-D-oliose (27) biosynthetic pathway.  D-Olivose is a component of 
many antibiotics, such as urdamycin from Streptomyces fradiae, simocyclinone from 
Streptomyces antibioticus, landomycin from Streptomyces globisporus, and others.  The 
16
formation of the 4-acetyl group on D-olivose in the structure of simocyclinone is 
proposed to take place after the sugar unit has been transferred to the aromatic 
polyketide.100,101,102


























Figure 1-6.  Structure of mithromycin
Mycarose is the terminal deoxysugar unit of the trisaccharide chain in mithramycin.  It 
also occurs in chromocyclomycin which is an antitumor drug produced by various 
Streptomyces strains.  The structure of chromocyclomycin is similar to that of 
mithramycin, having two oligosaccharide chains attached to an aromatic polyketide. In 
the biosynthesis of TDP-D-mycarose (26), two enzymes, 2,3-dehydratase and 3-
ketoreductase, catalyze the C-2 deoxygenation on the intermediate TDP-6-deoxy-4-keto-
glucose (3) to form TDP-2,6-dideoxy-4-keto-glucose (24) with an equatorial 3-hydroxyl 
group.  Next, a methyl group is attached to C-3 of the hexose by the action of a C-
methyltransferase.  Finally, TDP-2,6-dideoxy-4-keto-3-C-methyl-hexose (25) undergoes 
4-ketoreduction to form the final product TDP-D-mycarose (26).  While the biosynthetic 
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pathway of D-mycarose is based on sequence analysis of the deoxysugar gene cluster, the 
biosynthesis of L-mycarose has recently been biochemically established due to the efforts 
of our group.  From the common intermediate TDP-6-deoxy-4-keto-hexose (3), the 2-
hydroxyl group is removed by the action of a 2,3-dehydratase and a 3-ketoreductase.  The 
resulting 3-hydroxyl group in 28 is axial, unlike that of 24 in the biosynthesis of TDP-D-
mycarose.  Next, a methyltransferase catalyzes the attachment of a methyl to the C-3 
position followed by 5-epimerization and 4-ketoreduction.  The final product of TDP-L-
mycarose has a different stereochemistry at C-3, C-4, and C-5 from that of TDP-D-
mycarose.  L-Mycarose has been found in many antibiotics, such as tylosin and 
erythromycin, which are produced by various Streptomyces strains.103,104
Another 2,6-dideoxysugar that often occurs in natural products is L-oleandrose.  It 
has been found in the antibiotic oleandomycin produced by Streptomyces antibioticus and 
in the antiparasitic agent avermectin produced by Streptomyces avermitilis.  The 
biosynthesis of TDP-L-oleandrose (46) is unique since it is the only known deoxysugar to 
be synthesized by two alternate routes in Streptomyces antibioticus and Streptomyces 
avermitilis (Scheme 1-3).  Both routes begin with C-6 deoxygenation to form TDP-6-
deoxy-4-keto-glucose (3), which then undergoes 2,3-dehydration catalyzed by OleV and 
AveBVI in the oleandomycin and avermectin pathway, respectively. Based on sequence 
analysis and genetic studies, C-3 ketoreduction catalyzed by OleW in the oleandomycin 
pathway gives an equatorial hydroxyl group in 24, while that catalyzed by AveBVIII in 
the avermectin pathway gives an axial hydroxyl group in 28.  The same final product is 
18
obtained by 3,5-epimerization catalyzed by OleL in the oleandomycin pathway and 5-
























































































Scheme 1-3.  L-Oleandrose biosynthetic pathway.
from bioconversion experiments suggest that 3-O-methyltransfer occurs after 




































































































































Scheme 1- 4.  3,6-Dideoxy hexose biosynthetic pathways.
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Biosynthetic Pathways of 3,6-Dideoxysugars (Scheme 1-4)
3,6-Dideoxysugars are widely found as components of LPS and surface layer 
glycoproteins,24,108 and also occur in some secondary metabolites.  According to the 
definition of deoxysugar, 3-amino-6-deoxy-hexoses are also included in this class.  
However, the enzymes and mechanisms implicated in C-3 amino transfer are quite 
different from those of C-3 deoxygenation.  3,6-Dideoxy-3-amino-hexoses are often 
found in antibiotic structures.  
L-Ascarylose, D-abequose, D-paratose, and D-tyvelose are components of LPS 
from Yersinia pseudotuberculosis and different Salmonella strains.  They have attracted 
much attention because of their highly immunogenic properties.  The biosynthesis of 
these four 3,6-dideoxysugars begin with glucose-1-phosphate (1), which is activated to 
form CDP-D-glucose (19).  After the formation of the common intermediate CDP-6-
deoxy-4-keto-glucose (20), C-3 deoxygenation occurs, which is catalyzed by a 
combination of a 3-dehydrtase and a reductase.  After C-3 deoxygenation, the four 
biosynthetic pathways diverge from each other: a 5-epimerization and a 4-ketoreduction 
lead to the formation of CDP-L-ascarylose (80); two ketoreductases with different 
stereospecificities catalyze the 4-ketoreduction of CDP-3,6-dideoxy-4-keto-glucose to 
form CDP-D-abequose (76) and CDP-D-paratose (77), respectively; and a 2-epimerase 
catalyzes the conversion from CDP-D-parotose (77) to CDP-D-tyvelose (78).  It is 
worthwhile to note that although 3-, 5-, or 3,5-epimerization occurs often in the 
biosynthetic pathways of deoxysugars, as has been described for the biosynthesis of 6-
deoxy and 2,6-dideoxysugars, the occurrence of 2- or 4-epimerases is relatively rare.24,108
21
L-Colitose is a component of the LPS of E. coli O111.  The biosynthetic pathway 
of GDP-L-colitose (54) is quite similar to that of the CDP-L-ascarylose (80).  The 
functional characterization of each enzyme in the GDP-L-colitose (54) biosynthetic 
pathway has been completed due to the efforts of our group.69  First, GDP-D-mannose-
4,6-dehydratase converts GDP-D-mannose (12) to GDP-6-deoxy-4-keto-mannose (13).  
Then C-3 is deoxygenated by the action of ColD.  ColD is different from E1 and its close 
homologues in that ColD does not require a reductase protein, like E3, to catalyze this 
transformation.  The final enzyme, ColC has dual functions as an epimerase and a 
reductase, catalyzing 5-epimerization and the subsequent 4-ketoreduction to form the 
product, GDP-L-colitose (54).69
D-Mycaminose has been found to be a part of the structure of the well-studied 
antibiotic tylosin.86,109  This antibiotic is produced by Streptomyces fradiae and is 
commonly used as an antibiotic in veterinary medicine.  In the biosynthesis of TDP-D-
mycaminose (52), after the formation of TDP-6-deoxy-4-keto-glucose (3), an isomerase 
catalyzes the conversion of TDP-6-deoxy-4-keto-glucose (3) to TDP-6-deoxy-3-keto-
glucose (50).  Next, an amino group is attached to the C-3 position in a transamination 
reaction catalyzed by TylB.  The last step is TylM1 catalyzed N,N-dimethylation.109
A polyene macrolide consists of a large macrolactone ring that has a characteristic 
series of conjugated double bonds, as well as an exocyclic carboxyl group and a 
deoxysugar.  D-Mycosamine has been found to be the deoxysugar component in several 
antifungal polyene macrolides, such as pimaricin, nystatin A1, amphotericin B, and 












































































































































biosynthetic pathway of GDP-D-mycosamine (56) begins with the formation of GDP-6-
deoxy-4-keto-mannose (13) in a manner identical to that previously described.  Next, an 
isomerase whose encoding gene has not been identified, catalyzes the formation of GDP-
6-deoxy-3-keto-mannose (55).  Finally, an amino group is attached to the C-3 position of 
the hexose to form GDP-D-mycosamine.110,111
Biosynthetic Pathways of 2, 3, 6 -Trideoxysugars (Scheme 1-5)
The 2,3,6-trideoxysugars can be found in many antibiotics and antitumor drugs.  
The replacement of the three hydroxyl groups on the hexose with a range of functional 
groups creates a structurally diverse class of deoxysugars.  Accordingly, natural products 
carry 2,3,6-trideoxysugars have shown to display interesting biological activities.113
The first example of a 2,3,6-trideoxysugar discussed here is the widely observed 
sugar L-rhodinose.  L-Rhodinose is a component of many antibiotic and antitumor drugs, 
such as landomycin A, urdamycin A and granaticin.70,112,113  Landomycin A, the principle 
secondary metabolite of Streptomyces cyanogenus, is the largest angucycline known thus 
far, and the most active landomycin derivative.  As shown in Figure 1-7, L-rhodinose 
occurs as the third and the terminal sugar unit in the sugar chain attached to the 
polyketide of landomycin A.  Urdamycin A is also an angucycline antibiotic, and is 
produced by Streptomyces fradiae.  It consists of a polyketide moiety, an O-glycosidyl 
linked L-rhodinose moiety and a C-C connected trisaccharide chain.  Granaticin and the 
related metabolites, dihydrogranaticin, granaticin B and dihydrogranaticin B are 
produced by Streptomyces violaceoruber. One D-olivose sugar unit is unusually attached 
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to the aromatic polyketide via two C-C bonds at 9-C and 10-C and an L-rhodinose is 
linked to the D-olivose by a conventional glycosidic bond. 
In the proposed biosynthetic pathway of L-rhodinose, TDP-6-deoxy-4-keto-
glucose (3) is formed first, and is then converted to TDP-2,6-dideoxy-4-keto-glucose (24) 
by the sequential catalysis of a 2,3-dehydratase and a 3-ketoreductase.  Next, the 3-
hydroxyl group is removed by a 3-deoxygenase to form TDP-2,3,6-trideoxy-4-keto-
glucose (25), which is also called TDP-D-cinerulose.  The final two steps in the 
biosynthetic pathway are 5-epimerization, the product of which is TDP-L-cinerulose (26), 
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Figure1-7.  Structures of urdamycin A, granaticin and landomycin A.
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The polyether polyketide nanchangmycin is an antibiotic produced by 
Streptomyces nanchangensis NS3226.  The complete biosynthesis gene cluster of the 
antibiotic has been sequenced.114  4-O-Methyl-L-rhodinose is a sugar component in the 
structure of nanchangmycin.  The biosynthetic pathway of TDP-4-O-methyl-L-rhodinose 
(28) is proposed to be the same as that of TDP-L-rhodinose except an additional O-
methylation step after the formation of TDP-L-rhodinose (27).  From the preliminary 
analysis, the 4-hydroxyl group is methylated before the sugar unit is attached to the 
polyketide aglycone.114
Streptomyces peucetius and other Streptomyces strains are producers of 
daunorubicin and doxorubicin, both of which are clinically important drugs.  Both of 
these two antibiotics contain the deoxysugar L-daunosamine.  The daunorubicin 
biosynthetic gene cluster has been sequenced, and the functions of most of the genes in 
the cluster have been assigned based on sequence analysis.  There have also been 
heterologous expression and bioconversion experiments showing the minimum set of 
genes required for daunosamine biosynthesis and attachment.115  In the absence of any 
biochemical characterization of these gene products, two possible pathways for the 
biosynthesis of TDP-L-daunosamine (31) have been suggested.  In both pathways, the 
activated TDP-6-deoxy-4-keto-glucose (3) is formed first.  In one pathway, the steps 
following the formation of TDP-6-deoxy-4-keto-glucose are 3,5-epimerization (36), 2,3-
dehydration (37), 3-transamination (38) and 4-ketoreduction (31), in that order.  In the 
other proposed pathway, the reaction sequence is 2,3-dehydration to form TDP-6-deoxy-
3,4-diketo-glucose (23), followed by direct 3-transamination (29), 5-epimerization (30) 
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and 4-ketoreduction (31).  The two pathways differ in the step in which 5-epimerization 
occurs.  The establishment of the correct biosynthetic pathway of TDP-L-daunosamine 
(31) must await biochemical characterization.  However, it should be noted that in the 
deoxysugar biosynthetic pathways containing an epimerization step that have been fully 
or partially biochemically established, epimerization reactions generally occur in late 
steps.24,115
Aclarubicin, isolated from Streptomyces galilaeus, has remarkable cytotoxic 
activity and is a member of the anthracycline antibiotic family.  Aclarubicin consists of 
an aklavinone aglycone and a trisaccharide moiety, which includes the 3-amino-2,3,6-
trideoxysugar rhodosamine.115  The structure of L-rhodosamine is similar to that of L-
daunosamine but with two methyl groups attached to the amino.  The methylation is 
suggested to occur before the sugar is transferred to the polyketide aglycone.  Therefore, 
the biosynthetic pathway of TDP-L-rhodosamine (32) is proposed to be identical to that 
of TDP-L-daunosamine (31), but with the addition of a final N,N-dimethylation step.115
D-Angolosamine is the sugar component of the aromatic antibiotic medermycin.  
Medermycin was isolated from Streptomyces sp. AM-7161 and has proved to be very 
effective against gram-positive bacteria.127  In the biosynthetic pathway of TDP-D-
angolosamine (35), TDP-6-deoxy-4-keto-glucose (3) is proposed to undergo 2,3-
dehydration (23) followed by 3-transamination (33).  The amino group thus formed has 
an equatorial orientation (33).  The subsequent 4-ketoreduction (34) and 3-N,N-
dimethylation complete the formation of TDP-D-angolosamine (35).127
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Nogalamycin is an anthracycline antibiotic produced by Streptomyces nogalater.  
Nogalamine is a 3,6-dideoxy-3-N,N-dimethyl-aminosugar that forms part of the structure 
of nogalamycin.  The entire biosynthetic gene cluster of nogalamycin has been cloned 
and sequenced.  The genes that are involved in nogalamine formation have been 
identified by gene deletion studies.  Functions of some of the genes have been assigned 
based on the results from the deletion studies. Surprisingly, it was discovered that the 
sugar unit is synthesized as 2-deoxynogalamine before being transferred to the polyketide 
of nogalamycin.116  The discovery of the genes involved in 2-deoxygenation in the sugar 
biosynthetic pathway is consistent with this conclusion.  Thus, the proposed biosynthetic 
pathway of 2-deoxynogalamine has been suggested: the enzymes encoded by snogJ and 
snogK catalyze the formation of TDP-6-deoxy-4-keto-glucose (3) from glucose-1-
phosphate (1) which then becomes the substrate of the 3,5-epimerase encoded by snogF.  
Next, a 2,3-dehydratase, probably encoded by gene snogH, catalyzes the formation of the
unstable intermediate, TDP-2,6-dideoxy-3,4-diketo- L-glucose (37) that undergoes 
transamination at C-3 by the action of the gene product of snogJ.  The subsequent steps 
are 4-ketoreduction and 3-N,N-dimethylation.  The enzyme encoded by snogG catalyzes 
the 4-ketoreduction based on sequence analysis while interestingly, both snogA and 
snogX encode putative N-methyltransferases.  Thus, the attachment of the two methyl 
groups to the amino might be completed by two individual enzymes, which is different 
from the previously described N,N-dimethylations that are thought to be catalyzed by a 
single enzyme.  The 2-oxygenase that is required to regenerate the 2-hydroxyl group at 
C-2 in nogalamine has not yet been identified.116
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Vancomycin has been used as the last line of antibiotic to treat bacterial strains 
that have become drug-resistant.  Vancomycin belongs to the glycopeptide antibiotic 
family whose aglycone is made of an oligopeptide with several crosslinked amino acids.  
A disaccharide chain is attached to the phenolic oxygen of the tyrosine residue of the 
aglycone.  The biosynthetic gene cluster of vancomycin has been cloned and sequenced.  
A biosynthetic pathway for the terminal sugar of the disaccharide chain, named L-
vancosamine, has been suggested.  After the formation of TDP-6-deoxy-4-keto-glucose 
(3), 3,5-epimerization (36) followed by 2,3-dehydration leads to the formation of the 
unstable TDP-2,6-dideoxy-3,4-diketo-L-glucose (37), as was proposed for nogalamine 
biosynthesis.  The keto group at C-3 then undergoes transamination (40) followed by 3-
C-methylation (41) as occurs in nogalose, D- and L-mycarose biosynthesis.  The final step 
is 4-ketoreduction to give TDP-L-vancosamine (42).117







































Scheme 1-6.  TDP-D-desosmaine biosynthetic pathway.
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Desosamine has been found to be a sugar component of many natural products, 
such as erythromycin produced by Saccharopolyspora erythraea, oleandomycin 
produced by Streptomyces antibioticus, and methymycin, neomethymycin, narbomycin 
and picromycin produced by Streptomyces venezuelae (ATCC 15439).  The presence of 
the desosamine is essential to the antibiotic potency and specificity of these compounds.  
Structural changes of this sugar unit in these compounds can severely compromise their 
capacities as antibiotics.  The biosynthetic gene cluster of desosamine has been cloned 
and sequenced, and the biosynthetic pathway established due mainly to the efforts of our 
group.  Genes desIII and desIV encode a TDP-D-glucose synthase and a TDP-D-glucose-
4,6-dehydratase, respectively.  These two enzymes together convert glucose-1-phosphate 
(1) to TDP-6-deoxy-4-keto-glucose (3).  Next, the aminotransferase DesI catalyzes 
addition of an amino group to C-4.  Subsequently, DesII catalyzes the formation of TDP-
4,6-deoxy-3-keto-glucose (58).  It had been unclear whether C-4 aminotransfer was a step 
in the biosynthetic pathway until in vivo gene deletion studies unambiguously established 
the functions of the gene products of desI and desII.  Next, another aminotransferase 
encoded by desV catalyzes a transamination reaction at C-3.  Finally, further 3-N,N-
dimethylation leads to the formation of TDP-D-desosamine (60).72
Diverse sugar structures have been discovered during the past twenty years as a 
result of searching for more powerful antibiotics in order to counteract the increasingly 
serious problem of antibiotic resistance.  These discoveries are also the result of intensive 
studies on cell-cell interaction, recognition and immunospecificity designed to find 
effective anti-tumor and anti-cancer drugs.  Much progress has been made in these fields, 
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but much work remains.  With ongoing research in relevant fields, increasing numbers of 
sugar structures are being identified.  However, studies of the biosynthesis of naturally 
occurring sugars are in many cases inadequate, and conclusive information is limited.  
The number of the genes whose functions have been confirmed by in vivo gene deletion 
studies and/or by in vitro enzymatic characterization, is still small considering the vast 
amount of genes that might be involved in the biosynthesis of deoxysugars.  Most of the 
biosynthetic pathways that have been discussed are only speculative, and are often solely 
based on sequence analysis.  It is possible that the actual pathways may be different from 
those that have been suggested since some genes whose products are proposed to catalyze 
certain steps in the pathway, have not yet been verified.  It is also possible that the 
reaction sequences that have been suggested may vary from the actual biosynthetic 
pathways. 
3.  C-O BOND CLEAVAGE IN THE BIOSYNTHESIS OF DEOXYSUGARS
As explained previously, deoxysugars, which have hydroxyl groups on the sugar 
replaced with hydrogens display different biological activities compared with their parent 
sugars, and are frequently utilized in the biosynthesis of bacterial cell wall and in the 
construction of natural products to convey immunogenic activity and biological 
specificity.  Thus, the mechanistic logic involved in the C-O bond cleavage has attracted 
much attention and has been an active field of carbohydrate research.52,53  Years of 
studies have expanded our understanding of the intricacies of deoxygenation 
mechanisms: no single mechanism can apply to all deoxygenation reactions; multiple 
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machineries are possible depending on the structure of the substrate and the site of 
deoxygenation on the sugar ring.  A more underlying reason why different mechanisms 
are involved is that the carbon atoms where the hydroxyl groups are attached to are 
differentially activated.  In the case of 2-deoxyribose biosynthesis, to break an 
unactivated C-O bond, a protein radical must previously be generated to facilitate the 
formation of the substrate radical.76,77  As for C-O bond cleavage at C-2 and C-3 of a 
hexose, the substrate must be activated by the presence of a 4-keto functional group.  C-2 
and C-3 are at α and β positions relative to the keto group respectively.  The removal of 
the hydroxyl group at C-2 usually goes through a β-elimination/reduction mechanism,70,71
while that at C-3 needs further activation by the enzyme cofactor PMP/PLP.63,64,69  The 4-
keto group in the substrate first forms a Schiff base with the amine group of PMP.  After 
deprotonation at C-4’ of PMP, the high reduction potential of the PMP pyridine provides 
the driving force for the α-hydroxyl detachment.  The overall reduction of the sugar 
substrate is balanced by the oxidation of another substrate.  For the mechanisms that have 
been clarified, the other substrate can be either a simple L-glutamate which is oxidized to 
α-ketoglutarate, or it can be a reducing agent such as NAD(P)H, whose electrons are 
transferred through a reductase to the PMP-substrate complex by a radical mechanism.  
Although the substrate for C-O bond cleavage at C-6 position is not an activated keto-
hexose, the well-studied mechanism has demonstrated that the first ministep in the 
reaction is indeed the formation of the 4-keto group which facilitates the later β-
elimination/reduction.  The 4-keto form is retained in the product structure, thus 
activating the sugar to achieve the subsequent conversions.  The C-O bond cleavage at C-
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4 is rare compared with that at other positions of the hexose.  More evidence is required 
to completely decode the mechanism of 4-deoxygenation.  Nevertheless, it has been well 
accepted that an activated PMP/PLP-substrate complex is an obligatory intermediate in 
its mechanism.72
C-O Bond Cleavage at the C-6 of Hexose (Figure 1-8)
C-6 deoxygenation, catalyzed by a NAD+-dependent NDP-hexose 4,6-
dehydratase, commonly named Eod, is the first committed step in the biosynthetic 































Figure 1-8 .  Mechanism of C-6 deoxygenation catalyzed by Eod. Adapted 
from He, X. M. et al. Curr. Opin. Chem. Biol. 2002, 6, 590.
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corresponding NDP-6-deoxy-4-keto-hexose (64) through the catalysis of Eod.  The 
reaction involves a three-step sequential mechanism and requires the involvement of the 
cofactor NAD+.  The first step is the regiospecific oxidation of the substrate NDP-D-
hexose to form NDP-4-keto-hexose (62) with the concomitant formation of NADH.  A 
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water molecule is then eliminated across C-5 and C-6 (63).  Since the first step has 
formed the activated NDP-4-keto-hexose, the water elimination in the second step is 
initiated by proton abstraction at C-5.  The third step is the reduction of the NDP-4-keto-
∆5,6-glucoseen (63) intermediate by NADH to give the final product NDP-6-deoxy-4-
keto-hexose (64).  Clearly, Eod is a multifunctional enzyme, possessing keto oxidase, 
dehydratase and enoyl reductase activities.52,53,118,119
The analysis using stereospecifically radio-labeled NAD+ has showed that the 
internal hydride transferred to and from NAD+ is pro-S specific.122  By monitoring the 
solvent isotope exchange, when the reaction is carried out in D2O or H2
18O, it has been 
concluded that the β-hydroxy elimination by dehydration is a concerted reaction.123
Studies of the stereochemical course of this reaction have demonstrated that the 
dehydration across C-5/C-6 happens with syn elimination stereochemistry, while the 
reduction of the double bond in the enoyl intermediate proceeds in an anti manner.120-122
Because NAD+ is regenerated at the end of each catalytic cycle, Eod belongs to a 
small group of enzymes whose pyridine nucleotide coenzyme is a genuine prosthetic 
group.  Site-directed mutagenesis and kinetic studies have demonstrated the importance 
of residue Asn190, His232 and Tyr160 that are conserved between E. coli Eod and a 
mechanistically related enzyme, UDP-galactose-4-epimerase.  Based on the available 
crystal structure of UDP-galactose-4-epimerase, it is speculated that the side chains of 
Asn190 and His232 may play important roles in facilitating hydride transfer between the 
sugar substrate and the nicotinamide cofactor; Tyr160 is likely to be the general base that 
deprotonates the 4-OH with the assistance of Thr134 and Lys164 via a proton relay 
34
network.  The importance of Asp135, Glu146, Glu198, Lys199 and Tyr301, which are 
only conserved among 4,6-dehydratases, have also been verified by mutagenesis and 
kinetic studies. 67,124-126,128
C-O Bond Cleavage at the C-2 of Hexose (Figure 1-9)
The 2-hydroxyl elimination has been successfully characterized in the 
biosynthetic pathways of two deoxysugars, L-mycarose and L-rhodinose.70,71  After TDP-
6-deoxy-4-keto-glucose is formed, the hydroxyl group at C-2 is at the β position relative 
to the 4-keto group.  As in the case of 6-deoxygenation, the detachment of the β-hydroxyl 







































































Figure 1-9 .  Mechanism of C-2 deoxygenation.  Adapted from He, X. M. et al. Curr.








For the biosynthesis of both L-mycarose and L-rhodinose, the α proton at C-3 
position of TDP-6-deoxy-4-keto-glucose is acidic and can be easily abstracted by a base 
from the enzyme.  The instability of the thus-formed enediolate intermediate drives the 
elimination of the 2-hydroxyl group to occur in either a concerted or a stepwise manner 
(65).  The enzymes catalyzing the dehydration step are TylX3 and Gra Orf27 in the 
biosynthetic pathways of L-mycarose and L-rhodinose, respectively.  Some initial 
characterization of TylX3 has shown that the enzyme is a Zn2+-dependent dehydratase.71
The Zn2+ ion could be responsible for polarizing the C-4 keto group of the substrate in 
order to ease the generation of an enolate, which would be used to expel the 2-hydroxyl 
group.  Another possibility is that it could serve as an active site Lewis acid to assist the 
departure of the hydroxyl group at C-2.  The actual role of Zn2+ in TylX3 catalysis is still 
not understood and further investigation is required.  TylX3 has a high degree of 
sequence similarity to several deduced enzymes from antibiotic biosynthetic gene 
clusters, such as EryBVI in the erythromycin pathway, LanS in the landomycin pathway, 
Orf23 in the vancomycin pathway, SnogH in the nogalamycin pathway, and DnmT in the 
daunorubicin pathway.  Accordingly, it is possible that each of these enzymes plays a role 
as a Zn2+-dependent dehydratase catalyzing C-2 deoxygenation in each respective 
deoxysugar biosynthetic pathway.47,99,103,113,117,116
The dehydration product of TylX3 (65) is unstable.  Without the immediate action 
of the following enzyme in the biosynthetic pathway, the dehydration product easily 
degrades to form maltol (66) and TDP.70,71  The identity of maltol (66) has been 
confirmed by comparing the HPLC retention time and 1H-NMR to those of the authentic 
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sample.  Therefore, the following reduction step must happen instantly after the 
dehydration product is formed.  In the biosynthesis of L-mycarose and L-rhodinose, 
TylC1 and Gra Orf26 are the reductases in their respective pathways.  It has been 
assumed that TylX3 and TylC1 form a complex in vivo and that the dehydration product 
(65) formed by the catalysis of TylX3 is transferred to the reductase TylC1 through an 
internal channel.  However, yeast two-hybrid analysis failed to detect an interaction 
between TylX3 and TylC1.  This might be because the interaction between the two 
proteins is fairly weak, and that the two-hybrid system is not sensitive enough to detect 
the interaction.  The existence of a protein–protein interaction between the dehydratase 
TylX3 and the reductase TylC1 is a favorable explanation to the puzzle of how 
degradation of the dehydration product is avoided in the 2-deoxysugar biosynthesis.  
More examination of the interaction between the two proteins is necessary.  However, in 
the absence of solid evidence for the interaction, other explanations should not be 
excluded.  
Although 2-deoxygenation in the biosynthesis of L-mycarsoe and L-rhodinose 
occurs through the same β-elimination/reduction mechanism, the stereochemistry of the 
reformed 3-hydroxyl group in the product is different.  The hydroxyl group in the Gra 
Orf27/Gra Orf26 product (24) is equatorial while that in the TylX3/TylC1 product (28) is 
axial.  Having an intermediate with a relatively high-energy axial group in the L-
mycarose pathway could be beneficial in that it may facilitate the subsequent C-3 
























































































































Figure 1-10 .  E1/E3 catalyzed C-3 deoxygenation.  Adapted from 





TylC1 acts as a typical ketoreductase and contains a Rossman fold 
(277GXXGXXXG284) near its C-terminus.  It is likely a member of the long-chain alcohol-
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dehydrogenase (ADH) family.  The TylC1 reaction with (4S)-[4’-2H]NADPH as 
reductant has indicated that the hydride transfer from NADPH is pro-R specific.129  While 
TylX3 and Gra Orf27 share substantial sequence similarity, TylC1 and Gra Orf26 lack 
significant sequence similarity, which could explain the different stereochemistry of the 
hydroxyl groups in their products and might also indicate that the two enzymes have 
different evolutionary origins. 
C-O Bond Cleavage at the C-3 of Hexose 
E1/E3 Radical Mechanism (Figure 1-10)
The biosynthesis of 3,6-dideoxy hexoses has drawn particular attention.  3,6-
Dideoxyhexoses have been found primarily at the non-reducing terminus of the O-
antigen of the lipopolysaccharide on the outer cell membrane of many Gram-negative 
bacteria.  The presence of 3,6-dideoxyhexoses in the O-antigen is considered to be the 
primary determinant of microbial pathogenicity and virulence.  The 3,6-dideoxyhexoses, 
like 2,6-dideoxyhexoses, are derived from the common precursor NDP-6-deoxy-4-keto-
hexose.  However, deoxygenation at C-3 is mechanistically different from those at C-2 
and C-6.  The deoxygenation at C-2 and C-6 eliminates the β-OH group relative to the 4-
keto in the hexose.  The 4-keto group is either present in the substrate as in the case of C-
2 deoxygenation, or is formed in the earlier catalytic steps as in the case of C-6 
deoxygenation.  In contrast, the C-3 deoxygenation occurs at the α-carbon relative to the 
4-keto group.  Because of the efforts of our group, along with the early work of 
Strominger and coworkers, the enzymatic mechanism of the C-3 deoxygenation in the 
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biosynthesis of CDP-ascarylose has been unraveled.  The 3-deoxygenation on CDP-6-
deoxy-4-keto-hexose is mediated by two enzymes: CDP-6-deoxy-L-threo-D-glycero-4-
hexulose-3-dehydratase (E1) and CDP-6-deoxy-L-threo-D-glycero-4-hexulose-3-
dehydratase reductase (E3).  The E1 enzyme is a pyridoxamine 5’-phosphate (PMP) 
dependent, [2Fe-2S] containing dimeric enzyme.  The [2Fe-2S] cluster exhibits slightly 
rhombic symmetry (g1 = 2. 012; g2 =1.950; and g3 = 1.932).
58,65  Different from other 
coenzyme B6-dependent enzymes, whose cofactor pyridoxal 5’-phosphate (PLP) is 
covalently linked to a conserved lysine residue, PMP in E1 is non-covalently bound and 
the conserved lysine residue is replaced with His220.55  In the E1 catalyzed reaction, PMP 
first forms a Schiff base with the 4-keto group of the substrate (67).  Then, the pro-S C-4’ 
hydrogen of the PMP-ketimine complex is abstracted by base His220 (68), triggering the 
expulsion of the C-3 hydroxyl group and producing the transient PMP-∆3,4-glucoseen 
intermediate (69).63  The nearby His222 may substitute for His220 as base, since the 
H220A mutant of E1 still demonstrates certain activity.
55  When the reaction was 
conducted with radio labeled PMP, (4S)-[4’-3H]PMP or (4R)-[4’-3H]PMP, only the 
solvent in the reaction with (4S)-[4’-3H]PMP was enriched with the radioactivity.  This 
demonstrates that the proton abstraction from the C-4’ of the PMP-ketimine complex (67) 
is pro-S specific.63  It was also found that the replacement of the 3-OH group with a 
solvent hydrogen proceeds with retention of the configuration.63  Up to this point, the E1-
catalyzed reaction is reversible.  Without further driving force, the desired product CDP-
3,6-dideoxy-4-keto-glucose could not be stably formed.  The reversibility of the E1
catalyzed reaction was confirmed by the reaction conducted in [18O]H2O.
63  Both the C-3 
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and C-4 positions of the recovered substrate incorporated 18O as judged by GC-MS, with 
the equilibrium strongly favoring the starting material.  The reduction of the glucoseen 
intermediate followed by the release of the 3,6-dideoxysugar is achieved by the other 
enzyme, E3.  
E3 is an electron transfer protein, closely resembling many iron-sulfur 
flavoproteins in the ferredoxin-NADP+ reductase (FNR) family.56  The reduction of the 
glucoseen intermediate is most effectively mediated by E3, but other electron transfer 
systems such as diaphorase and methane monooxygenase are competent as well, but with 
much lower efficiency.63  Chemical reductant dithionite can also provide the required 
electrons and transfer them directly to the glucoseen intermediate under anaerobic 
conditions.66  The CDP-3,6-dideoxy-∆3,4-glucoseen intermediate (69) is reduced by the 
two electron equivalents in a step-wise manner.  The ultimate reducing agent NADH 
provides the two electron equivalents in a hydride form to the FAD cofactor of E3.  The 
cofactor FAD, which is capable of transferring either a single electron or two electrons, 
functions as the 2e-/1e- switch and delivers the electrons one at a time to the [2Fe-2S] 
center, which is an obligatory one-electron redox coenzyme in E3.  The single electron is 
next delivered to the [2Fe-2S] center in E1, where the electron is used to reduce the 
glucoseen intermediate.  Since the complete reduction of the glucoseen intermediate 
requires two electron equivalents, the molar ratio between the substrate CDP-4-keto-6-
deoxy-D-glucose and NADH should be 1:1.  The E1/E3-catalyzed reaction involves single 
electron transfer and entails the formation of radical intermediates (71).  Characterization 
of the assumed radical intermediates has been pursued via stopped-flow 
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spectrophotometry and rapid freeze-quench EPR spectroscopy.62,68  When [4’,5’-
2H4]PMP-reconstituted E1 was used in the reaction, the radical signal was narrowed by 3 
G as compared with that of a reference spectrum obtained by using non-labeled PMP.  
Moderately large 2H hyperfine couplings were found to exist between the unpaired 
radical and the deuterium of the labeled PMP in pulsed ENDOR spectroscopy.  The 
combination of these studies provides compelling evidence for the radical formation in 
the mechanism of the E1-E3 reaction and unambiguously locates the radical on the PMP 
skeleton.
E1 shows a high degree sequence similarity to quite a few enzymes that are 
suggested to be involved in the biosynthesis of 3,6-dideoxysugars.  The elucidation of the 
E1/E3 mechanism may be useful in understanding the functions of homologous enzymes 
and may be beneficial in establishing other 3,6-dideoxysugar pathways.  Mechanistically, 
the involvement of PMP in a radical-mediated reduction makes E1 unique among 
coenzyme B6-dependent enzymes. 
α-Elimination by Coenzyme B6 (Figure 1-11)
Several genes in the 3-deoxysugar biosynthesis gene clusters are considered to



















































Figure 1-11 .  ColD catalyzed C-3 deoxygenation.  Adapted from Beyer, N. et al. J. Am. 




enzyme encoded by colD in the biosynthetic gene cluster of GDP-L-colitose, is also 
assigned as a 3-deoxygenase, but the sequence similarity among ColD and E1 and its 
homologs is only moderate.  The fact that ColD alone catalyzes 3-deoxygenation might 
suggest that the ColD-catalyzed reaction in the biosynthetic pathway of GDP-L-colitose, 
a 3,6-dideoxyhexose found in the O-antigen of the gram-negative lipopolysaccharides, 
has a different mechanism from the E1-catalyzed reaction.  ColD is a coenzyme B6-
dependent enzyme.  However, the lysine residue that is conserved among PLP-dependent 
enzymes and is the site of linkage to PLP, is replaced by a histidine residue in ColD.  
Such a substitution also occurs in E1, and has been considered a characteristic unique to 
PMP-dependent enzymes.  Different from the E1/E3 catalyzed reaction, the ColD-
catalyzed reaction requires only an amino donor and no auxiliary protein.  These 
differences are reasonable in light of the low level of sequence identity between ColD 
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and E1, and are also consistent with the fact that a gene encoding E3 homolog was not 
identified from the L-colitose biosynthetic gene cluster.69  In the first step of the ColD 
reaction mechanism, the cofactor PMP is thought to form a Schiff base (81) with the 4-
keto group of GDP-6-deoxy-4-keto-mannose (13).  Next, deprotonation of C-4’ of the 
ketimine complex forces the repulsion of the 3-hydroxyl group (82), which is at the α
position relative to the keto group.  Next, PLP is released from the complex and 
regenerated to become PMP, with the concomitant conversion of L-glutamate to α-
ketoglutarate.  Finally, by the action of water, the ammonia is discharged from the hexose 
(84) and the 4-keto group is restored.  The overall reaction can be considered as a α-
elimination reaction, one of the various types of reactions in which the versatile 
coenzyme B6 plays an important role.  Further experiments showed that L-glutamate is a 
better amino donor than L-glutamine and L-alanine, while D-glutamate and L-aspartate 
are inactive as cosubstrates.130  The reversibility and stereochemistry of the reaction was 
studied by incubation with radioactivity-labeled PMP.131  When the reaction was 
conducted with (4R)-[4’-3H]PMP, radioactivity could be found in the solvent after the 
substrate, cofactor, and enzymes were removed.  Unlike E1, the pro-R hydrogen at C-4’ 
of the ketimine is removed in the reaction.  The utilization of PMP instead of PLP in a 
dehydration reaction is rare.  Also, its combined deoxygenation-transamination activity 
distinguishes ColD as a unique enzyme.69










































































































































Figure 1-12 .  DesII (DesI) catalyzed C-4 deoxygenation. (a) collaboration between DesI and 
DesII. (b) sequential action of DesI and Des II.  Adapted from He, X. M. et al. Curr. Opin. 













The conversion of TDP-6-deoxy-4-keto-glucose (3) to TDP -4,6-dideoxy-3-keto-
glucose (58) is an intriguing process in the biosynthetic pathway of desosamine, a sugar 
component of several antibiotics produced by various Streptomyces strains, such as 
methymycin, pikromycin, and erythromycin.  The TDP-desosamine biosynthetic gene 
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cluster has been cloned and sequenced.  Based on sequence analysis, the desIII encoded 
enzyme is a glucose-1-phosphate thymidylyltransferase while that encoded by desIV is a 
TDP-glucose-4,6-dehydratase.  The enzymatic functions deduced from the sequences of 
desV, desVI and desVII are aminotransferase, methyltransferse, and glycosyltransferase, 
respectively.  They are the enzymes catalyzing the late steps in the pathway.  From 
sequence analysis, the enzyme encoded by desI has a coenzyme B6 binding site and that 
encoded by desII should contain an iron-sulfur center.  Initially, it was proposed that 4-
hydroxyl group elimination begins with isomerization, possibly catalyzed by the enzyme 
encoded by desVIII.  The isomerization product, TDP-6-deoxy-3-keto-glucose would 
then undergo α-hydroxyl group elimination to remove the 4-OH group which is at the α-
carbon relative to the 3-keto group.  It was assumed that the deoxygenation mechanism 
should be similar to that of the E1/E3 reaction: DesI would play the role of dehydratase by 
forming a PMP-substrate complex, while DesII would act as a reductase analogous to E3, 
transferring electrons from a reducing agent, possibly NADH.  However, neither the 
proposed dehydrase/reductase function of DesI/DesII nor the isomerase function of 
DesVIII could be demonstrated by in vitro enzymatic assays.  In vivo gene disruption
experiments were carried out for the genes encoding DesI and DesII and yielded 
interesting results.  If C-4 deoxygenation followed a similar path to C-3 deoxygenation, 
the phenotypes of desI and desII deletion mutants should have been the same.  However, 
while macrolide analogues carrying a quinovose (85) were isolated from the fermentation 
broth of the KdesI mutant, macrolides containing an N-acetylated 4-aminosugar (86) 
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were produced by the KdesII mutant (Figure 1-13).49,72  The fact that deletion of desII
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Figure 1-13 . In vivo desI and desII deletion studies.  Adapted from He, X. M. 
et al. Curr. Opin. Chem. Biol. 2002, 6, 590.
production of a 4-aminosugar provided initial evidence indicating that DesI is a 4-
aminotransferase.  The in vitro enzymatic reaction, including the Eod product, DesI and an 
amino donor, such as L-glutamate, indeed produced TDP-4-amino-4,6-dideoxy-glucose.  
The formation of an amino group at the site where the de oxygenation should occur 
differentiates the mechanism of C-4 deoxygenation by DesI/DesII from that of C-3 
deoxygenation catalyzed by E1/E3.  
Bioinformatic analysis by H. J. Sofia lists DesII as a SAM radical -dependent 
enzyme,132  although the consensus peptide sequence where SAM binds has not been 
ascertained for DesII.  However, X-ray crystallographic studies revealed that SAM 
radical binds close to a [4Fe-4S] center in biotin synthase, another SAM radical enzyme 
which has been well studied.  Most SAM radical dependent enzymes contain a [4Fe-4S] 
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center, the binding motif of which has been established as CXXXCXXC.  In the sequence 
of DesII, this [4Fe-4S] binding motif has been identified.  This provides additional 
evidence that DesII is not a homolog of E3, which contains a [2Fe-2S] center. 
In summary, C-4 deoxygenation may require SAM and the [4Fe-4S] center from 
DesII and the coenzyme B6 from DesI, and go through a radical mechanism.  Although 
the detailed mechanism is still not clear, there are two propositions: one is that DesI and 
DesII collaborate in a single step (Figure 1-12 (a)); the other is that each enzyme 
catalyzes a separate step and the DesI product is the substrate of the DesII catalyzed 
reaction (Figure 1-12 (b)).  There has been one example where cofactors PLP, SAM, and 
[4Fe-4S] are all implicated in one reaction: the well-studied lysine 2,3-aminomutase 
catalyzed interconversion between L-lysine and L-β-lysine.133,134  DesI and DesII may 
cooperate to have a reaction mechanism similar to this reaction: the cofactor PMP from 
DesI may form a Schiff base (88) with the 4-keto group in TDP-6-deoxy-4-keto-glucose.  
The 5’-adenosyl radical then abstracts the hydrogen at C-3 through homolytic cleavage of 
the C-H bond and generates a radical at C-3 of the sugar.  By rearrangement, the radical 
first moves to the C-4’ of PMP and then to the C-4 of the sugar (90), while at the same 
time, the linkage site between PMP and the hexose is switched from the C-4 to the C-3 of 
the hexose.  The radical at the C-4 of the sugar then abstracts the hydrogen that has been 
taken away by the 5’-adenosyl radical to regenerate the SAM radical and complete the C-
O bond cleavage at C-4 (91).  In subsequent steps, PLP is released from the ketimine 
complex and elimination of a molecule of ammonia yields the final product TDP-4,6-
dideoxy-3-keto-glucose (58).  In the alternate hypothesis DesI and DesII work 
48
independently.  DesI is a 4-aminotransferase catalyzing the formation of TDP-6-dideoxy-
4-amino-glucose (57), while DesII catalyzes the elimination of the 4-amino group.  The 
DesII-bound SAM undergoes reductive cleavage to form the 5’-adenosyl radical, which 
initiates the reaction.  The 5’-adenosyl radical abstracts the hydrogen at C-3 of the hexose 
through homolytic cleavage of the C-H bond to generate a radical at the C-3 of the sugar 
(93).  Next, the hydroxyl group at C-3 is deprotonated to form an anion-radical 
intermediate (94).  Electron rearrangement converts the oxygen anion-carbon radical to 
the carbon anion-oxygen radical.  The instability of the latter drives the elimination of the 
amino group at the C-4 of the sugar.  Subsequently, the oxygen radical (95) abstracts the 
hydrogen that has been taken by the 5’-adenosyl radical.  The final rearrangement from 
the enolate (96) to the keto form gives the product of TDP-4,6-dideoxy-3-keto-glucose 
(58).53
The two proposals that have been described above are largely speculative and are 
only two among several possibilities.  The yeast two-hybrid system failed to confirm the 
formation of a DesI-DesII complex in vivo.135  However, it is still too early to eliminate 
the possibility that DesI and DesII work together to achieve deoxygenation at C-4.  For 
the sake of simplicity, it is worthwhile to note that whether DesI and DesII act together or 
independently, the overall reaction from TDP-6-deoxy-4-keto-glucose (3) to TDP-4,6-
dideoxy-3-keto-glucose (58) is a reductive one.  Consequently, the amino donor that 
regenerates PMP must be oxidized.  If the amino donor is L-glutamate, the oxidized 
product should be α-ketoglutarate. 





























































































































Figure 1- 14.  UDP-galactopyranose mutase catalyzed C-O bond cleavage at C-1.  Adapted from 








Sugars without an NDP group attached to the anomeric carbon exist in solution in 
an equilibrium between the linear form and the cyclized form.  Thus, bond cleavage 
between the anomeric carbon and the oxygen from the C-5 hydroxyl group of a pyranose 
or from the C-4 hydroxyl group of a furanose occurs quickly and easily without need of 
an enzyme.  However, once sugars are converted to NDP derivatives, the sugar ring 
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becomes more stabilized and usually does not reopen during the course of biosynthetic 
processing.  But C-O bond cleavage at the anomeric carbon, usually accompanied by ring 
contraction, does occur in a few rare cases through the actions of certain enzymes.  The
conversion from UDP-D-galactopyranose (97) to UDP-L-galactofuranose (107) catalyzed 
by the FAD-dependent UDP-galactopyranose (UDP-Galp) mutase is one example.73,74
Galactofuranose is an abundant component of the cell surface biomolecules of many 
microorganisms, including bacterial O-antigens, fungal exopolysaccharides, protozoal 
glycoproteins, and the cell walls of mycobacteria.136  UDP-Galp mutase-catalyzed UDP-
galactofuranose formation is mechanistically interesting.  When the enzyme is reduced by 
sodium dithionite, its catalytic efficiency increases significantly.  However, since the 
overall reaction exhibits no net change in the redox state of the substrates involved, it is 
puzzling how enzyme-bound FAD plays an active role in catalysis.  The mechanistic 
properties of FAD have been studied extensively and are relatively well characterized.  
FAD can accept and deliver either one electron or two electrons as an enzyme cofactor.  
As a result, an FAD-catalyzed reaction can go through either a radical or an anion 
intermediate.  To study the catalytic properties of UDP-Galp mutase, the enzyme was 
reconstituted with deaza-FADs.  It was found that the mutase reconstituted with FAD or 
1-deaza-FAD had comparable activities, while that reconstituted with 5-deaza-FAD was 
catalytically inactive.74  Because 5-deaza-FAD can only catalyze a two-electron process 
while FAD and 1-deaza-FAD can undergo both concerted two-electron and stepwise one-
electron reactions, the loss of the activity of the 5-deaza-FAD reconstituted enzyme 
supports the following proposed radical mechanism:74 FAD is first reduced to FADH-
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(100) by dithionite or other reducing agent in the actual system.  In a likely basic 
environment, the UDP of the substrate UDP-D-galactopyranose (97) is repelled by the 
electron donating effect from the ring-oxygen and an oxocarbenium (98) is formed.  The 
two-electron reduced FADH- (100) then transfers one of the electrons to the oxonium 
ring to form a radical at C-1 (99), with concomitant conversion of FADH- to the radical 
form FADH• (101).  The radical cofactor then loses one proton to form an anion radical 
delocalized on the isoalloxazine ring (102).  The radicals from the substrate and the 
cofactor are then quenched through formation of a covalent bond between the anomeric 
carbon and the N-5 of the isoalloxazine ring (103).  Next, the C-O bond at C-1 of the 
sugar ring is broken by the electron donating effect of N-5 to generate an imine 
intermediate (104).  The nucleophilic hydroxyl group at C-4 then forms a C-O bond with 
the electrophilic carbon of the ketimine to achieve the ring contraction (105).  Finally, the 
UDP is reattached to the anomeric carbon.  
The results from the pH dependence studies are consistent with the above 
proposal.  The activity of the UDP-Galp mutase that had been reconstituted with FAD 
increased considerably at high pHs.74  The basic environment may facilitate the departure 
of the UDP group and the deprotonation of the cofactor during the catalysis. 
C-O Bond Cleavage at the C-2 of Pentose 
The deoxygenation reactions that have been described thus far have one thing in 
common: the carbon where the C-O bond cleavage occurs has been activated by the 
formation of a nearby keto group.  The activation has either been achieved in formation 
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of the substrate, or is attained during the course of the catalysis.  The 4-keto group 
activates the α-carbon and β-carbon in C-2, C-3 and C-6 deoxygenation, while to 
accomplish deoxygenation at C-4, the 4-keto group is converted to a 4-amino by a 
transaminase to facilitate later bond cleavage.  Different from these courses, 
deoxygenation at the C-2 of pentose is not pre-activated by any functional group 
formation on the pentose ring.  The product, 2-deoxy- D-ribose, is used as the building 
block for DNA synthesis, and is also required for all DNA repairs.  Since DNA has 
existed since the early days of life on earth, it is obvious that the C-2 deoxygenation of 
pentoses has a tremendously long history.  Thus, enzymes catalyzing this reaction, which 
are called ribonucleotide reductase (RNR), have had considerable time to refine their 
catalytic mechanisms.  Interestingly, the several classes of RNRs known exhibit little 
sequence similarity, and follow several distinct mechanisms of C-2 deoxygenation of 
pentose. RNRs that have been identified thus far can be grouped into four classes.76,77
The classification is based on the cofactor requirements and the mechanism of formation 
of the thiyl radical, which is required to initiate unactivated C-O bond cleavage (Figure 1-
15).  Class I RNR enzymes contain a non-heme diiron center, which through complicated 
interactions with O2 is able to produce an intermediate tyrosine radical.  Homolytic 
cleavage of the S-H bond of a conserved cysteine residue quenches the tyrosine radical 
and simultaneously generates the necessary thiyl radical.  Class II RNRs use 
adenosylcobalamin, a vitamin B12 derivative, to catalyze the homolytic cleavage of the C-
H bond in order to form the thiyl radical.  The homolytic cleavage of the Co-C bond in 
the cofactor generates a 5’-adenosyl radical that abstracts a hydrogen from the active site 
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cysteine.  Class III RNRs contain an iron-sulfur center that is sensitive to O2, and a SAM 
molecule that is proposed to bind in the vicinity of the iron-sulfur center.  One electron 
equivalent is transferred through the iron-sulfur center to induce reductive cleavage of the 
SAM molecule to generate a molecule of methionine and a 5’-adenosyl radical.  The 














































Figure 1-15 . Four classes of RNRs all generate active thiyl radical, but differ from each other by 
the cofactor requirements.  Adapted from Kolberg, M. et al. Biochim Biophys Acta. 2004, 1699(1-
2), 1.
glycyl radical that is quenched by the hydrogen radical from S-H homolytic cleavage of 
the active site cysteine.  As a result, the thiyl radial, which is necessary to commence the 



















































































Figure 1-16 . RNRs catalzyed C-2-deoxygenation of pentose.  Adapted from Follmann, H.  Chem 




















center, are less characterized.  It is suggested that due to a complicated interaction with 
O2, an intermediate radical, possibly a tyrosine radical, is generated.  This radical then 
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abstracts the hydrogen from the S-H bond of an active site cysteine to yield the necessary 
thiyl radical. 
Once the thiyl radical is formed, the enzymes from the four different classes 
display a similar chemical strategy (Figure 1-16).77,78  The thiyl radical first abstracts the 
hydrogen from the C-3 of the pentose to form a radical on the sugar ring.  Next, 3-keto 
formation assisted by the active site glutamate through hydrogen bonding drives the 
elimination of the hydroxyl group at the C-2, which leaves as a H2O molecule.  At the 
same time, the single electron at C-3 is relocated to the C-2.  Next, the radical at the C-2 
abstracts a hydrogen from one of the two other active site cysteines.  It should be noted 
that neither of these cysteines is the one that generates the thiyl radical and abstracts the 
hydrogen from the C-3.  Disulfide bond formation between these two cysteines generates
a protein anion radical.  The extra electron, along with a proton, reduces the keto group at 
C-3 to a hydroxyl group.  Consequently, a C-3 radical is again generated.  The C-3 
radical then abstracts the hydrogen that has been taken by the primary active site thiyl 
radical to complete the C-2 deoxygenation and regenerate the thiyl radical.  However, the 
protein disulfide bond formed during catalysis must be reduced in order to start another 
catalytic cycle.77
4.  C-N BOND FORMATION IN DEOXYSUGAR BIOSYNTHESIS
Aminosugars, a class of deoxysugars whose hydroxyl group is replaced with an 
amino group or an amino derivative, have been found to be constituents of glycoproteins, 
glycolipids and a variety of secondary metabolites.  They have been shown to play a 
pivotal role in determining the efficacy and specificity of numerous clinically relevant 
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natural products.75  Methylation and acetylation are common enzymatic modifications of 
the amino group.  The C-N bond thus generated is not on the backbone of the sugar ring.  
The derivations usually occur by nucleophilic addition of the amino group to an 
electrophilic carbon that is either the methyl cation of SAM or the carbonyl center of an 
acetyl group.  In contrast, C-N bond formation involving a backbone carbon usually 
occurs by a transamination reaction.  That is, the keto group is replaced with an amino 
group by the catalysis of a coenzyme B6-dependent enzyme. 


















































































Figure 1-17 . Coenzyme B6 catalyzed transamination.
Although very few transamination reactions in the aminosugar biosynthesis have 
been characterized, it is probable that these reactions follow a mechanism similar to other 
aminotransferase catalyzed reactions.  The overall catalysis can be divided into two 
discrete half-reactions.  In the first half-reaction, an amino donor enters the active site of 
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the enzyme to form a Schiff base with the coenzyme PLP that has been covalently linked 
to a conserved lysine residue (115).  An α-proton is then abstracted and the electron 
equivalent from the generated carbanion is relocated and deposited in the pyridine ring of 
the ketimine intermediate (116).  After electron rearrangement, the C-4’ carbon of the 
intermediate is protonated (117).  Hydrolysis of the ketimine yields an α-keto acid and 
the PLP coenzyme is converted to the PMP form (118).  In this half reaction, the 
coenzyme undergoes a two-electron reduction from an aldehyde to form the primary 
amine in PMP.  The second half-reaction begins with Schiff base formation between the 
2e- reduced PMP and the keto sugar substrate (119).  The hydrogen at C-4’ of the 
ketimine intermediate is then abstracted by a base.  The electron on the generated C-4’ 
anion is relocated in the pyridine ring of PMP (120).  Next, tautomerization of the PMP-
hexose intermediate protonates the α-carbon of the sugar and regenerates the pyridinium 
ring of PMP (121).  Lastly, hydrolysis releases the aminosugar as the final product and 
the coenzyme is converted back to its PLP form (122).  As detailed analysis reveals, the 
second half reaction is simply the reverse of the first half reaction.  The amino group is 
provided by the amino donor, carried by the coenzyme and then transferred to the sugar 
substrate.  In contrast, the amino donor is oxidized to the keto product. 
Some enzymes deduced from gene sequences in biosynthetic clusters of 
aminosugars contain coenzyme B6 binding motifs and show significant sequence 
similarity to known aminotransferases.137  The functions of some of them have been 
confirmed by either in vivo gene deletion studies or in vitro biochemical characterization.  
C-3 aminotransferases have been shown to be regiospecific, being unable to take 4-keto 
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sugars as substrates.49,72  It is speculated that C-4 aminotransferases are also unable to 
take 3-keto sugars as substrates.  It is not surprising to observe that the sequences of C-3 
aminotransferases and C-4 aminotransferases are only distantly related.






















































Figure 1- 18.  GlmS catalyzed C-N bond formation.  Adapted from 
Badet-Denisot, M. A. et al. Arch. Biochem. Biophys. 1997, 337, 129.
The well-studied glucosamine-6-phosphate synthase catalyzes the conversion 
from fructose 6-phosphate to glucosamine 6-phosphate using glutamine as the nitrogen 
donor.138  Glucosamine 6-phosphate is a precursor of uridine diphospho-N-
acetylglucosamine from which other C-2 aminosugars are generally derived.  In addition 
to C-N bond formation at C-2, the overall reaction includes a ring expansion from a 
furanose to a pyranose.  Glucosamine 6-phosphate synthase (GlmS) is an enzyme that 
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catalyzes two distinct enzymatic reactions.  The glutaminase domain catalyzes the 
hydrolysis of glutamine to yield glutamate and enzyme-sequestered ammonia.  The newly 
formed NH3 is then transferred to the fructose 6-phosphate acceptor domain.  It is 
believed that the opening of the furanose ring of the substrate begins with the formation 
of a Schiff base between the substrate sugar and an active site lysine of GlmS (110).  The 
NH3 transferred from the glutaminase domain then reacts with the enzyme-substrate 
ketimine intermediate to form a substrate-substrate Schiff base (111).  Subsequent 
isomerization gives rise to an aldose product (109).139-141
The stereochemical course of the ketose/aldose isomerization in the glucosamine 
biosynthesis has been studied.  By using both (1R)-[1-3H] and (1S)-[1-3H]fructose-6-
phophate as substrates, GlmS was shown to catalyze the stereospecific exchange of the 
pro-R C-1 proton of the sugar.  The vast majority of (1R)-3H was released into 
medium.142



























The amino groups of many aminosugars are further modified to fine-tune their 
biological activities.  N-methylation and N-acetylation are the two common types of 
amino group derivations that have been demonstrated in many systems with purified 
enzymes.  It is well accepted that the modifications are facilitated by the nucleophilic 
nature of the amino groups of the sugar, although the detailed mechanism of this type of 
reactions has not been demonstrated.  N-methylation can go through an SN1-like reaction 
pathway where SAM, the typical methyl donor, breaks down to form a molecule of 
methionine and a methyl cation, with subsequent nucleophilic addition to make the 
linkage between the methyl group and the amino group.  Alternatively, the nucleophilic 
addition of the amino group and the leaving of the methionine can happen concomitantly 
in an SN2-like reaction.  In N-acetylation reaction, it is believed that the derivitization is 
completed by nucleophilic addition of the amino group to the carbonyl center of acetyl-
CoA.  A tetrahedral intermediate is formed first, followed by elimination to release the 
free CoA and the acetylated amino group.  The reaction course of the N-acetylation may 
be analogous to the nucleophilic replacement reactions known to occur with the carbonyl 
group. 
5.  Summary
The C-O bond cleavage reaction is a fundamental process in synthesizing 
deoxysugars.  In recent years, progress has been made in understanding the enzymatic 
mechanisms of deoxygenations at the various carbons on the sugar unit.  C-2 
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deoxygenation occurs through a β-elimination/reduction route.  Deoxygenation at C-3 
may undergo α-elimination or step wise reduction, with PMP playing an important role in 
either case.  C-4 deoxygenation may involve a [4Fe-4S] center reduced SAM radical.  C-
1 deoxygenation accompanied by ring contraction may involve an FAD-dependent 
radical mechanism. 
Compared with the C-O bond cleavage, the C-N bond formation is relatively 
straightforward, occurring either by nucleophilic addition or transamination.  The 
seemingly complicated chemistry of glucosamine-6-phosphate synthase is, in essence, 
still a transamination reaction at C-2 of the sugar.
Deoxysugars have probably existed as components of the cell surfaces of various 
organisms throughout evolution.  Due to this long evolutionary history, it is reasonable 
that the mechanisms involved in the C-O bond cleavage are diverse.  Thus, it is logical to 
keep an open mind for the discovery of other possible mechanisms of C-O bond 
cleavage.  A comprehensive understanding of many of the mechanisms proposed thus far 
must await more detailed studies as well.
6.  Thesis Statement
In spite of the great progress that has been made in the last twenty years, the 
explicit characterization of deoxysugar biosynthetic pathways remains limited.  Many of 
the proposed pathways remain speculative.  In this thesis, detailed studies of the 
biosynthesis of TDP-D-forosamine are carried out.  Overexpression, purification, and 
characterization of each enzyme in the biosynthetic pathway of forosamine have been 
achieved.  The enzymatic functions and cofactor requirements of each enzyme have been 
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unambiguously established by product separation and characterization.  Comprehensive 
biochemical studies of each enzyme have been performed.  The enzymatic reactions 
include C-O bond cleavage at C-2, C-3, C-4 and C-6.  New evidence has been obtained to 
support the C-2 β-elimination/reduction mechanism.  An aminotransferase catalyzing the 
C-4 transamination reaction has been identified.  This work also gives a firm explanation 
why the forosamine biosynthetic gene cluster lacks an E3 reductase homologue involved 
in C-3 deoxygenation, as well as demonstrates a reaction system for C-3 deoxygenation 
that is different from the well-established E1/E3 pair.  In addition, the methyltransferase 
identified in this study is the first 4-amino-N,N-dimethyltransferase that has ever been 
characterized.  The step-wise methylation catalyzed by this methyltransferase is 
established as well.  Together, studies carried out in this thesis have significantly 
enriched our knowledge of deoxysugar biosynthesis.  Forosamine is the first 2,3,4,6-
tetradeoxysugar whose biosynthetic pathway has been completely characterized. 
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Chapter 2. Characterization of SpnO, a TDP-6-deoxy-4-keto-D-glucose 
2,3-dehydratase and SpnN, a TDP-2,6-dideoxy-3,4-diketo-D-glucose 3-
ketoreductase
1. INTRODUCTION
The spinosyns are novel secondary metabolites produced by Saccharopolyspora 
spinosa.  Spinosyns are comprised of a tetracyclic macrolide and appendages D-
forosamine and L-rhamnose, differing from each other by the degree of methylation on 























































Figure 2-1 .  Structures of spinosyns. Forosamine and tri-O-methylrhamnose are 





components in Saccharopolyspora spinosa extracts are spinosyn A and spinosyn D, 
differing from each other by the presence or absence of a single methyl substituant at 
position 6 of the polyketide.  Spinosad, a combination of spinosyn A and spinosyn D, is 
marketed by Dow AgroSciences for control of agricultural insect pests.  Spinosad is 
highly effective against target insects and has an excellent environmental and mammalian 
toxicological profile.143-145  Incorporation studies with 13C-labeled acetate, propionate, 
and methionine established that spinosyns are assembled by a polyketide pathway, and 
that the two N-methyl groups of forosamine and the three O-methyl groups of tri-O-
methylrhamnose are derived from SAM.146
The spinosyn biosynthetic gene cluster has been identified and sequenced (Figure 
2-2).147  The macrolide of spinosyn differs from common type-I polyketide macrolide in 
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Figure 2- 2. Organizations of the spinosyn biosynthetic gene cluster.
sugar gene cluster
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that it is tetracyclic instead of being monocyclic.  Identification of the genes involved in 
these C-C bond formation steps helped in locating the whole biosynthetic gene cluster.147
To aid the cloning and analysis, a gene transfer system that employed conjugation from 
E. coli was developed.148  Using conjugation, cosmids containing large inserts of 
Saccharopolyspora spinosa DNA were introduced into blocked mutants of S.  spinosa.  
These inserts were efficiently inserted into the chromosome by homologous 
recombination, and the effects of the introduction studied.148  By gene disruption and 
bioconversion analysis, the boundaries of the spinosad biosynthetic gene cluster were 
established.  Interestingly, the TDP-L-rhamnose biosynthetic genes were not found in the 
sequenced gene cluster.  This is probably because TDP-L-rhamnose is also an important 
primary metabolite and thus the organism has multiple routes to synthesize this sugar.  
From sequence analysis, the genes spnH, spnI, and spnK are proposed to encode 
rhamnose O-methyl transferase while spnG is proposed to encode rhamnosyltransferase.  
In addition, the enzymes encoded by genes spnO, spnN spnQ, spnR and spnS, are 
proposed to participate in TDP-D-forosamine biosynthesis.  The five genes are adjacent 
to each other and located close to the PKS region.  However, the genes encoding the 
thymidylyltransferase and TDP-glucose-4,6-dehydratase were not found in the vicinity.  
The biosynthesis of TDP-D-forosamine might recruit these two enzymes directly from the 
cellular pool since these two enzymes are widely used in many deoxysugar biosynthetic 
pathways.  
The biosynthetic pathway of forosamine has been proposed based on sequence 
analysis (Scheme 2-1).  It is proposed that the biosynthesis of TDP-D-forosamine begins 
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with glucose-1-phosphate (1).  TDP-6-deoxy-4-keto-glucose (3) is synthesized by a 
glucose-1-phosphate thymidylyltransferase and a TDP-glucose-4,6-dehydratase from the 
cellular pool.  Next, the 2-hydroxyl group of TDP-6-deoxy-4-keto-glucose is proposed to 
be removed by action of the enzymes encoded by spnO and spnN.  The TDP-2,6-
dideoxy-4-keto-glucose (24) is then deoxygenated at the C-3 by the spnQ-encoded 
enzyme to give 126.  The two enzymes encoded by spnR and spnS are proposed to 
catalyze transamination of C-4 to give 127, and N,N-dimethylation of the resulting 4-


































Scheme 2-1. Proposed TDP-forosamine biosynthetic pathway. The first two steps in the
pathway are suggestedto be catalyzed by enzymes from the cellular pool, while the other steps 
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to the polyketide is probably encoded by spnP.  As has been explained in Chapter 1, few 
deoxysugar biosynthetic pathways have been completely characterized in spite of the 
progress made in assigning enzymatic functions to the gene products of deoxysugar 
biosynthetic gene clusters.  Most of the biosynthetic pathways in the literature are still 
speculative.  The correlation between each enzyme and the specific reaction it catalyzes 
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in the pathway is rarely unambiguously established.  Forosamine is the most highly 
deoxygenated sugar whose biosynthetic pathway has been studied to date.  The hydroxyl 
groups at C-2, C-3, C-4, and C-6 in the hexose have been replaced with hydrogen, 
hydrogen, N,N-dimethyl amino group, and hydrogen, respectively.  However, the 
assigned reaction sequence is only tentative.  It is reasonable to consider that the SpnS 
catalyzed reaction would occur after the SpnR catalyzed reaction since SpnS is proposed 
to be an N,N-dimethyltransferase and the substrate must have installed an amino group.  
Moreover, the SpnR reaction should occur later than the C-2 and C-3 deoxygenations 
because the deoxygenation reactions at the C-2 and C-3 require the presence of the C-4 
Scheme 2-2.  Two possible pathways to obtain TDP-2,3,6-trideoxy-4-keto-glucose.  In 














































keto functional group to activate the substrate.  However, the order of the C-2 and C-3 
deoxygenations is uncertain as none of the biosynthetic pathways of 2,3-dideoxysugars 
have been previously characterized (Scheme 2-2).  Thus, TDP-6-deoxy-4-keto-glucose 
(3) might first undergo C-3 deoxygenation (130) followed by C-2 deoxygenation.  In 
addition, the participation of SpnO and SpnN in C-2 deoxygenation is based solely on 
their homology to TylX3/TylC1 and Gra Orf27/Gra Orf26 whose functions have been 
demonstrated in vitro,70,71 and thus must be confirmed.  The respective aminotransferase 
and methyltransferase activities of SpnR and SpnS are also yet to be demonstrated.  
Moreover, the C-3 deoxygenation proposed to be catalyzed by SpnQ is intriguing.  In this 
chapter, the study of the first two enzymatic steps in TDP-D-forosamine biosynthesis, 




































Scheme 2-3.  Biosynthesis of TDP-L-oleandrose and TDP-L-rhodinose requires Gra Orf27/Gra 















BLAST search of the spnO gene product through the National Center for 
Biotechnology Information (NCBI) data base has found more than 30 homologs of SpnO 
with identity higher than 25%.  The functions of two of them have been characterized by 
in vitro studies (Scheme 2-3).  TylX3 (43.8% identity to SpnO) was demonstrated to 
catalyze 2,3-dehydration in the biosynthesis of TDP-L-mycarose (32), one of the 
deoxysugar components in antibiotic tylosin that is produced by Streptomyces fradiae.71
Gra Orf27 (41.8% identity to SpnO) catalyzes the same reaction in the biosynthesis of 
TDP-L-oleandrose (49) and TDP-L-rhodinose (27), deoxysugar components of the 
antibiotics granaticin and granaticin B that are produced from Streptomyces 
violaceoruber Tü2270.  BLAST search of the spnN gene product gives numerous proteins 
with significant similarity to SpnN.  Most of them are ketoreductases, while others are 
assigned as epimerases.  The sequence similarity between ketoreductase and epimerase 
can be rationalized by the common use of NAD(P)(H) cofactor.  Among these homologs, 
the enzyme Gra Orf26, which has high sequence identity to SpnN (47.7%), has been 
shown to be a ketoreductase in the biosynthetic pathway of TDP-L-oleandrose (49) or 
TDP-L-rhodinose (27) (Scheme 2-3).70  Interestingly, TylC1 is only distantly related to 
SpnN.  It should be noted that Gra Orf27 and Gra Orf26 are found in the same gene 
cluster.  Gra Orf26 was demonstrated to convert the product of Gra Orf27 (23) to TDP-
2,6-dideoxy-4-keto-glucose (24) with the reintroduced C-3 hydroxyl group in an 
equatorial position.  In summary, based on the sequence similarity to characterized 
enzymes, SpnO and SpnN are proposed to catalyze deoxysugar 2,3-dehydration and 3-
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ketoreduction, respectively.  It is interesting to note that the two genes spnO and spnN are 
physically next to each other in the S. spinosa genome.
2.  EXPERIMENTAL PROCEDURES
Materials. Saccharopolyspora spinosa genomic DNA, used as a PCR template 
for amplification of spnO and spnN, was previously prepared by Dr. Kent Zhao.  E. coli
DH5α cells were purchased from Bethesda Research Laboratories (Muskegon, 
Michigan).  Vector pET17b(+), pET24b(+), pET28b(+), and pET41a(+) were purchased 
from Novagen (Madison, WI).  Overexpression host cell E. coli BL21(DE3), BL21(DE3) 
pLysS, HMS174(DE3), RosettaTM2(DE3), and RosettaBlueTM2(DE3) were also obtained 
from Novagen.  Overexpression host BL21-CodonPlus(DE3)-RP was purchased from 
Stratagene (La Jolla, CA).  Components of culture media were purchased from Difco 
(Detroit, MI).  pfu DNA polymerase was obtained from Stratagene.  Qiaquick Linear 
DNA Purification Kit and Qiaprep DNA Miniprep Kit were purchased from Qiagen 
(Valencia, CA).  The 1kb DNA ladder and agarose were from Gibco BRL (Grand Island, 
NY).  Oligonucleotides used in the PCR amplification of desired inserts were prepared by 
Invitrogen (Carlsbad, CA) and used without further purification.  Restriction 
endonucleases were from either Invitrogen, Gibco BRL, or Promega (Madison, WI).  Ni-
NTA resin for purification of His-tagged proteins was a product of Qiagen.  Bio-Gel P2 
extra-fine resin was purchased from BioRad (Richmond, CA).  Small amount of solution 
was disinfected by filtering through Sterile Syringe Filter purchased from Corning Inc 
(Coring, NY).  Protein markers were obtained from Sigma (St. Louis, MO).  Mini trans-
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blot assembly apparatus for Western blot and non-fat dry milk were purchased from 
BioRad.  Also used for Western blot were nitrocellulose Hybond-C Extra membrane 
from Amersham (Piscataway, NJ), and each from Sigma, monoclonal anti-polyhistidine 
clone His-1, anti-mouse IgG, and alkaline phosphatase conjugate.  For Western blot 
detection, nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate 
(BCIP) were both obtained from Promega.  NADH, NADPH, TMP, morpholine, DCC, 
and 1H-tetrazole were purchased from Sigma-Aldrich.  All other chemicals were 
analytical grade or the highest quality commercially available.  Sequence analysis and 
comparison were performed using Vector NTI software and BLAST network service 
with the NCBI computing system. 
General Equipment.  Ultraviolet-visible data were recorded with a Beckman DU-
650 spectrophotometer.  The pH values were obtained using a Corning pH meter 240.  
The cell membrane disruption was done using Fisher 550 Dismembrator from Fisher 
Scientific (Pittsburg, PA).  The DNA-100 submarine gel equipment from Pharmacia 
Biotech (Uppsala, Sweden) powered by either a FB600 or FB 135 supply from Fisher 
Scientific were used for all agarose gel electrophoresis.  DNA gel documentation was
performed with camera FBTIV-88 and ID (version 3.5) software from Kodak (Rochester, 
New York).  DNA gels were illuminated by Transilluminator from Fisher Scientific.  
Polymerase chain reactions were carried out in either Perkin Elmer Cetus DNA Thermal 
Cycler (Norwalk, CT) or Mastercycler Gradient Thermal Cycler from Brinkmann 
Instruments (Westbury, NY).  The Mini-Protein II electrophoresis system for SDS-PAGE 
analysis was manufactured by Bio-Rad.  Polyacrylamide gels were dried using a Bio-Rad 
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Gel Air Dryer.  HPLC separation was achieved on a HP1090 Liquid Chromatograph from 
Hewlett Packard (Rolling Meadow, IL).  Centrifugation was performed with an Avanti J-
25 or J-10 machine from Beckman (Arlington Heights, IL), while microcentrifugations 
were done with an Eppendorf 5415D from Brinkmann Instrument.
Preparation of Competent Cells.  Cells were made competent according to a 
slightly modified CaCl2 method.
154,155  A single fresh colony of an appropriate E. coli
strain was used to inoculate 5 mL of LB medium and the resulting culture was grown 
overnight at 37 °C with shaking at 250 rpm.  A 400 µL aliquot of this overnight culture 
was used to inoculate 100 mL of LB medium in a sterile Erlenmeyer flask.  When the cell 
growth at 37 °C reached an OD600 of about 0.4, the culture was apportioned into two 
prechilled polypropylene tubes (Falcon 2070) and left on ice for 10 min.  After 
centrifugation at 1,600 g for 7 min, the cell pellets were gently resuspended in 5 mL of 
ice-cold CaCl2 solution (60 mM CaCl2, 15% glycerol, 10 mM PIPES, pH 7.0, disinfected 
by filtering through sterile syringe filter).  Another centrifugation step at 1,100 g, 4 °C for 
7 min was performed and the cells were then resuspended in 5 mL of ice-cold CaCl2
solution.  After incubation on ice for 30 min, the cells were spun down for 5 min at 1,100 
g, 4 °C.  Finally, the cells were resuspended in 500 µL of the cold CaCl2 solution and 
aliquotted in 20 µL portions into prechilled microcentrifuge tubes and frozen at –80 °C or 
used directly for transformation.  
PCR Amplification of the spnO Gene.  Three oligonucleotide primers were 
obtained to amplify the spnO gene: primer (O-1) 5’-GGGGCCTCATATG AGCA-
GTTCTGTCGAAGC-3’ containing an NdeI restriction site (in bold), primer (O-2) 5’-
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GAGAAGCTTTTATCGCCCCAACGCCCACAAG-3’ containing a HindIII restriction 
site (in bold), and primer (O-3) 5’-TATAAGCTTTCGCCCCAACGCCCACAAGC-3’ 
containing a HindIII restriction site (in bold).  The start primer O-1 is designed to include 
the first six codons of the spnO gene while the halt primers O-2 and O-3 include the last 
six codons of the spnO gene upstream of the HindIII restriction site.  Two polymerase-
mediated amplifications were carried out, both in 0.5 mL microcentrifuge tubes.  In the 
first reaction, to the reaction mixture was added 37.5 µL of double-deionized H2O, 5.0 µL 
of pfu polymerase buffer (10 x), 4.0 µL of deoxyribonucleotidyltriphosphate mix (2.5 
mM each), 1.0 µL of start primer O-1 (10 µM), 1.0 µL of halt primer O-2 (10 µM), 0.5 
µL of genomic DNA (about 0.1 µg) from Saccharopolyspora spinosa as the amplification 
template, and 1.0 µL of cloned pfu polymerase (2.5 units).  The reaction mixture was then 
overlaid with a layer of mineral oil and subjected to the following thermal cycles: (1) 1 
denaturation cycle of incubation at 95 °C for 3 min; (2) 30 amplification cycles of 
incubation at 95 °C for 30 s, 60 °C for 30 s and 72 °C for 1.5 min; (3) 1 extension cycle 
of incubation at 72 °C for 10 min.  The tube was held at 4 °C prior to being removed 
from the thermal cycler.  The amplification product is the natural spnO gene with 
restriction sites of endonucleases NdeI and HindIII at the 5’- and 3’- ends, respectively.  
In the second polymerase-mediated amplification reaction all the other components are 
the same as in the first set of reaction, except that the halt primer is changed to O-3 of the 
same concentration.  The thermal cycles and the afterward treatment are also the same.  
The amplification product from the second reaction is the spnO gene without the natural 
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stop codon and with restriction sites of endonucleases NdeI and HindIII at the 5’ and 3’ 
ends, respectively.
Cloning of the spnO Gene.  After PCR amplification, standard recombinant DNA 
techniques were used to clone the genes into appropriate expression vectors.  The PCR 
product mixtures from the two PCR reactions were individually separated from the 
mineral oil and electrophoresed on a 0.7% agarose gel.  The DNA fragments of the 
correct size were purified with QIAquick Spin Kit.  The cleaned products of the two PCR 
reactions were each double digested with NdeI and HindIII in appropriate buffer (10 x 
restriction buffer 2, Invitrogen) at 37 °C overnight.  The mixtures from the two digestion 
reactions, containing the two digested spnO genes that are named O-w-stop-diges and O-
wo-stop-diges, were loaded on a 0.7% agarose gel for electrophoresis.  The desired DNA 
fragments with the size of the spnO gene were excised and purified with QIAquick Spin 
Kit.  Digestion of vectors pET24b(+) and pET28b(+) with NdeI and HindIII was carried 
out in an appropriate buffer (10 x restriction buffer 2, Invitrogen) for two hours at 37 °C.  
The digestion product of O-w-stop-diges was ligated into each of digested vectors 
pET28b(+) and pET24b(+) using high concentration T4 DNA ligase in 5 x ligase buffer.  
The reactions were carried out at room temperature for 2 h.  Ligation into pET28b(+) 
created a 60bp in-frame extension of the gene, containing six successive His codons, 
attached to the 5’ end of the gene.  When expressed, this clone would produce an N-
terminal His6-tagged fusion protein.  Ligation of the same insert into pET24b(+) 
maintains the natural gene which at the time of protein expression would produce the 
native protein.  The digestion product of O-wo-stop-diges was ligated into the digested 
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vector pET24b(+) using high concentration T4 DNA ligase in 5 x ligase buffer.  The 
ligation product contained a 39bp in-frame extension, containing six successive His 
codons, attached to the 3’ end of the gene, producing a C-terminal His6-tagged fusion 
protein when expressed.  
Transformation of 20 µL of E. coli DH5α host cells was carried out with 20 ng of 
the ligation product.  The resulting cells were incubated on ice for 30 min followed by 
heat shock at 42 °C for 90 s.  The cells were then incubated on ice for another 2 min, and 
mixed with 800 µL of LB medium.  The cells were incubated at 37 °C for 45 min with 
shaking at 200 rpm and then briefly centrifuged (1 min at 13,000 rpm).  A total of 700 µL 
of the supernatant was removed.  The small cell pellet was resuspended in the remaining 
medium and then plated out on LB plates supplemented with 30 µg/mL of the antibiotic 
kanamycin.  The plates were incubated for 20 h at 37 °C before six clonies were picked to 
individually inoculate small liquid cultures.  Plasmid DNA was isolated from 5 mL of 
each of the cultures that had grown for 12 h at 37 °C by using QIAprep Spin Miniprep 
Kit.  An amount of 40 ng plasmid DNA from each miniprep was digested with restriction 
enzymes NdeI and HindIII.  Positive clones were identified by the presence of the DNA 
fragment having the size of spnO on the agarose gel after electrophoresis and were 
further confirmed by DNA sequencing.  The plasmid DNA of the positive clones, named 
pLHON having extra His codons at the 5’ end of the natural spnO gene, pLHOO
maintaining the natural spnO gene, and pLHOC having extra His codons at the 3’ end of 
the spnO gene, were used to transform E. coli BL21(DE3).  
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PCR Amplification of the spnN-short Gene.  This work was completed by Dr. 
Zhao in our laboratory.  Many PCR reactions using various primer pairs were carried out 
in generating clones for the many trials of expression of the spnN-short gene, which was 
named after the gene deposited in the NCBI data base.  Two of them were described here.  
The start primer (pKZ-8), 5’-GGCCATATGCGAAAGCCGGTGCGCATC-3’, contains 
an NdeI restriction site (in bold).  The ATG sequence at the NdeI site could also serve as 
the start codon for the spnN gene.  The halt primer (pKZ-12), 5’-
GCCCTCGAGCTATGTGGACCCGCA-3’ incorporated an XhoI restriction site (in 
bold) immediately downstream from the coding sequence.  Another halt primer (pKZ-9), 
5’-GCCCTCGAGTGTGGACCCGCACCGACG-3’, also contains an XhoI restriction 
site.  However, the stop codon of spnN was removed in pKZ-9 to allow six His codons to 
be added at the 3’-end of the spnN gene after the gene is cloned into pET24b(+).  
Polymerase mediated amplifications were carried out in 0.5 mL microcentrifuge tubes.  
To one reaction mixture was added 71.0 µL of double-deionized H2O, 10.0 µL of pfu
polymerase buffer (10 x), 1.5 µL of deoxyribonucleotidyltriphosphate mix (10 mM each), 
10.0 µL of DMSO, 1.5 µL of 80% glycerol, 2.0 µL of pKZ-8 (20 µM), 2.0 µL of pKZ-12 
(20 µM), 0.5 µL of genomic DNA (about 0.1 µg) from Saccharopolyspora spinosa, and 
1.5 µL of cloned pfu polymerase (2.5 U/ µL).  The reaction mixture was then overlaid 
with a layer of mineral oil and subjected to the following thermal cycles: (1) 1 cycle of 
incubation at 95 °C for 1 min; (2) 30 cycles of incubation at 95 °C for 1 min, 55 °C for 1 
min, and 70 °C for 3.5 min; (3) 1 cycle of incubation at 72 °C for 10 min.  The tubes 
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were held at 4 °C prior to further manipulations.  In the other reaction, the pKZ-12 was 
replaced with pKZ-9.  
PCR Amplification of the spnN-long Gene.  In order to amplify the spnN-long
gene which is in frame with spnN-short, but with 12 more nucleotides at the 5’- end of 
spnN-short, another oligonucleotide primer complementary to the sequence at the 5’- end 
of spnN-long was designed.  The start primer (pKZ-NL), 5’-
GGCCATATGACCAGCTCGATGCGAAAG-3’, contains an NdeI restriction site (in 
bold).  The polymerase mediated amplification of spnN-long had the same components as 
the amplification reaction of spnN-short except that the start primer used was pKZ-NL 
and the halt primer used was pKZ-9.  The thermal cycles and the subsequent treatment 
were also the same as for spnN-short.  The resulting PCR product was the spnN-long 
gene without the natural stop codon. 
Cloning of the spnN-short and spnN-long Genes.  After PCR amplification, 
standard recombinant DNA techniques were used to clone the genes into appropriate 
expression vectors.  Typically, the PCR product mixtures were separated from the 
mineral oil and subjected to electrophoresis.  The amplified genes were purified with the 
QIAquick Spin Kit.  After digestion with appropriate amounts of NdeI and XhoI, the 
mixtures were separately loaded onto a 0.7% agarose gel for electrophoresis.  The desired 
DNA fragments with the correct size of the spnN gene were excised and purified with the 
QIAquick Spin Kit.  The DNA inserts were ligated with NdeI and XhoI-digested vectors 
using high concentration T4 DNA ligase.  Typically, a ligation reaction of 20 µL was 
carried out with 5.0 units of ligase for 2 h at room temperature. 
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Transformation of E. coli DH5α host cells was carried out with 4 µL of the above 
ligation mixture.  The procedure was the same as that for the spnO gene transformation.  
Positive clones were identified by digesting the plasmid DNA, which had been isolated 
by QIAprep Spin Miniprep Kit, with restriction enzymes NdeI and XhoI.  The presence of 
the expected DNA fragments was visualized by agarose gel electrophoresis using 0.7% 
agarose.  Three positive clones will be subsequently discussed: pKZ-N-short-N is spnN-
short cloned into the vector pET28b(+) with a His6-tag encoded at the 5’ end; pKZ-N-
short-C is the spnN-short gene cloned into the vector pET24b(+) with a His6-tag encoded 
at the 3’ end and missing the stop codon of the natural gene; pKZ-N-long-C is spnN-long 
ligated to pET24b(+) with a His6-tag encoded at the 3’ end and missing the stop codon.  
The plasmid DNA of these three clones was transformed into various types of expression 
host cells, and expression was attempted in order to find the optimal conditions for 
protein expression.  The expression host cells that were tried include E. coli BL21(DE3), 
BL21(DE3) pLysS, HMS174(DE3), RosettaTM2(DE3), RosettaBlueTM2(DE3), E. coli
BL21-CodonPlus(DE3)-RP, as well as others not mentioned here.  
Codon Changes of the spnN-long Gene.  There is one occurrence of AGGAGG 
starting from nucleotide 352 in spnN-long.  Two oligonucleotide primers were designed 
to mutate the rare Arg codons to Arg codons that are more commonly found in E. coli.  
The upstream primer, 5’-GGGCTGGCCCGTCGCAAGAACCTG-3’ (pKN-11), 
contains the mutation from AGGAGG to CGTCGC (in bold) with the rest of the 
sequence complementary to the spnN gene.  The downstream primer, 5’-
GCAGGTTCTTGCGACGGGCCAGC-3’ (pKN-12) contains the corresponding changes 
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(in bold) and is complementary to the start primer.  Polymerase mediated mutation was 
carried out in 0.5 mL microcentrifuge tube.  To the reaction mixture was added 39.0 µL 
of double-deionized H2O, 5.0 µL of reaction buffer (10 x) of Turbo pfu polymerase, 1.0 
µL of deoxyribonucleotidyltriphosphate (20.0 mM each), 1.5 µL of start primer pKN-11 
(10.0 µM), 1.5 µL of halt primer pKN-12 (10.0 µM), 1.0 µL of template DNA pKZ-N-
long-C (50.0 ng), and 1.0 µL of Turbo pfu polymerase (2.5 units).  The reaction mixture 
was then overlaid with a layer of mineral oil and subjected to the following thermal 
cycles: (1) 1 cycle of incubation at 95 °C for 30 s; (2) 16 cycles of incubation at 95 °C for 
30 s, 55 °C for 1 min, and 68 °C for 14 min; (3) 1 cycle of incubation at 72 °C for 10 
min.  The tube was held at 4 °C prior to further treatment.
DpnI restriction enzyme (1.0 µL, 10 U/ µL) was added directly to each 
amplification reaction below the mineral oil overlay using a small pointed pipet tip.  The 
reaction mixture in the microcentrifuge was spun down for 1 min and immediately 
incubated at 37 °C for 1 h to digest the parental supercoiled double-stranded-DNA.  
The XL1-Blue supercompetent cells, 50 µL, was aliquotted to prechilled 
microcentrifuge tubes before transformation.  The DpnI-treated DNA, 1 µL, in the 
digestion reaction was added to an aliquot of the supercompetent cells.  The resulting 
cells were incubated on ice for 30 min prior to a 45 s heat pulse at 42 °C.  After cooling 
the reaction on ice for 2 min, 800 µL of LB medium was added to the cooled cells and the 
resulting culture was incubated at 37 °C for 1 h with shaking at 225 rpm.  The cells were 
spun down and resuspended in 120 µL of LB medium after removal of the extra medium.  
The culture was then plated out on agar plates containing 30 µg/mL kanamycin.  The 
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transformation plate was incubated at 37 °C for 20 h.  Clear clonies with a diameter 
larger than 0.5 mm were chosen for screening. 
Each single colony was used to inoculate 5 mL of LB medium and incubated at 
37 °C overnight.  An aliquot of 4.5 mL of the culture was spun down and the plasmid 
DNA was isolated using the QIAprep Spin Miniprep Kit.  Several plasmid isolates were 
subjected to DNA sequencing.  The one obtained with the expected mutations was named 
pKZ-N-long-C-opt, and was used to transform E. coli BL21-CodonPlus(DE3)-RP 
overexpression cells.  
Purification of the SpnO Protein.  All purification steps were carried out at 4 °C. 
Step 1:  Growth of E. coli-pLHON Cells.  An overnight culture of E. coli
BL21(DE3)-pLHON, grown in LB medium supplemented with kanamycin (30 µg/mL) at 
37 °C, was diluted 250-fold by addition of 4 mL of the overnight culture to each of six 1 
L flasks of the same medium and incubated at 37 °C until the OD600 reached 0.3.  The 
incubation temperature was then lowered to 24 °C and the incubation was continued for 
one more hour before the OD600 reached 0.4.  The culture was then induced with IPTG to 
a final concentration of 0.2 mM and allowed to grow for an additional 15 h at 24 °C.  The 
cells were harvested by centrifugation at 5,000 g for 10 min at 4 °C and stored at –80 °C. 
The typical yield of wet cells was about 6 g per liter.
Step 2:  Crude Extract Preparation.  The cells were resuspended in 80 mL of lysis 
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, 5 mM 
2-mercapto-ethanol, pH 8.0), and disrupted with five 1 min sonication bursts, with one 
min cooling intervals between bursts.  Cellular debris was removed by centrifugation at 
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35,000 g for 20 min.  The supernatant was transferred into a large centrifuge bottle for 
incubation with Ni-NTA resin.
Step 3:  Ni-NTA Affinity Chromatography.  To the crude extract, was added 6 mL 
of Ni-NTA slurry (3 mL of resin) and the resulting mixture was incubated for 2 h at 4 °C 
with gentle shaking.  The majority of the supernatant was decanted after the resin was 
spun down to the bottom of the centrifuge bottle by brief centrifugation at low speed 
(1,000 g).  The remaining resin slurry was mixed well and loaded into an empty glass 
column (1 x 25 cm).  The column was washed with 20 mL of lysis buffer followed by 
various amounts of wash buffers.  The wash buffers and elution buffer used contained the 
same ingredients as the lysis buffer except that the concentrations of imidazole were 
altered.  The column was washed sequentially with 20 mL of wash buffer containing 20 
mM imidazole, 20 mL of wash buffer containing 40 mM imidazole and 15 mL of wash 
buffer containing 60 mM imidazole.  No peristaltic pump was used.  The buffer passed 
through the column by gravity at a flow rate of 0.5 mL/min.  After washing, SpnO 
protein was eluted with 10 mL of elution buffer containing 250 mM imidazole.  Eluted 
protein was transferred into a dialysis bag and dialyzed against four1.0 L portions of 
dialysis buffer (50 mM Tris, 15% glycerol, pH 7.5) for 1 h per liter of buffer.  The 
dialyzed protein was concentrated by ultrafiltration in an Amicon concentrator using a 
YM-10 membrane (Amicon) and stored at –80 °C.  
Purification of the SpnN protein.  All purification steps were carried out at 4 °C.
Step 1:  Growth of E. coli BL21-CodonPlus(DE3)-RP-pKZ-N-long-C-opt Cells.  
An overnight culture of E. coli BL21-CodonPlus(DE3)-RP-pKZ-N-long-C-opt, grown in 
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LB medium supplemented with kanamycin (30 µg/mL) at 37 °C, was diluted 250-fold by 
addition of 4 mL of the overnight culture to each of six 1 L flasks of the same medium 
and incubated at 37 °C until the OD600 reached 0.3.  The incubation temperature was then 
adjusted to 24 °C and the incubation was continued for one more hour before the OD600
reached 0.4.  The culture was then induced with IPTG to a final concentration of 0.2 mM 
and allowed to grow for an additional 15 h at 24 °C.  The cells were harvested by 
centrifugation at 5,000 g for 10 min at 4 °C and stored at –80 °C.  The typical yield of 
wet cells was about 6 g per liter.
Step 2:  Crude Extract Preparation.  The cells were resuspended in 80 mL of lysis 
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, 5 mM 
2-mercapto-ethanol, pH 8.0), and disrupted with five 1 min sonication bursts, with one 
min cooling intervals between bursts.  Cellular debris was removed by centrifugation at 
35,000 g for 20 min.  The supernatant was transferred into a large centrifuge bottle for 
incubation with Ni-NTA resin.  
Step 3:  Ni-NTA Affinity Chromatography.  To the crude extract was added 8 mL 
of Ni-NTA slurry (4 mL of resin) and the resulting mixture was incubated for 2 h with 
gentle shaking at 4 °C.  The majority of the supernatant was decanted after the resin was 
spun down to the bottom of the centrifuge bottle with brief centrifugation at low speed 
(1,000 g).  The remaining resin slurry was mixed well and loaded into an empty glass 
column (1 x 25 cm).  The column was washed with 30 mL of the lysis buffer followed by 
various amounts of wash buffers.  The wash buffers and elution buffer used contained the 
same ingredients as the lysis buffer except that the concentrations of imidazole were 
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altered.  The column was washed sequentially with 30 mL of wash buffer containing 20 
mM imidazole, 30 mL of wash buffer containing 40 mM imidazole and 15 mL of wash 
buffer containing 60 mM imidazole.  No peristaltic pump was used.  The buffer passed 
through the column by gravity at a flow rate of 0.5 mL/min.  After washing, the SpnN 
protein was eluted with 15 mL of elution buffer containing 100 mM imidazole.  The 
eluted protein was transferred into a dialysis bag and dialyzed against four 1.0 L portions 
of dialysis buffer (50 mM Tris, 15% glycerol, pH 7.5) for 1 h per liter of buffer.  The 
dialyzed protein was concentrated by ultrafiltration in an Amicon concentrator using a 
YM-10 membrane (Amicon) and stored at –80 °C.  
Purification of the RfbB Protein.  The gene encoding the protein TDP-glucose-
4,6-dehydratase, commonly abbreviated as RfbB, from the genome of E. coli K12 has 
been cloned into vector pUC18 to give the rfbB gene with a 60bp extension containing 
six successive His codons attached to the 5’ end, by Dr. Yun-nan Liu of our laboratory.  
This construct is subsequently referred to as pYNL-RfbB.  Consequently, the expressed 
protein has a His6-tag at the N-terminus.  All purification steps were carried out at 4 °C.
Step 1:  Growth of E. coli BL21(DE3)-pYNL-RfbB Cells.  An overnight culture of 
E. coli BL21(DE3)-pYNL-RfbB, grown in LB medium supplemented with ampicilin (50 
µg/mL) at 37 °C, was diluted 250-fold by addition of 4 mL of the overnight culture to 
each of six 1 L flasks of the same medium and incubated at 37 °C for another 20 h.  The 
cells were harvested by centrifugation at 5,000 g for 10 min at 4 °C and stored at –80 °C.  
The typical yield of wet cells was about 10 g per liter.
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Step 2:  Crude Extract Preparation.  The cells were resuspended in 80 mL of lysis 
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, pH 
8.0), and disrupted with five 1 min sonication bursts, with one min cooling intervals 
between bursts.  Cellular debris was removed by centrifugation at 35,000 g for 20 min.  
The supernatant was transferred into a large centrifuge bottle for incubation with Ni-NTA 
resin.  
Step 3:  Ni-NTA Affinity Chromatography.  To the crude extract was added 10 mL 
of Ni-NTA slurry (5 mL of resin) and the resulting mixture was incubated for 1.5 h with 
gentle shaking at 4 °C.  The majority of the supernatant was decanted after the resin was 
spun down to the bottom of the centrifuge bottle with brief centrifugation at low speed 
(1,000 g).  The remaining resin slurry was mixed well and loaded into an empty glass 
column (1 x 25 cm).  The column was washed with 100 mL of wash buffer containing the 
same ingredients as the lysis buffer but with 20 mM imidazole.  No peristaltic pump was 
used.  The buffer passed through the column by gravity at a flow rate of 1.0 mL/min.  
After washing, the RfbB protein was eluted with 15 mL of the elution buffer (50 mM
sodium phosphate, 300 mM NaCl, 250 mM imidazole, 15% glycerol, pH 8.0).  Eluted 
protein was transferred into a dialysis bag and dialyzed against four 1.0 L portions of 
dialysis buffer (50 mM Tris, 15% glycerol, pH 7.5) for 1 h per liter of buffer.  The 
desalted protein was concentrated by ultrafiltration in an Amicon concentrator using a 
YM-10 membrane (Amicon) and stored at –80 °C.  The typical yield was about 120 mg 
of pure RfbB from a 6 L culture.  
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Purification of the TylX3 Protein.  The gene encoding TylX3 has been cloned into 
vector pET28b(+) to give the tylX3 gene with a 60bp extension containing six successive 
His codons attached to the 5’ end, by Dr. Huawei Chen of our laboratory.  This construct 
was referred to as pHC45.  The expressed protein has a His6 tag at the N-terminus.  All 
purification steps were carried out at 4 °C.  
Step 1:  Growth of E. coli BL21-pHC45 Cells.  An overnight culture of E. coli
BL21(DE3)-pHC45, grown in LB medium supplemented with kanamycin (30 µg/mL) at 
37 °C, was diluted 250-fold by addition of 4 mL of the overnight culture to each of six 1 
L flasks of the same medium and incubated at 37 °C until the OD600 reached 0.3.  The 
incubation temperature was adjusted to 24 °C and the incubation was continued for one 
more hour before the OD600 reached 0.4.  The culture was then induced with IPTG at a 
final concentration of 0.05 mM and allowed to grow for an additional 15 h at 24 °C.  The 
cells were then harvested by centrifugation at 5,000 g for 10 min at 4°C and stored at –80 
°C.  The typical yield of wet cells was about 8 g per liter.
Step 2:  Crude Extract Preparation.  The cells were resuspended in 80 mL of lysis 
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, 5 mM 
2-mercapto-ethanol, pH 8.0), and disrupted with five 1 min sonication bursts, with one 
min cooling intervals between bursts.  Cellular debris was removed by centrifugation at 
35,000 g for 20 min.  The supernatant was transferred into a large centrifuge bottle for 
incubation with Ni-NTA resin. 
Step 3:  Ni-NTA Affinity Chromatography.  To the crude extract was added 10 mL 
of Ni-NTA slurry (5 mL of resin) and the resulting mixture was incubated for 2 h with 
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gentle shaking at 4 °C.  The majority of the supernatant was decanted after the resin was 
spun down to the bottom of the centrifuge bottle with brief centrifugation at low speed 
(1,000 g).  The remaining resin slurry was mixed well and loaded into an empty glass 
column (1 x 25 cm).  The column was washed with 10 mL of lysis buffer and various
amounts of wash buffers.  The wash buffers and elution buffer used contain the same 
ingredients as the lysis buffer except that the concentrations of imidazole were altered.  
The column was washed sequentially with 50 mL of wash buffer containing 20 mM 
imidazole, and 20 mL of wash buffer containing 40 mM imidazole.  No peristaltic pump 
was used.  The buffer passed through the column by gravity at a flow rate of 1.0 mL/min.  
After washing, TylX3 protein was eluted with 20 mL of elution buffer containing 250
mM imidazole.  Eluted protein was transferred into a dialysis bag and dialyzed against 
four 1.0 L portions of dialysis buffer (50 mM Tris, 15% glycerol, pH 7.5) for 1 h per liter 
of buffer.  The dialyzed protein was concentrated by ultrafiltration in an Amicon 
concentrator using a YM-10 membrane (Amicon) and stored at –80 °C.  The typical yield 
was about 60 mg of pure TylX3 from 6 L culture.  
Purification of the TylC1 Protein.  The gene encoding TylC1 has been cloned into 
vector pET24b(+) to give the tylC1 gene with a 60bp extension containing six successive 
His codons attached to the 3’ end, by Dr. Huawei Chen of our laboratory.  This construct 
was referred to as pHC46.  Thus, the expressed protein has a His6 tag at the C-terminus.  
All purification steps were carried out at 4 °C.  
Step 1:  Growth of E. coli BL21-pHC46 Cells.  An overnight culture of E. coli
BL21(DE3)-pHC46, grown in LB medium supplemented with kanamycin (30 µg/mL) at 
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37 °C, was diluted 250-fold by addition of 4 mL of the overnight culture to each of six 1 
L flasks of the same medium and incubated at 37 °C until the OD600 reached 0.3.  The 
incubation temperature was adjusted to 24 °C and the incubation was continued for one 
more hour before the OD600 reached 0.4.  The culture was then induced with IPTG to a 
final concentration of 0.05 mM and allowed to grow for an additional 15 h at 24 °C.  The 
cells were then harvested by centrifugation at 5,000 g for 10 min at 4 °C and stored at –
80 °C.  The typical yield of wet cells was about 8 g per liter.
Step 2:  Crude Extract Preparation.  The cells were resuspended in 80 mL of lysis 
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, 5 mM 
2-mercapto-ethanol, pH 8.0), and disrupted with five 1 min sonication bursts, with one 
min cooling intervals between bursts.  Cellular debris was removed by centrifugation at 
35,000 g for 20 min.  The supernatant was transferred into a large centrifuge bottle for 
incubation with Ni-NTA resin.  
Step 3:  Ni-NTA Affinity Chromatography.  To the crude extract was added 6 mL 
of Ni-NTA slurry (3 mL of resin) and the resulting mixture was incubated for 2 h with 
gentle shaking at 4 °C.  The majority of the supernatant was decanted after the resin was 
spun down to the bottom of the centrifuge bottle with brief centrifugation at low speed 
(1,000 g).  The remaining resin slurry was mixed well and loaded into an empty glass 
column (1 x 25 cm).  The column was washed with 30 mL of lysis buffer and wash 
buffers of increasing concentrations of imidazole.  The wash buffers and elution buffer 
used contained the same ingredients as the lysis buffer except that the concentrations of 
imidazole were altered.  The column was washed sequentially with 30 mL of wash buffer 
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containing 20 mM imidazole, 30 mL of wash buffer containing 40 mM imidazole and 15 
mL of wash buffer containing 60 mM imidazole.  No peristaltic pump was used.  The 
buffer passed through the column by gravity at a flow rate of 1.0 mL/min.  After 
washing, the TylC1 protein was eluted with 15 mL of elution buffer containing 250 mM 
imidazole.  The eluted protein was transferred into a dialysis bag and dialyzed against 
four 1.0 L portions of dialysis buffer (50 mM Tris, 15% glycerol, pH 7.5) for 1 h per liter 
of buffer.  The dialyzed protein was concentrated by ultrafiltration in an Amicon 
concentrator using a YM- 10 membrane (Amicon) and stored at –80 °C.  
Polyacrylamide Gel Electrophoresis.  The subunit molecular mass and the purity 
of the protein samples were assessed by SDS-PAGE.  Electrophoresis was carried out in 
the discontinuous buffer system of Laemmli,149 and the separating gel and stacking gel 
were 12% and 4% polyacrylamide, respectively.  Prior to electrophoresis, protein samples 
were mixed with 2 x loading buffer (62.5 mM Tris-HCl, 10% glycerol, 2% SDS, 5% β-
mercaptoethanol, and 0.0025% bromophenol blue, pH 6.8) and heated in boiling water 
for 3 min.  Electrophoresis was done in SDS-PAGE running buffer (25 mM Tris-HCl, 
192 mM glycine, and 0.1% SDS, pH 8.3) at 200 V.  Gel was stained with Coomassie blue 
and destained with acetic acid/ethanol/water (10: 8: 82 by volume).  The subunit 
molecular mass was estimated by SDS-PAGE as described by Laemmli.149  Protein 
standards for SDS-PAGE include α-lactalbumin (14 kDa), trypsin inhibitor (20 kDa), 
trypsinogen (24 kDa), carbonic anhydrase (29 kDa), glycerol-3-phosphate dehydrogenase 
(36 kDa), egg albumin (45 kDa), and bovine serum albumin (66 kDa). 
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Molecular Weight Determination.  Native molecular weights of SpnO and SpnN 
were measured by size exclusion chromatography using a Pharmacia FPLC equipped 
with a Superdex 200 HR 10/30 column.  The buffer (50 mM sodium phosphate, 0.15 M 
NaCl, pH 7.0) was recommended by the column manufacturer, A flow rate of 0.5 mL/ 
min was used in the analysis.  Calibration of the column was achieved using the 






















































1) a. Dowex (H+); b. Et3N. 2) a. Dowex (H
+); b.  morpholine, DCC. 3) 1H-tetrazole, pyridine, 
r.t..
Scheme 2-4 . Synthetic scheme for TDP-glucose.
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kDa), bovine serum albumin (66 kDa), alcohol dehydrogenase (150 kDa), and β-amylase 
(200 kDa).  The void volume (Vo) of the column was measured using blue dextran.  A 
linear fit to a plot of the molecular weight versus Ve/Vo was used to estimate the native 
molecular mass (Mr).
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Synthesis of TDP-glucose.  Chemical synthesis of TDP-glucose was carried out 
according to the scheme shown in Scheme 2-4.Preparation of TMP (H+).  Dowex cation 
exchange resin was packed in a glass column (2.5 x 22 cm) and was charged with 
hydrogen cation by washing with 1 L of 8% (w/v) HCl.  Excess acid was removed by 
extensive washing with H2O until the pH of the eluent was between 5 and 6.  TMP 
disodium salt was dissolved in 2 mL of H2O and applied to the top of the resin.  The 
column was washed with water by gravity.  The fraction size of the eluent was set at 8 
mL.  The fractions whose pH values were near 1 as tested by pH paper were combined 
and subjected to lyophilization.  
Preparation of 1H-tetrazole.  The commercial 1H-tetrazole is a 3% (w/v) solution 
in acetonitrile.  Evaporation in vacuo gave the solid white powder 1H-tetrazole.  The 
identity of the compound was confirmed by 1H NMR.  1H NMR (D2O): δ 9.00 (1H, s).
Preparation of TMP- morpholidate.  The synthesis was carried out according to 
the procedure described by Moffatt and Khorana.152  A solution of dicyclohexyl-
carbodiimide (4.126 g, 20 mmol) in t-butyl alcohol (45 mL) was added dropwise to a 
refluxing solution of TMP (5 mmol of free acid) in a mixture of water (30 mL), t-butyl 
alcohol (30 mL) and 99.5% morpholine (1.7 mL).  The addition was completed in 10 h, 
and the mixture was further refluxed overnight.  When the mixture was cooled down to 
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room temperature, any crystalline material present was removed by filtration and washed 
with t-butyl alcohol.  The filtrate was evaporated in vacuo until t-butyl alcohol was 
largely removed.  The remaining aqueous phase was extracted three times with ether.  
The clear aqueous solution was then evaporated to dryness in vacuo and the last traces of 
water were removed by lyophilyzation.  The glassy residue was transferred as a solution 
in a minimum volume of methyl alcohol to three 50-mL centrifuge tubes and the volume 
of the methyl alcohol in each centrifuge tube was carefully reduced in vacuo to about 4 
mL.  The addition of dry ether (35 mL) precipitated a gummy solid which on 
precipitation with fresh ether changed to dry white powder.  After a further wash with dry 
ether, the product was dried in vacuo at room temperature.  The TMP-morpholidate was 
obtained as salt of 4-morpholine N,N’-dicyclohexylcarboxamidine in 90% yield.  31P 
NMR (D2O): δ 8.42 ppm.  Low-resolution ESI-MS calculated for C30H53N6O8P (M-H)-
was 655, and a mass of 655 was found.
Preparation of Glucose-1-phosphate Triethylamine.  Dowex cation exchange 
resin was packed in a glass column (2.5 x 22 cm) and charged with hydrogen cation by 
washing with 1 L of 8% (w/v) HCl.  Excess acid was removed by extensive washing with 
H2O until the pH of the eluent was between 5 and 6.  D-glucose-1-phosphate sodium salt 
(1.2 g) was dissolved in 5 mL of H2O and applied to the top of the resin.  The column 
was washed with H2O and the eluent was collected in 8 mL fractions.  The fractions 
whose pH values were near 1 judged by pH paper were combined, and 2 mL of 
triethylamine was added.  After mixing well, the sample was dried by lyophilization. 
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Preparation of TDP-glucose.  Glucose-1-phosphate triethylamine salt (540 mg, 
1.5 mmol), and TMP-morpholidate (1.54 g, 2.25 mmol) were dissolved in 8 mL of 
anhydrous pyridine and the solution was evaporated to dryness in vacuo.  The process of 
dissolving and evaporation was repeated twice with 1H-tetrazole (190 mg, 2.7 mmol) 
added to the solution the second time.  After the last trace amounts of water had been 
removed, the mixture was dissolved in 12 mL of anhydrous pyridine and stirred at room 
temperature under nitrogen for 3 days.  The solvent was removed by evaporation in 
vacuo, while the residue was resuspended in 20 mL of water and extracted with 
chloroform (3 x 15 mL).  The aqueous portion was dried by lyophilization.  The dried 
compounds were redissolved in 2 mL of water and applied to Bio-Rad P2 (extra fine) 
column (2.5 x 120 cm).  The column was run with 25 mM NH4HCO3 buffer at a flow rate 
of 0.24 mL/min.  The fraction size was 6 mL.  The absorbance of each fraction at 267 nm 
was examined with a spectrophotometer and the ones that showed strong absorbance 
were lyophilized as individual fractions.  The purity of each fraction was inspected by 1H 
NMR.  The fractions that contained pure TDP-glucose were saved, while the ones with 
impurities were further purified with Dowex cation exchange column.  The impure 
fractions was concentrated to 12 mg/mL and applied to the Dowex cation exchange 
column (2.5 x 20 cm).  The compounds were eluted with water with a fraction size 
between 2 and 3 mL.  The fractions collected from the Dowex column whose pH values 
were near 1 as judged by pH paper were neutralized with ammonium bicarbonate and 
lyophilized individually.  The purity the TDP-glucose obtained was inspected by 1H 
NMR.  1H NMR (D2O): δ 1.78 (3H, s, 5’’-Me), 2.22 (2H, m, 2’-H), 3.28-3.40 (2H, m, 2-
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H, 3-H), 3.59-3.78 (2H, m, 4-H, 5-H), 3.95-4.06 (3H, m, 4’-H, 5’-H), 4.45 (1H, m, 3’-H), 
5.44 (1H, dd, J = 6.9, 3.3 Hz, 1-H), 6.20 (1H, t, J = 6.9 Hz, 1’-H), 7.59 (1H, s, 6’’-H).  
31P NMR (D2O): δ –10.30 (d, J = 21.4 Hz), -11.83 (d, J = 21.4 Hz).
Preparation of TDP-4-keto-6-deoxy-D-glucose (the RfbB product).  This 
compound was prepared by the RfbB enzymatic reaction with TDP-glucose as the 
substrate.  The 1.5 mL reaction mixture contained 30 mg of TDP-glucose and 1.5 mg of 
RfbB in 20 mM Tris-HCl buffer (pH 7.5).  The reaction was allowed to proceed for 2 h at 
37 °C.  An HPLC based assay with an Adsorbsphere SAX analytical column (5 u, 4.5 x 
250mm) was used to monitor the progress of the reaction.  A linear gradient from 20% to 
60% buffer B (500 mM potassium phosphate, pH 3.5) in buffer A (50 mM potassium 
phosphate, pH 3.5) over 20 min gave satisfactory separation between the substrate 
(retention time = 12.5 min) and the product (retention time =13.2 min).  The RfbB 
protein was removed with Centricon YM-10 microconcentrator (Amicon), and the filtrate 
was used directly without further purification.  Spectra of RfbB product: 1H NMR (D2O): 
δ 1.04 (3H, d, J = 6.6 Hz, 5-Me), 1.75 (3H, s, 5’’-Me), 2.14-2.24 (2H, m, 2’-Hs), 3.44 
(1H, ddd, J = 10.0, 3.6, 3.3 Hz, 2-H), 3.60 (1H, d, J = 10.0 Hz, 3-H), 3.92 (1H, q, J =6.6 
Hz, 5-H), 3.95-4.06 (3H, m, 4’-H, 5’-Hs), 4.40-4.48 (1H, m, 3’-H), 5.36 (1H, dd, J = 7.0, 
3.6 Hz, 1-H), 6.17 (1H, t, J = 6.9 Hz, 1’-H), 7.56 (1H, s, 6’’- H).  
Activity Assays for SpnN.  
a. UV-absorption Activity Assay.  The activity of SpnN was examined 
spectrophotometrically by following the consumption of NADPH at 340 nm (ε340 = 6220 
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M-1 cm-1).  A typical assay mixture of 100 µL contained 0.85 mM of the RfbB product, 
0.18 mM of NADPH, 2 µg of TylX3 and 4 µg of SpnN in 50 mM potassium phosphate 
buffer (pH 7.5).  The reaction was initiated by the addition of TylX3 and was carried out 
at room temperature (24 °C).  The absorbance decrease at 340 nm was linear for the first 
5 min.  
b. HPLC Activity Assay.  The HPLC assay was developed for SpnN by 
monitoring the formation of new product(s) at 267 nm with a Dionex CarboPacTM PA1 
analytical column (4 x 250 mm) connected to a CarboPacTM PA1 guard column (4 x 50 
mm).  A typical assay mixture of 50 µL contained 0.42 mM of TDP-Glu, 80 µg of RfbB, 
0.1 mM of NADPH, 1 µg of TylX3, 2 µg of of SpnN, and 50 mM potassium phosphate 
(pH 8.0).  The reaction was initiated by the addition of TylX3 and was carried out at 
room temperature (24 °C).  A suitable amount of reaction mixture was withdrawn at 
appropriate time intervals.  The reaction was terminated by dilution with a 10-fold excess 
of water and flash freezing in liquid nitrogen.  The enzyme was removed by filtering 
through Centricon YM-10 microconcentrator by centrifugation.  The filtrate was then 
subjected to HPLC analysis.  A linear gradient from 5 to 20% B over 15 min followed by 
another linear gradient from 20 to 60%B over 20 min was used to resolve the substrate 
TDP-glucose (retention time = 41.5 min) and the SpnN product (retention time = 33.4 
min).  Buffer A was water and Buffer B was 500 mM NH4OAc, pH 7.0, adjusted with 
diluted NH3·H2O.  The elution gradient was followed by a final wash with 100% B for 5 
min, and a reequilibration with 5% B for 15 min.  
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Determination of the Reducing Agent.  Two reducing agents, NADH and NADPH 
were examined for their ability to reduce the SpnO product in the SpnN catalyzed 
reaction.  The compounds were individually added to a final concentration of 0.15 mM in 
the SpnN UV-absorption activity assays described above.  The efficiency of the two as 
reducing agents was compared by calculating the initial rate of absorbance decrease at 
340 nm. 
Catalytic Activity of SpnN Compared with TylC1.  Two enzyme pairs, 
TylX3/SpnN and TylX3/TylC1 were examined for their efficiency to produce each 
corresponding 2-deoxygenated sugar.  The UV-absorption assays were carried out as 
described before with 0.92 µM of TylX3 and 2.0 µM of SpnN or TylC1 in the reaction 
mixture.  The catalytic activities of the two enzyme pairs were compared by calculating 
the initial rate of absorbance decrease at 340 nm. 
Activity Assays for SpnO.
a. UV-absorption Activity Assay.  The activity of SpnO was determined 
spectrophotometrically by following the consumption of NADPH at 340 nm (ε340 = 6220 
M-1 cm-1).  A typical assay mixture of 100 µL contained 17 µM of TDP-6-deoxy-4-keto-
glucose, 18 µM of NADPH, 0.4 µg of SpnN and 0.2 µg of SpnO in 50 mM potassium 
phosphate buffer (pH 7.5).  The reaction was initiated by the addition of SpnO and was 
carried out at room temperature (24 °C).  
b. HPLC Activity Assay.  The HPLC assay that was developed for SpnO was 
carried out by monitoring the formation of the degradation product, maltol, at 267 nm 
with a Dionex CarboPacTM PA1 analytical column (4 x 250 mm) connected to a 
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CarboPacTM PA1 guard column (4 x 50 mm).  A typical assay mixture of 50 µL contained 
30 µM of RfbB product, 1 mM of MgCl2, 4.2 µM of SpnO, and 50 mM potassium 
phosphate (pH 7.5).  The reaction was initiated by the addition of SpnO and was carried 
out at room temperature (24 °C).  A suitable amount of reaction mixture was withdrawn 
at appropriate time intervals.  The reaction was terminated by a 10-fold dilution in water 
and flash freezing in liquid nitrogen.  The enzyme was removed by filtering through a 
Centricon YM-10 microconcentrator with centrifugation.  The filtrate was then subjected 
to HPLC analysis.  A linear gradient from 5 to 20% B over 15 min followed by another 
linear gradient from 20 to 60%B over 20 min was used to resolve the substrate RfbB 
product (retention time = 35.3 min) and the degradation product (retention time = 2.4 
min).  Buffer A was water and Buffer B was 500 mM NH4OAc, pH 7.0 adjusted with 
diluted NH3·H2O.  The elution gradient was followed by a final wash with 100% B for 5 
min, and a reequilibration with 5% B for 15 min.  
Isolation and Characterization of the SpnN product.  A preparative incubation 
contained 25 mg of TDP-glucose (41.8 µmol), 2.1 mg of RfbB, and 21.6 mg of NADPH 
(26.0 µmol) in 1.5 mL of 50 mM Tris-HCl buffer (pH 7.5, containing 10% glycerol).  
The reaction was initiated by the addition of TylX3 (15 nmol) and SpnN (25 nmol).  Due 
to the instability of the TylX3 product, an excess of SpnN was used.  The reaction was 
incubated at room temperature and was followed by monitoring the consumption of 
NADPH at 340 nm.  Usually, the decrease of the absorbance at 340 nm stopped after 4 h.  
The enzymes were removed with a Centricon YM-10 microconcentrator (Amicon), and 
the filtrate was then separated by a gel filtration column (Bio-Rad P2, extra fine, 2.5 x 
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120 cm) that had been preequilibrated with 25 mM NH4HCO3.  The column was run with 
the same buffer at a flow rate of 12 mL/h at 4 °C.  Fractions were analyzed 
spectrophotometrically at 267 nm and 340 nm.  The fractions that displayed a single 
absorption maximum at 267 nm were lyophilized individually and analyzed by NMR.
Spectra data for the TylX3/SpnN product: 1H NMR (D2O): δ 1.07 (3H, d, J = 6.3 Hz, 5-
Me), 1.71 (1H, m, 2-Hax), 1.79 (3H, s, 5’’-Me), 2.01 (1H, ddd, J = 13.2, 5.2, 1.2, 2-Heq), 
2.22 (2H, m, 2’-H), 3.88 (1 H, dd, J = 11.7, 5.1 Hz, 3-H), 3.90 (1H, q, J = 6.6 Hz, 5-H), 
4.03 (3H, m, 4’-H, 5’-H), 4.48 (1H, m, 3’-H), 5.48 (1H, dd, J = 6.9, 3.3 Hz, 1-H), 6.21 
(1H, t, J = 7.2 Hz, 1’-H), 7.62 (1H, s, 6’’-H).  13C NMR (D2O): δ 11.6, 11.9, 36.1 (d, J = 
6.3 Hz), 38.9, 68.3, 70.3, 71.2, 85.2, 85.6 (d, J = 9.3 Hz), 93.3, 94.7 (d, J = 5.5 Hz), 
112.0, 137.6, 152.0, 166.9, 207.2.  31P NMR (D2O): δ –10.7 (d, J = 21.2 Hz), -12.7 (d, J = 
21.2 Hz).  High-resolution FAB-MS calculated for C16H23N2O14P2 (M-H)
- was 529.0624, 
and a mass of 529.0627 was found.  
3.  RESULTS AND DISCUSSION
Cloning and Overexpression of the SpnO Protein.  The protein encoded by spnO
gene has significant sequence similarity to several proteins that are proposed to be 
dehydratases in deoxysugar biosynthesis.  In order to clearly demonstrate the role that 
SpnO plays in TDP-D-forosamine biosynthesis, we decided to isolate the protein.  Three 
clones were made with spnO gene ligated to either the pET28b(+) or the pET24b(+) 
vector.  Both pET24b and pET28b carry a T7 promoter.  A high level of expression of T7 
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RNA polymerase is induced in the BL21 host strain by addition of IPTG, thereby 
inducing a high level of expression of the gene downstream of the promoter. 
 The N-terminal His6-tagged SpnO was highly expressed.  When the whole cell 
lysate of the pLHON-transformed cells was solubilized with SDS and analyzed by SDS-
PAGE, there was a significant enrichment of a protein of molecular weight of 56 kDa, the 
size of SpnO, as compared to the negative control.  In the negative control, the expression 
cells were transformed with empty pET28b(+) vector and were grown under the same 
conditions as the expression cells transformed with the pLHON clone.  The natural gene 
without any tag when expressed in E. coli induced with IPTG, produced a moderate 
amount of the 54 kDa protein as judged by SDS-PAGE analysis of the solubilized whole 
cell lysate.  However, a solubility test, in which only soluble proteins were analyzed by 
SDS-PAGE, showed that neither the N-terminal tagged SpnO nor the native SpnO was 
soluble to a significant extent.  Most of the expressed protein formed inclusion bodies 
and precipitated after the cells were lysed.  The C-terminal His6-tagged SpnO was poorly 
expressed, and thus, the protein was not subjected to a solubility test.  The cells 
transformed with pLHON were used for further expression tests. 
Various expression conditions were examined.  Expression at 15 °C did not 
significantly improve the protein solubility.  On the other hand, the cell yield of the 
culture grown at 15 °C was much lower than that grown at higher temperatures.  The 
expression condition found to be optimal was to grow the culture at 24 °C for 20 h after 
IPTG induction.  
99
Purification and Characterization of the SpnO Protein (Figure 2-3). N-terminal 
His6-tagged SpnO protein was purified to near homogeneity by a single Ni-NTA affinity 
chromatographic step.  Precipitation of the protein during dialysis was observed.  
Inclusion of 20% glycerol was helpful in stabilizing the protein, but precipitation could 
not be completely avoided.  The yield of SpnO from a 6 L culture, which was 2 mg, was 
much lower than the 60 mg obtained from purification of the homologous protein, TylX3.  
The subunit molecular weight of 56 kDa as estimated by SDS-PAGE correlated well with 
the predicted value of 56,553 Da calculated from the deduced amino acid sequence (plus 
the N-terminal His6-tag).  A Mr of 96 kDa, as judged by gel filtration chromatography, 
indicates that the native SpnO exists as a homodimer.  The standard curve for molecular 
weight determination is shown in Figure 2-4.  The absorption spectrum of the purified 
protein shows no absorbance above 300 nm.
Cloning and Expression of the SpnN Protein.  To examine the function of the 
spnN-encoded enzyme, the gene was cloned into various expression vectors.  Numerous 
attempts to obtain a usable yield of soluble SpnN were carried out by Dr. Zhao.  
Originally, the start codon of the gene was thought to exist eight nucleotides downstream 
of the spnO gene (Figure 2-5).  This gene, named spnN-short, was ligated into several 
pET vectors.  However, none of these clones gave a decent expression of spnN-short.  
Several strategies, including ligation of spnN-short into pET vectors at different 
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Figure 2-3.  SDS-polyacrylamide gel electrophoresis of proteins obtained in Chapter 2. 
Lanes 1 and 7, molecular markers; lane 2, RfbB protein; lane 3, TylX3 protein; lane 4, 
TylC1 protein; lane 5, SpnO protien; lane 6, SpnN protein.
Figure 2-4. Molecular weigh determination standard curve.
restriction sites, and insertion of an E. coli ribosome binding site (RBS) directly upstream 
of spnN-short were tried, with no improvement in the protein expression observed.  In 
addition, various expression hosts were tested, such as E. coli BL21(DE3), BL21(DE3) 
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pLysS, HMS174(DE3), RosettaTM2(DE3), RosettaBlue-TM2(DE3), BL21-
CodonPlus(DE3)-RP, and yeast Pichia pastoris.  Again, no expression of spnN-short was 
observed.  Later, close inspection of the gene cluster revealed that there was another ATG 
start codon which overlapped with the stop codon of the spnO gene (Figure 2-5, a.).  This 
ATG codon is in frame with spnN-short, and begins 12 nucleotides upstream of the spnN-
short start codon.  Translation initiation at this upstream start codon would result in
CATAGCTTGT GGGCGTTGGG GCGATGACCA GCTCGATGCG AAAGCCGGTG CGCATCGGT










Figure 2-5.  (a). The spnN and spnO gene arrangement.  There are two possilbe ORFs for spnN: one 
starts 8 nts downstream of spnO gene; the other one starts just before the end of spnO gene.  (b). 
Mutation of rare Arg codons in spnN to commonly used codons in E.coli. The numbers indicate the 
location of the rare codons in spnN-long gene.  
addition of 4 amino acids, MTSS, to the N-terminus of SpnN-short.  This open reading 
frame (ORF), named spnN-long, was cloned into pET24b(+) vector.  The resulting vector 
was expressed in BL21(DE3), and showed a small improvement in the yield of SpnN 
protein.  However, a usable amount of SpnN could not be isolated from a large-scale 
preparation using this clone.  The sequence of spnN-long was scrutinized again.  It was 
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found that there is one occurrence of AGGAGG within the gene sequence, occurring 
from nucleotide 352 to nucleotide 357 (Figure 2-5, b.).  AGG encodes Arg, but is an 
extremely rare codon in the E. coli genome.  The occurrence of two rare codons in 
tandem could make expression of the gene very difficult.  In an attempt to overcome this 
problem, the AGGAGG sequence was mutated to CGTCGC. Both CGT and CGC are 
more commonly used codons encoding Arg in E. coli.  The clone containing the 
optimized spnN-long gene was transformed into E. coli BL21-CodonPlus(DE3)-RP 
expression strain.  The SpnN protein was finally expressed in high quantity after IPTG 
induction, as judged by SDS-PAGE and Western-Blot of the whole cell lysate which had 
been solubilized by SDS. 
Purification and Characterization of the SpnN Protein (Figure 2-3).  The protein 
was purified to near homogeneity by a single Ni-NTA chromatographic step.  However, 
the binding between SpnN and the Ni-NTA resin was not tight.  The protein began to 
elute from the resin along with impurities when the imidazole concentration in the 
washing buffer rose to 40 mM.  The remaining portion of SpnN that eluted with 100 mM 
imidazole was nearly pure.  About 4 mg of SpnN protein was obtained from 6 L of cell 
culture.  Considering the high level of expression of the protein, such a low yield 
indicated that most of the protein that was expressed in the host cells formed inclusion 
bodies.  Expression at lower temperatures, such as 15°C, did not improve the solubility of 
the protein.  The subunit molecular weight of 37 kDa estimated by SDS-PAGE is 
consistent with a molecular weight 37602 Da deduced from the translated amino acid 
sequence of SpnN (including the His6-tag).  The molecular weight of native SpnN was 
103
estimated to be 38 kDa by gel filtration chromatography, suggesting that the protein is a 
monomer in solution.  The absorption spectrum of the purified protein shows no 
absorbance above 300 nm.  
Synthesis of TDP-glucose.  Because TDP-glucose is the starting material in the 
TDP-D-forosamine biosynthetic pathway, a large amount of TDP-glucose is required in 
order to isolate the enzymatic products formed in the later steps in the forosamine 
biosynthesis.  The inhibitory cost of TDP-glucose from commercial sources prompted us 
to resort to chemical synthesis.  The commercially available starting materials TMP and 
glucose-1-phosphate were both in sodium salt form, making them less soluble in organic 
solvent and inactive for organic reactions.  By addition of the sodium salts of these 
compounds to a Dowex cation exchange column that had been charged with H+, glucose-
1-phophate and TMP were obtained in their acidic (H+) forms.  To improve the yield of 
the coupling reaction with TMP-morpholidate, the acidic form of glucose-1-phophate 
was further reacted with triethylamine to form glucose-1-phosphate triethylamine salt, 
which has improved solubility in pyridine.  The synthesis of TMP-morpholidate was 
done according to the procedure established by Moffatt and Khorana (90% yield).152  The 
compound was stable enough to tolerate overnight reflux.  The coupling reaction between 
glucose-1-phosphate triethylamine and TMP-morpholidate requires an anhydrous 
environment.  Trace amounts of water in the solvent reduce the product yield.  The 
reaction was monitored by 31P NMR and was quenched when the doublet peaks at around 
–10 ppm and –12 ppm stopped increasing.  Half of the TDP-glucose formed was isolated 
in pure form by Bio-Gel P-2 chromatography.  The remainder was further purified by 
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Dowex cation exchange chromatography.  The total yield of TDP-glucose was about 
80%. 
Purification of the TylX3 and RfbB Proteins (Figure 2-3).  TDP-6-deoxy-4-keto-
glucose is a common intermediate in TDP-deoxysugar biosynthetic pathways.  However, 
the enzyme catalyzing the conversion of TDP-glucose (2) to TDP-6-deoxy-4-keto-
glucose (3) could not be identified in the TDP-forosamine biosynthetic gene cluster.  In 
vivo, TDP-6-deoxy-4-keto-glucose (3) used for TDP-D-forosamine biosynthesis is likely 
obtained from general cellular pools, since the compound is used as a precursor in other 
pathways, known to exist in Actinomycetes.147,165,166   To characterize the enzymatic steps 
involved in TDP-D-forosamine biosynthesis in vitro, an enzyme that could convert TDP-
glucose (2) to TDP-6-deoxy-4-keto-glucose (3) is needed.  Thus, the RfbB protein, a 
TDP-glucose-4,6-dehydratase from E. coli K12 was purified.  An N-terminal His6-tag 
greatly facilitated RfbB purification procedures and the yield of the soluble protein was 
quite high.  The protein could be purified to near homogeneity by a single Ni-NTA 
chromatographic step.  About 120 mg of pure RfbB protein was obtained from a 6 L 
culture grown in LB medium.  
Since the yield of the purified SpnO protein was low and the protein showed 
significant instability, an SpnO replacement was needed in order to isolate the product 
from the SpnO/SpnN coupled reaction.  TylX3, the protein that catalyzes 2,3-dehydration 
of TDP-6-deoxy-4-keto-glucose (3) in the TDP-mycarose biosynthetic pathway, shows 
43.8% sequence identity to the SpnO protein and so was chosen to replace SpnO.  The N-
terminal His6-tagged protein was purified to near homogeneity by a single Ni-NTA 
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chromatographic step.  About 60 mg of pure protein was obtained from a 6 L culture 
grown in LB medium.  An amount of 15% glycerol was included in all buffers to reduce 
protein precipitation during purification.  Although some precipitation occurred, a 
significant amount of TylX3 remained stable.  It is interesting to observe that the two 
homologous proteins, TylX3 and SpnO, displayed different solubilities in the expression 
host cells, and different binding affinities to the Ni-NTA resin.  These differences lead to 
different yields of the proteins. 
Purification of the TylC1 Protein (Figure 2-3).  In the TDP-L-mycarose 
biosynthetic pathway (Scheme 2-3), TylC1 catalyzes the C-3 ketoreduction of the TylX3 
product, a function analogous to that proposed for SpnN, except that the stereochemistry 
of the C-3 hydroxyl group is predicted to be equatorial in the SpnN reaction, as opposed 
to axial, as was observed in previous studies by our group in the TylX3/TylC1 reaction.71
It would be interesting to compare the catalytic rates of the two enzymes SpnN and 
TylC1.  Thus, the C-terminal His6-tagged TylC1 protein was purified to near 
homogeneity by a single Ni-NTA chromatographic step.  About 4 mg of pure TylC1 was 
obtained from a 6 L culture grown in LB medium.  The inclusion of 15% glycerol in all 
the buffers was crucial to prevent TylC1 from precipitating during the purification.  
Activity Assays for SpnN.  TylX3 has been characterized as the hexose 2,3-
dehydratase in the TDP-L-mycarose biosynthetic pathway71.  The TylX3 product was 
previously shown to be reduced by the NADPH-dependent catalysis of the reductase 
TylC1.  Accordingly, in the UV activity assay for SpnN, the reduction of the TylX3 
product was quantified by following the decrease of A340 caused by NADPH oxidation.  
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In the HPLC assay, the disappearance of TDP-glucose and the simultaneous formation of 
the SpnN product were observed.  
Reducing Agent for SpnN.  NADPH has been shown to be the substrate in the Gra 
Orf26 and TylC1 catalyzed reduction reactions.  On the other hand, sequence analysis 
demonstrated that a number of ketoreductases and oxidoreductases that have significant 
sequence similarity to SpnN use NAD(H) as cosubstrate or cofactor.  Both NADH and 
NADPH were examined as possible reducing agents in the SpnN-catalyzed reaction.  It 
was found that NADH and NADPH could each act as a reducing agent in the SpnN-
catalyzed reaction, although NADPH was preferred (Figure 2-6).  The rate difference of 
the reactions using these two reducing agents was about 2 folds. 
Figure 2-6. Reducing agent determination: NADPH vs. NADH.
Catalytic Activity of SpnN vs. TylC1.  Since both enzymes pairs, SpnO/SpnN and 
TylX3/TylC1, catalyze C-2 deoxygenation in deoxysugar biosynthesis, it would be 
interesting to compare the catalytic efficiency of the two pairs.  However, the fact that 
SpnO could only demonstrate its in vitro catalytic activity at low substrate concentrations 
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precluded accurate measurement of the activity of the SpnO/SpnN pair.  Nonetheless, it 
would still be informative to compare the catalytic rates of TylC1 and SpnN.  In 
TylX3/TylC1 and TylX3/SpnN coupled assays using the same concentration of TylX3, 
SpnN was demonstrated to be a superior reductase compared with TylC1, as shown by a 
20-fold increase in NADPH consumption for the TylX3/SpnN pair over the TylX3/TylC1 
pair (Figure 2-7).  This result is intriguing since TylX3/TylC1 is a natural enzyme pair, 
participating in TDP-L-mycarose biosynthesis, while TylX3 and SpnN are from different 
deoxysugar biosynthetic pathways.  It is possible that the inferior catalytic activity 
demonstrated by TylX3/TylC1 might be due to the stereochemistry of the hydroxyl group 
in the product.  The axial hydroxyl group of the TylC1 product (28, Scheme 2-3) is 
thermodynamically unstable compared with the equatorial hydroxyl group of the SpnN 
product (24, Scheme 2-1) and thus might be more difficult to form.
Figure 2-7.  Comparison of reduction efficiency between SpnN and TylC1.
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Activity Assays for SpnO.  SpnO has displayed low solubility in expression cells 
and poor binding affinity to Ni-NTA resin, which is quite different from the previously 
characterized TylX3.  However, a more unexpected difference came from the catalytic 
activities that the two enzymes displayed.  TylX3 has been demonstrated to be a quite 
efficient enzyme.129  When the enzyme was mixed with TDP-6-deoxy-4-keto-glucose (3, 
Scheme 2-3), the degradation product maltol (66, Scheme 2-3) quickly formed in the 
absence of a reductase.70,71,129  Moreover, in the UV activity assay for SpnN, the decrease 
of A340 was obvious after the addition of TylX3, revealing the efficiency of the 
TylX3/SpnN pair.  In contrast, the UV activity assay for SpnO showed that A340 did not 
decrease at all when the concentration of the substrate TDP-6-deoxy-4-keto-glucose was 
higher than 0.2 mM.  Since SpnN had been proved to be an active enzyme in the activity 
assays described previously, the failure to observe the absorbance decrease at 340 nm in 
the SpnO/SpnN coupled assay was ascribed to SpnO.  Originally, it was speculated that 
the presence of the N-terminal His6-tag in the recombinant protein interfered with the 
enzymatic activity.  However, removing the His6-tag by thrombin cleavage did not yield 
a more active protein.  Only when the concentration of TDP-6-deoxy-4-keto-glucose was 
decreased to lower than 0.2 mM, was a slight decrease of A340 observed (Figure 2-8, a).  
Lower concentrations of TDP-6-deoxy-4-keto-glucose were tested in an attempt to 
improve SpnO catalytic activity.  The extent of A340 decrease was only slightly greater 
when the substrate concentration was reduced to 15 µM compared with that observed at 
0.2 mM substrate concentration.  Mg2+ did not improve the efficiency of SpnO. 
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SpnO was thought to catalyze the same reaction as TylX3 in the forosamine 
biosynthetic pathway.  The authentic TylX3 product undergoes degradation to yield TDP 
and maltol (66) in the absence of TylC1.  Thus, when incubating TDP-6-deoxy-4-keto-








I. with SpnO in the reaction. II. without SpnO in the reaction.
Figure 2-8.  SpnO activity assays. (a). UV-absorption assay. (b). HPLC assay. 
The assay conditions were described in the Experimental Procedures section.
glucose with SpnO, the products are expected to be TDP and maltol.  Formation of maltol 
was immediately observed after the addition of SpnO when the reaction was monitored 
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by HPLC (Figure 2-8, b).  Since the substrate TDP-6-deoxy-4-keto-glucose contained a 
small amount of TDP, a slight increase in the amount of TDP was difficult to confirm.  
Although the size of the maltol peak in HPLC traces of the SpnO reaction is small, its 
presence was definite by comparison of the trace with that of a control reaction in which 
SpnO was omitted.  This is also consistent with the minor A340 decrease observed in the 
SpnO reaction when monitored by UV.  Consistent with the UV activity assay, the 
degradation products of the SpnO reaction could only be observed when the substrate 
concentration was lower than 0.2 mM.  In spite of the low conversion percentage, the 
formation of maltol was quick and reached near maximum level within 1 min.  Extending 
the incubation time to 1 h only slightly increased the amount of maltol formed.
In summary, SpnO can catalyze the 2,3-dehydration of the substrate TDP-6-
deoxy-4-keto-glucose (3) to form TDP-2,6-dideoxy-3,4-diketo- glucose (23), which in the 
presence of SpnN and NADPH was reduced to TDP-2,6-dideoxy-4-keto-glucose.  In the 
absence of SpnN and NADPH, the SpnO product was hydrolyzed to form TDP and 
maltol (66).  However, SpnO was catalytically less competent than the homologous 
TylX3.  One justification for these results is that the conditions of an in vitro assay where 
product accumulates, are quite different from the in vivo system where the SpnO 
catalyzed reaction is coupled to both upstream and downstream reactions.  In vivo, the 
substrate is produced gradually by upstream pathway enzymes, and the product of the 
SpnO reaction may be quickly channeled to the downstream enzymes in the TDP-D-
forosamine biosynthetic pathway allowing SpnO to achieve its maximal catalytic rate 
without encountering substrate or product inhibition.  It is also possible that the 
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production of TDP-L-rhamnose and TDP-D-forosamine are fine-tuned by the 
concentration of TDP-6-deoxy-4-keto-glucose by the action of SpnO. When the 
concentration is high, 2,3-dehydration of TDP-6-deoxy-4-keto-glucose may be minor 
compared to 3,5-epimerization of it to initiate TDP-L-rhamnose biosynthesis.  SpnO may 
have evolved to be less competent so that the majority of TDP-6-deoxy-4-keto-glucose in 
the general cellular pool is routed toward production of other products besides TDP-D-
forosamine.  A full understanding of the differences that TylX3 and SpnO have displayed 
must await further investigation.  Study of the interaction between SpnO and SpnN to 
support possible substrate channeling of the unstable SpnO product using two-hybrid 
system in Yeast is ongoing.153
Isolation and Characterization of the TylX3/SpnN Product.  The SpnN product 
was isolated from a one-pot reaction mixture containing TDP-glucose, RfbB, NADPH, 
TylX3 and SpnN.  The use of TylX3 instead of SpnO in the reaction was due to the low 
yield and the instability of the latter protein.  It had been explained earlier that TylX3 and 
SpnO share 43.8% identity and catalyze identical reactions.  Thus, the replacement of 
SpnO with TylX3 is a reasonable choice from a practical standpoint, where the highest 
percent conversion to SpnN product is desired.  The RfbB catalyzed TDP-6-deoxy-4-
keto-glucose formation has been demonstrated to be a quick and efficient reaction.  In 
addition, an excessive amount of RfbB was added in the reaction mixture to ensure that 
the TDP-glucose-4,6-dehydration reaction would not be rate-limiting.  As shown in 
Figure 2-9, there were some major changes in the NMR spectrum of the TylX3/SpnN 
product compared to that of the starting material TDP-glucose: a sharp doublet appeared 
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at 1.05 ppm, there were two groups of multiplets centered at 1.70 ppm and 2.00 ppm 
respectively, and the portion of the spectrum between 3.20 ppm and 4.00 ppm became 
simplified.  The spectrum is consistent with the structure of TDP-2,6-dideoxy-4-keto-
glucose.  The sharp doublet at 1.05 ppm was assigned as the 5-Me group; the two groups 
of multiplets at 1.70 ppm and 2.00 ppm were assigned to 2-Hax and 2-Heq respectively; 
the simplification of the spectrum between 3.20 and 4.00 pm was due to the 
disappearance of 4-H and the upfield shift of two 2-H protons.  In the TDP-L-oleandrose 
biosynthetic pathway (Scheme 2-3), the Gra Orf27/Gra Orf26 enzyme pair catalyzes the 
conversion from TDP-6-deoxy-4-keto-glucose (3) to TDP-2,6-dideoxy-4-keto-D-glucose 
(24) whose structure has been characterized with 1D and 2D 1H NMR by Floss group70.  
Our laboratory has isolated the product from the TylX3/TylC1 catalyzed reaction in the 
TDP-L-mycarose biosynthetic pathway (Scheme 2-3), which was established to be TDP-
2,6-dideoxy-4-keto-D-allose (28)71.  Although the two compounds that had been isolated 
in the two groups were both C-2 deoxygenated products, they were different in the 
stereochemistry at C-3.  The C-3 hydroxyl group in the latter case was axial, as revealed 
by the coupling constants for 3-H and the lack of the Nuclear Overhauser Effect (NOE) 
between 3-H and 5-H.71,129  In contrast, the C-3 hydroxyl group in the Gra Orf27/Gra 
Orf26 product is equatorial.70  The product from the TylX3/SpnN reaction has an 
identical 1H NMR spectrum as the compound isolated from the Gra Orf27/Gra Orf26 
reaction.  Combined with the evidence from the high-resolution FAB-MS, 31P NMR and 
13C NMR, the structure of the product from the TylX3/SpnN reaction was determined to 
be TDP-2,6-dideoxy-4-keto-glucose (24) with an equatorial C-3 hydroxyl group.  In view
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of the high sequence similarity between TylX3 and SpnO, the 2,3-dehydratase activity 
that SpnO displayed in the activity assays, and the successful TylX3/SpnN product 
isolation and characterization, the functions of SpnO and SpnN as hexose 2,3-
dehydratase and hexose 3-ketoreductase, respectively, were unambiguously proved. 
4.  CONCLUSIONS
The results presented in this chapter provide unequivocal evidence that SpnO and 
SpnN are TDP-6-deoxy-4-keto-D-glucose 2,3-dehydratase and TDP-2,6-dideoxy-3,4-
diketo- D-glucose 3-ketoreductase, respectively, in the forosamine biosynthetic pathway.  
Through the TylX3/SpnN product isolation and characterization, the removal of the 2-
hydroxyl group in the TDP-forosamine biosynthesis is confirmed to occur through a 
dehydration/reduction route, providing another example of the 2-deoxygenation 
mechanism that has been implicated in all 2-deoxysugar biosynthetic pathways 
characterized thus far.  This may be the general mechanism used in all sugar 2-
deoxygenation reactions that occur in nature. 
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Chapter 3.  Characterization of SpnQ, the TDP-2,6-dideoxy-4-keto-D-
glucose-3-dehydrase
1.  INTRODUCTION
Forosamine is a highly deoxygenated hexose which is deoxygenated at C-2, C-3, 
C-4 and C-6, and possesses an N,N-dimethylamino group at C-4.  The absence of any of 
the hydroxyl groups on the hexose backbone distinguishes forosamine from other 
pyranose sugars and deoxysugars and may confer its specific biological activity.  The 
presence of forosamine has been proven to be essential for the effectiveness of spinosad 
as an insectcide.147
The genes responsible for spinosad biosynthesis have been located and 
sequenced.  The forosamine biosynthetic genes are clustered in a region adjacent to the 
polyketide synthase genes.  Among them, the spnQ-encoded enzyme has been tentatively 
assigned as responsible for C-3 deoxygenation in forosamine biosynthesis based on 
sequence analysis.  The predicted sequence of the protein is similar to those of several 
other sugar biosynthetic enzymes, among which CDP-6-deoxy-L-threo-D-glycero-4-
hexulose-3-dehydrase (E1) has been characterized in detail.  Other examples of close 
homologs of spnQ include aknP, in the aclarubicin biosynthesis gene cluster of 
Streptomyces galilaeus,115 rdmI, in the β-rhodomycin biosynthesis gene cluster of 
Streptomyces violaceus,177 nanG3, in the nanchangmycin biosynthesis gene cluster of 
Streptomyces nanchangensis NS3226,114 and others (Table 1).  Although the structures of 
aclarubicin, β-rhodomycin, and nanchangmycin differ significantly from each other, the 
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AknP aclarubicin Streptomyces galilaeus
RdmI -rhodomycin Streptomyces violaceus



















enzyme organism sequence identitymetabolite
β
Table 3-1.  Enzymes homologous to SpnQ . Listed are the name of the enzyme, the primary or 
secondary metabolite whose biosynthesis requires the enzyme, the organism where the
metabolite is produced and the sequence identity of the enzyme to SpnQ.
spnQ homologs in their biosynthetic gene clusters are all proposed to encode the enzymes 
that catalyze C-3 deoxygenation in the biosynthesis of L-rhodinose, a 2,3-dideoxy-hexose 
sugar that is attached to the polyketide aglycones of these antibiotics.  The C-2 
deoxygenation reactions have been characterized in the biosynthesis of TDP-L-mycarose 
and TDP-L-oleandrose,70,71 as have C-3 deoxygenation reactions in the biosynthesis of 
CDP-L-ascarylose and GDP-L-colitose.59,60,68,69  However, none of the biosynthetic 
pathways of 2,3-dideoxy-hexoses including L-rhodinose have been studied in detail.  As a 
result, the question of the order in which C-2 and C-3 deoxygenation occurs in the 
biosynthesis of 2,3-dideoxy-hexose remains to be answered.  The two possible routes for 
C-2 and C-3 deoxygenation in the biosynthesis of TDP-forosamine are illustrated in 
Scheme 2-2.  In route A, C-2 deoxygenation occurs before C-3 deoxygenation.  As has 
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been characterized in Chapter 2, SpnO and SpnN together catalyze the removal of the C-
2 hydroxyl group, producing a deoxysugar having an equatorial C-3 hydroxyl group.  In 
the route A, this hydroxyl group is removed by the action of SpnQ.  In route B, TDP-6-
deoxy-4-keto-glucose is first deoxygenated at C-3 by the action of SpnQ.  The reaction of 
SpnQ in route B is quite similar to the well-studied E1-catalyzed reaction, with the only 
difference being that the NDP group attached at C-1 of the substrate is TDP rather than 
CDP.  In route B, SpnO would catalyze hexose-2,3-dehydration after the C-3 
deoxygenation to form a carbon-carbon double bond between C-2 and C-3, which would 
be reduced by the catalysis of SpnN.  In Chapter 2, SpnN was demonstrated to be a 
reductase capable of catalyzing 3-ketoreduction.  However, it is also possible that the 3-
keto is in equilibrium with its enol form, and the reduction is carried out on the double 
bond.  Both ketoreduction and alkene reduction are consistent with the use of NADPH as 
the reducing agent.  
In addition to the question of reaction sequence, the C-3 deoxygenation itself is 
mechanistically intriguing.  As described in Chapter 1, there have been two different C-3 
deoxygenation mechanisms characterized so far.  Although the SpnQ-catalyzed C-3 
deoxygenation is not likely to follow an oxidation/reduction or dehydration/reduction 
way as in the characterized C-2 and C-6 deoxygenation respectively, it is possible that the 
reaction might have a mechanism similar to the one proposed for C-4 deoxygenation.  
ColD has recently been characterized as another enzyme that is able to catalyze 
C-3 deoxygenation of a hexose.  Like E1, the enzyme contains a coenzyme B6 cofactor 
PMP that forms a complex with the substrate at the beginning of catalysis.  The ColD 
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reaction is different from the E1-catalyzed reaction in that completion of the reaction does 
not require a reductase, but instead requires the presence of a stoichiometric amount of L-
glutamate.  Although SpnQ is more distantly related to ColD than to E1, the 25.9% 
sequence identity between SpnQ and ColD is still significant enough as not to exclude the 
possibility that SpnQ catalyzes C-3 deoxygenation in a mechanism analogous to ColD.  


















































SpnQ forms a Schiff base with the 4-keto group of the substrate (132).  Abstraction of a 
C-4’ proton induces the departure of the 3-hydroxyl group of the substrate and forms a 
∆3, 4-amino-glucoseen intermediate (133), which upon hydrolysis generates PLP and an 
enamine sugar (134).  The former reacts with L-glutamate to regenerate PMP, while the 
latter undergoes tautomerization followed by hydrolysis to give the 3-deoxygenated 
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product.  The overall reaction begins with the sugar substrate and L-glutamate and ends 
with α-ketoglutarate, ammonia and the deoxygenated sugar product (126).  
Another possibility is that the SpnQ-catalyzed C-3 deoxygenation has a 
mechanism similar to that of DesI and DesII catalyzed C-4 deoxygenation.  It has been 
suggested that both DesI and DesII participate in the C-4 deoxygenation in the 
biosynthesis of desosamine either in a one-step manner requiring formation of a 
DesI/DesII complex or in a two-step manner.  DesI is proposed to be responsible for the 
aminotransfer reaction that occurs at C-4, while DesII is suggested to be a SAM radical 
dependent iron-sulfur protein catalyzing deamination at C-4 and oxidation at C-3.  Most 
of SAM radical-dependent proteins have a consensus CXXXCXXC motif that is 
proposed to be the [4Fe-4S] binding site.  SAM is suggested to bind near the iron-sulfur 
center.  Induced by an electron transferred from the iron-sulfur center, a molecule of 
SAM undergoes reductive cleavage to produce a molecule of methionine and an adenosyl 
radical that is capable of initiating complicated reactions.  From sequence analysis, SpnQ 
is homologous to quite a number of aminotransferases and has the four conserved 
cysteine residues that are the anchors of the iron-sulfur center in E1.  The iron-sulfur 
center in E1 has been well characterized as a [2Fe-2S] center.
55,60,64,65  Based on the 
overall sequence similarity and the perfect alignment of conserved cysteines between 
SpnQ and E1, SpnQ has been proposed to contain an [2Fe-2S] as well.  However, a [4Fe-
4S] is not an absolute requirement for a protein to be included in the SAM radical-
dependent superfamily.132  Thus, SpnQ is a possible SAM-radical dependent protein 
candidate.  Taken together, this information indicates that SpnQ could act similarly to the 
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combination of DesI and DesII, and as a result could catalyze C-3 deoxygenation 
following a mechanism similar to that of DesI and DesII catalyzed C-4 deoxygenation.  
In order to get a C-3 deoxygenated product by the mechanism just described, the 
substrate has to first undergo isomerization to convert TDP-2,6-dideoxy-4-keto-glucose 
(24) to TDP-2,6-dideoxy-3-keto-glucose (136).  An enzyme catalyzing such an 
isomerization has been identified in the biosynthetic gene cluster of TDP-mycaminose.153
However, this isomerization can also occur as a nonenzymatic process.30,31,129  This could 
explain why an isomerase gene has not been discovered in the biosynthetic gene cluster 
of TDP-forosamine.  Thus, another mechanism, mechanism B (Figure 3-2), of SpnQ-
























































is first converted to TDP-2,6-dideoxy-3-keto-glucose (136).  Then SpnQ catalyzes the 
formation of TDP-2,6-dideoxy-3-amino-glucose (137).  The SAM molecule that is 
proposed to bind to SpnQ undergoes reductive cleavage to produce an adenosyl radical.  
The active adenosyl radical then abstracts a hydrogen from C-4 of the sugar to form a 
molecule of adenosine and a radical at C-4 (138).  After deprotonation, C-4 becomes a 
carbanion while the radical is relocated to the C-4 oxygen (140).  The high energy C-4 
carbanion drives the elimination of the amino group at C-3 (141).  Next, the oxygen 
radical abstracts a hydrogen from the adenosine to yield an enol-hexose (142), which 
upon tautomerization transforms to TDP-2,3,6-trideoxy-4-keto-glucose (126) and 
regenerating the adenosyl radical for the next catalysis cycle.  It should be noted that 
since the SAM radical-catalyzed deoxygenation is still mechanistically unsolved, there 
are several ways to illustrate the involvement of the SAM radical.  Mechanism B is only 
one of them.  
In the E1-catalyzed reaction, the completion of C-3 deoxygenation is assisted by 
another protein, CDP-6-dexoy-L-threo-D-glycero-4-hexulose-3-dehydrase (E1) reductase 
(E3).  The coenzyme B6 cofactor PMP in E1 reacts with the substrate to form a CDP-6-
deoxy- ∆3, 4-glucoseen intermediate (70, Figure 1-10) that is reduced in a step-wise 
manner by the electrons transferred from NADH through E3.  E3 is a ferredoxin 
reductase-like protein containing a [2Fe-2S] cluster and a bound FAD cofactor.  
Considering the high sequence identity between E1 and SpnQ (49% identity), SpnQ was 
originally assumed to catalyze the C-3 deoxygenation in a manner analogous to E1.  
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Accordingly, mechanism C was proposed (Figure 3-3).  However, an ORF that encodes 





















































































































been illustrated in Chapter 2, the genes that are involved in the biosynthesis of 
forosamine are clustered together and the protein encoded by each of them has been 
assigned with an appropriate function based on sequence analysis.  It is highly unlikely 
that a gene located in the region encoding the polyketide synthase (PKS) could 
beinvolved in the C-3 deoxygenation since the genes for type-I PKS are present as very 
large ORFs and the domains within each ORF have all been assigned functions.  It is also 
highly unlikely that the genes in the biosynthetic gene cluster that have not been assigned 
with any functions might encode the auxiliary protein of SpnQ.  Sequence analysis shows 
that none of them shares significant sequence identity with E3.  Moreover, the 
biosynthetic gene clusters of all the previously mentioned antibiotics whose structures 
contain an attached L-rhodinose have also been scrutinized.  None of them contains an 
ORF whose encoded protein has significant sequence similarity to E3.  Thus it is puzzling 
how SpnQ might catalyze the reaction in a manner analogous to E1/E3, but without a 
reductase. 
In this chapter, the expression and purification of SpnQ are described.  SpnQ was 
shown in vitro to be the enzyme catalyzing C-3 deoxygenation of the SpnO/SpnN 
product.  The reaction requires the electron transfer protein pair, either 
ferredoxin/ferredoxin reductase or flavodoxin/flavodoxin reductase.  The mechanism of 
the SpnQ catalyzed C-3 deoxygenation is likely to be similar to the E1/E3 mechanism, 
with the combination of ferredoxin or flavodoxin and its respective reductase playing the 
role of E3 and SpnQ acting analogously to E1.  Since no reaction occurred when SpnQ 
was incubated with TDP-6-deoxy-4-keto-glucose (3) under identical condition used to 
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show SpnQ activity with the SpnN product (24), it was shown that C-2 deoxygenation 
precedes C-3 deoxygenation. 
2.  EXPERIMENTAL PROCEDURES
Materials.  Most materials used in the experiments in this chapter were the same 
as those described in Chapter 2.  Ferredoxin and Ferredoxin reductase were purchased 
from Sigma-Aldrich.  The E1 protein was kindly provided by Dr. Beth Paschal in our 
laboratory.  E. coli JM105-pOPI frozen culture, used for overexpression and purification 
of E3, was obtained from central collection in our laboratory.  Econo-Pac 10 DG column 
was purchased from Bio-Rad.  Any chemicals that were used in this chapter but not 
mentioned in Chapter 2 were purchased from Sigma.
General Equipment.  The equipment and other experimental apparatus were the 
same as those described in Chapter 2.
Bacterial Strains.  Various E. coli host cell strains used were the same as those 
described in Chapter 2.   
PCR Amplification of the spnQ Gene.  Three oligonucleotide primers were 
obtained to amplify the spnQ gene: primer (Q-1) 5’-GGGGCCTCCATATGAGCAGT-
TCTGTCGAAGC-3’ containing an NdeI restriction site (in bold), primer (Q-2) 5’-
GAGCTCGAGTTATCGCCCCAACGCCCACAAG-3’ containing an XhoI restriction 
site (in bold), and primer (Q-3) 5’-TATCTCGAGTCGCCCCAACGCCCACAAGC-3’ 
containing an XhoI restriction site (in bold).  The start primer Q-1 was designed to 
hybridize to the first 20 nucleotides at the 5’ end of spnQ gene while the halt primers Q-2 
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and Q-3 are designed to hybridized to 23 and 20 nucleotides at the 3’ end of the gene, 
respectively.  Two sets of polymerase-mediated amplifications were carried out, both in 
0.5 mL microcentrifuge tubes.  In the first reaction, 37.5 µL of double-deionized H2O, 5.0 
µL of pfu polymerase buffer (10 x), 4.0 µL of deoxyribonucleotidyltriphosphate mix (2.5 
mM each), 1.0 µL of start primer Q-1 (10 µM), 1.0 µL of halt primer Q-2 (10 µM), 0.5 
µL of genomic DNA (about 0.1 µg) from Saccharopolyspora spinosa as the amplification 
template, and 1.0 µL of cloned pfu polymerase (2.5 units) were used.  The reaction 
mixture was then overlaid with a layer of mineral oil and subjected to the following 
thermal cycles: (1) 1 denaturation cycle of incubation at 95 °C for 3 min; (2) 30 
amplification cycles of incubation at 95 °C for 30 s, 60 °C for 30 s and 72 °C for 2.5 min; 
(3) 1 extension cycle of incubation at 72 °C for 10 min.  The reaction tube was held at 4 
°C prior to further manipulations.  This amplification product of the spnQ gene 
containing its natural stop codon, was called Q-w-stop.  In the second polymerase 
mediated amplification reaction, all components were the same as in the first reaction 
except that the halt primer was changed to Q-3 of same concentration.  The thermal 
cycles and the treatment of the second reaction after thermal cycling were the same as in 
the first reaction.  The stop codon of the natural spnQ gene was deleted in the product of 
the second amplification reaction.  This PCR product was named Q-wo-stop. 
Cloning of SpnQ Gene.  After PCR amplification, standard recombinant DNA 
techniques were used to clone the genes into pET24b(+).  Ligation of Q-w-stop into 
pET24b(+) gave pKZQO, and ligation of Q-wo-stop into pET24b(+) gave pKZQC.  
PKZQO, when expressed, should produce the native SpnQ protein, while pKZQC, when 
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expressed, should produce the SpnQ protein with a C-terminal tail of about 8 amino acids 
containing a His6 repeat at the extreme C-terminal end.  Positive clones were identified 
by digestion analysis of the plasmid DNA with the appropriate restriction enzymes and 
further confirmed by sequencing the plasmid DNA with T7 promoter and T7 terminator 
primers (Novagen).  The plasmid DNAs of the positive clones, pKZQC and pKZQO 
were used to transform E. coli BL21(DE3).  The general methods and protocols for 
recombinant DNA manipulations used were as described by Sambrook et al.156
Purification of C-terminal His-tagged SpnQ.  All purification steps were carried 
out at 4 °C. 
Step 1:  Growth of E. coli-pKZQC Cells.  An overnight culture of E. coli
BL21(DE3)-pKZQC, grown in LB medium supplemented with kanamycin (30 µg/mL) at 
37 °C, was diluted 250-fold by addition of 4 mL of the overnight culture to each of six 1 
L flasks of the same medium and incubated at 37 °C until the OD600 reached 0.3.  The 
incubation temperature was then adjusted to 24 °C and the incubation was continued for 
one more hour before the OD600 reached 0.4.  The culture was then induced with IPTG to 
a final concentration of 0.2 mM and allowed to grow for an additional 18 h at 24 °C.  The 
cells were harvested by centrifugation at 5,000 g for 10 min at 4 °C and stored at –80 °C.  
The typical yield of wet cells was about 6 g per liter.
Step 2:  Crude Extract Preparation.  The cells were resuspended in 80 mL of lysis 
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, 5 mM 
2-mercapto-ethanol, pH 8.0), and disrupted with five 1 min sonication bursts, with one 
minute cooling intervals between bursts.  Cellular debris was removed by centrifugation 
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at 35,000 g for 20 min.  The supernatant was transferred into a large centrifuge bottle for 
incubation with Ni-NTA resin.  
Step 3:  Ni-NTA Affinity Chromatography.  To the crude extract was added 10 mL 
of Ni-NTA slurry (5 mL of resin) and the resulting mixture was incubated for 2 h with 
gentle shaking at 4 °C.  The resin was then spun down to the bottom of the centrifuge 
bottle with brief centrifugation at low speed (1,000 g) and the majority of the supernatant 
was decanted.  The remaining resin slurry was mixed well and loaded into an empty glass 
column (1 x 25 cm).  The column was washed with 25 mL of lysis buffer and various 
amounts of wash buffers.  All the wash buffers and the elution buffer used contained the 
same ingredients as the lysis buffer except that each contained a different concentration 
of imidazole.  The column was washed sequentially with 50 mL of wash buffer 
containing 20 mM imidazole, 20 mL of wash buffer containing 40 mM imidazole, and 20 
mL of wash buffer containing 60 mM imidazole.  No peristaltic pump was used.  The 
buffer passed through the column by gravity at a flow rate of 0.8 mL/min.  After 
washing, the SpnQ protein was eluted with 10 mL of the elution buffer containing 250 
mM imidazole.  Eluted protein was transferred into a dialysis bag and dialyzed against 
four 1 L portions of dialysis buffer (50 mM Tris·HCl, 15% glycerol, pH 7.5) for 1 h per 
liter.  The dialyzed protein was concentrated by ultrafiltration using an Amicon 
concentrator and a YM-10 membrane (Amicon) and stored at –80 °C.  
Purification of Native SpnQ.  All purification steps were carried out at 4 °C.  
Step 1:  Growth of E. coli BL21 (DE3)-pKZQO Cells.  An overnight culture of E. 
coli BL21(DE3)-pKZQO, grown in LB medium supplemented with kanamycin 
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(30µg/mL) at 37 °C, was diluted 250-fold with 6 L of the same medium and incubated at 
37 °C until the OD600 reached 0.3.  The incubation temperature was adjusted to 24 °C and 
the incubation was continued for one more hour in order for the OD600 of the culture to 
reach 0.4.  The culture was then induced with IPTG to a final concentration of 0.2 mM 
and allowed to grow for an additional 18 h at 24 °C.  The cells were harvested by 
centrifugation at 5,000 g for 10 min at 4 °C and stored at –80 °C.  The typical yield of 
wet cells was about 6 g per liter.
Step 2:  Crude Extract Preparation.  Thawed cells were resuspended in 60 mL of 
lysis buffer (25 mM Tris·HCl, 0.6 mM PMSF, 5 mM 2-mercapto-ethanol, 10% glycerol, 
pH 7.5), and disrupted with five 1 min sonication bursts, with 1 min cooling intervals 
between bursts.  Cellular debris was removed by centrifugation at 35,000 g for 25 min.  
Step 3: Ammonium Sulfate Precipitation.  Ammonium sulfate crystals were added 
to the supernatant from the previous step in two portions over 20 min to give 10% 
saturation.  After stirring for 1 h, the precipitated proteins were removed by 
centrifugation at 15,000 g for 20 min and more ammonium sulfate crystals were added to 
the supernatant in three portions over 30 min to give 70% saturation.  The mixture was 
slowly stirred for 2 h.  The precipitated protein was collected by centrifugation at 15,000g 
for 20min, and resuspended in a minimal amount of lysis buffer.  The resulting protein 
solution was desalted by dialysis against four 1 L of lysis buffer which were changed 
every 1.5 h.
Step 4: DEAE-Sepharose CL6B Chromatography.  The dialysate from step 3 was 
applied to a DEAE-Sepharose CL6B column (2.5 x 40 cm) preequalibrated with buffer A 
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(25 mM Tris·HCl, 1 mM 2-mercapto-ethanol, 15% glycerol, pH 7.5).  The column was 
washed with 200 mL of the same buffer, and eluted with a linear gradient of 800 mL of 
buffer A and 800 mL of buffer B (buffer A plus 0.8 M NaCl).  The flow rate was 1.5 
mL/min and fractions of 12 mL were collected throughout the entire gradient elution.  
The fractions containing the desired SpnQ protein as judged by SDS-PAGE were 
combined, desalted by repeated dilution with buffer A and concentration by 
ultrafiltration, and finally concentrated to 8 mL.
Step 5: Hydroxyapatite Chromatography.  The protein from the previous step was 
applied to a Hydroxyapatite column (2.5 x 22 cm) that was preequalibrated with buffer C 
(10 mM potassium phosphate, 1 mM 2-mercapto-ethanol, 15% glycerol, pH 7.5).  The 
column was washed with 100 mL of the same buffer, and eluted with a linear gradient of 
400 mL of buffer C and 400 mL of buffer D (600 mM potassium phosphate, 1 mM 2-
mercapto-ethanol, 15% glycerol, pH 7.5).  The flow rate was 1.0 mL/min and fractions of 
8 mL were collected throughout the entire gradient elution.  The fractions containing the 
desired SpnQ protein as judged by SDS-PAGE, were pooled and concentrated to 3 mL by 
ultrafiltration.
Step 6: Sephacryl S-200 HR Chromatography.  The protein from step 5 was 
applied to a Sephacryl S-200 HR column (2.5 x 100 cm) preequalibrated with buffer E 
(25 mM Tris·HCl, 15% glycerol, pH 7.5).  The column was washed/eluted with the same 
buffer at a flow rate of 0.8 mL/min.  Fractions of 8 mL were collected throughout the 
entire elution.  Pure fractions were identified by SDS-PAGE, and concentrated to 2.0 mL 
by ultrafiltration.  The purified SpnQ protein was stored at –80 °C.
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Purification of E3.  All purification steps were carried out at 4 °C, except for the 
FPLC step, which was done at room temperature.  
Step 1:  Growth of E. coli JM105-pOPI Cells.  An overnight culture of E. coli 
JM105-pOPI, grown in LB medium supplemented with ampicillin (100µg/mL) at 37 °C, 
was diluted 250-fold with 6 L of TB (terrific broth) medium containing 100 µg/mL 
ampicillin and incubated at 37 °C until the OD600 reached 0.6.  The culture was then 
induced with IPTG to a final concentration of 0.25 mM and allowed to grow for an 
additional 12 h at 37 °C.  The cells were harvested by centrifugation at 5,000 g for 10 
min at 4 °C and stored at –80 °C.  The typical yield of wet cells was about 12 g per liter.
Step 2:  Crude Extract Preparation.  Thawed cells were resuspended in 60 mL of 
lysis buffer (25 mM Tris·HCl, 0.6 mM PMSF, 5 mM 2-mercapto-ethanol, 0.1 mM 
EDTA, 10% glycerol, pH 7.5), and disrupted with six 1 min sonication bursts, with 1 min 
cooling intervals between bursts.  Cell debris was removed by centrifugation at 35,000 g 
for 25 min.  
Step 3:  Ammonium Sulfate Precipitation.  Ammonium sulfate crystals were 
added in three portions over 30 min to the protein solution from the previous step to give 
25% saturation.  After stirring for 0.5 h, the precipitated proteins were removed by 
centrifugation at 15,000 g for 20 min and more ammonium sulfate crystals were added in 
three portions over 30 min to give 72% saturation.  The mixture was slowly stirred for 0.5 
h.  The precipitated protein was collected by centrifugation at 15,000g for 20 min, and 
resuspended in a minimal amount of lysis buffer.  The resulting protein solution was 
desalted by dialysis against four 1 L of lysis buffer over the course of 5 h.  
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Step 4: DEAE-Sepharose CL6B Chromatography.  The dialysate from step 3 was 
applied to a DEAE-Sepharose CL6B column (2.5 x 40 cm) preequalibrated with buffer A 
(25 mM Tris·HCl, 1 mM 2-mercapto-ethanol, 0.1 mM EDTA, 15% glycerol, pH 7.5).  
The column was washed with 200 mL of the same buffer, and eluted with a linear 
gradient of 600 mL of buffer A and 600 mL of buffer B (buffer A plus 0.3 M NaCl).  The 
flow rate was 1.5 mL/min and fractions of 12 mL were collected throughout the entire 
gradient elution.  The fractions containing the desired E3 protein as judged by SDS-
PAGE were combined and ammonium sulfate was added to give 72% saturation.  The 
ammonium sulfate precipitated proteins were collected by centrifugation at 15,000g for 
20 min and resuspended in a minimal amount of buffer C (buffer A plus 3.0 M NaCl).
Step 5: Phenyl-Sepharose Chromatography.  The protein solution from the 
previous step was applied onto a phenyl-Sepharose column (2.5 x 18 cm) preequalibrated 
with buffer C.  The column was washed with 100 mL of the same buffer and eluted with 
a linear gradient of 250 mL of buffer C and 250 mL of buffer A.  The flow rate was 1.5 
mL/min and fractions of 12 mL were collected throughout the entire gradient elution.  
The fractions containing the desired E3 protein as judged by SDS-PAGE, were pooled, 
and desalted by repeated dilution with buffer A and concentration by ultrafiltration, and 
finally concentrated to 3 mL.
Step 6:  FPLC MonoQ Chromatography.  The protein from step 5 was further 
purified by FPLC using a MonoQ HR (10/10) column with buffer A and buffer D (buffer 
A plus 0.5 M NaCl).  The elution profile began with a linear gradient of 0 to 100% B in 
20 min followed by a wash with 100% B for 6 min and a reequalibration with buffer A 
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for 6 min.  The flow rate was 3 mL /min and the detector was set to 280 nm.  The sharp 
peak with a retention time of 10.0 min was collected, desalted by repeated dilution with 
storage buffer (25 mM Tris·HCl, 15% glycerol, pH 7.5) and concentration by 
ultrafiltration, and finally concentrated to 3 mL and stored at –80 °C.  A typical yield of 
120 mg of pure E3 was obtained from 6 L culture. 
Purification of FLD Protein.  The gene encoding flavodoxin (FLD) has been 
cloned into vector pET24b(+)by Dr. Hua Zhang.  The resulting expressed protein will 
have a C-terminal tail containing a His6 tag at the extreme C-terminus.  All purification 
operations were carried out at 4 °C.  
Step 1:  Growth E. coli BL21-pHZFLD cells.  An overnight culture of E. coli
BL21(DE3)-pHZFLD, grown in LB medium supplemented with kanamycin (30 µg/mL) 
at 37 °C, was diluted 250-fold with 2 L of the same medium and incubated at 37 °C until 
the OD600 reached 0.3.  The culture was then induced with IPTG to a final concentration 
of 0.1 mM and allowed to grow for an additional 6 h at 37 °C.  The cells were harvested 
by centrifugation at 5,000 g for 10 min at 4 °C and stored at –80 °C.  The typical yield of 
wet cells was about 8 g per liter.
Step 2:  Crude Extract Preparation.  The cells were resuspended in 50 mL of lysis 
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, 5 mM 
2-mercapto-ethanol, pH 8.0), and disrupted with three 1 min sonication bursts, with 1 min 
cooling intervals between bursts.  Cellular debris was removed by centrifugation at 
35,000 g for 20 min.  The supernatant was transferred into a large centrifuge bottle for 
incubation with Ni-NTA resin.  
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Step 3:  Ni-NTA Affinity Chromatography.  A volume of 6 mL of Ni-NTA slurry 
(3 mL of resin) was added to the crude extract and the resulting mixture was incubated 
for 2 h with gentle shaking at 4 °C.  The majority of the supernatant was decanted after 
the resin was spun down to the bottom of the centrifuge bottle with brief centrifugation at 
low speed (1,000 g).  The remaining resin slurry was mixed well and loaded into an 
empty glass column (1 x 25 cm).  The column was washed with 80 mL of wash buffer 
and eluted with 15 mL of elution buffer.  The wash buffer and elution buffer have the 
same components as the lysis buffer except that they contain 20 mM and 250 mM 
imidazole, respectively.  The buffer passed through the column by gravity at a flow rate 
of 1.0 mL/min.  The eluted flavodoxin protein was transferred into a dialysis bag and 
dialyzed against four 1 L portions of dialysis buffer (50 mM Tris, 15% glycerol, pH 7.5), 
changing the buffer every hour.  The dialyzed protein was concentrated by ultrafiltration 
using an Amicon concentrator with an YM-10 membrane (Amicon) and stored at –80 °C.  
Purification of FNR Protein.  The gene encoding flavodoxin reductase (FNR) has 
been cloned into vector pET24b(+) by Dr. Hua Zhang in our laboratory.  The resulting 
expressed protein has a C-terminal tail containing a His6 tag at the extreme C-terminus.  
The purification procedure of FNR is same as that of FLD.  The frozen culture used to 
initiate cell culture was E. coli BL21-pHZFNR cells from central collection of our 
laboratory.
Apo-enzyme Preparation.  The as-purified native SpnQ protein was mixed with 
Na2S2O4 and EDTA in a molar ratio of 1.0: 12.2: 16.2 in 1.5 mL of Tris·HCl buffer (25 
mM, 15% glycerol, pH 7.5).  The resulting solution was incubated at room temperature 
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(24 °C) for 1.5 h.  The excess Na2S2O4 and EDTA were removed by Econo-Pac 10 DG 
column (Bio-Rad) according to the provided protocols.  Briefly, the reaction mixture was 
diluted to 3 mL with Tris·HCl buffer and was applied to the column which had been 
equilibrated with Tris·HCl buffer (25 mM Tris·HCl, 15 % glycerol, pH 7.5).  The column 
was washed with the same buffer and the first 3 mL of eluent from the column was 
collected as the desalted protein.  The protein was concentrated by ultrafiltration and 
stored at –80 °C.
Reconstitution of SpnQ protein.  Reconstitution of native SpnQ protein or apo-
SpnQ protein was conducted in an anaerobic environment.  All the buffer, chemicals and 
enzyme were degassed according to standard procedures before being put into the 
anaerobic glove box (Coy Laboratory Products Inc.).  The reconstitution was performed 
in the glove box under the atmosphere which has an O2 content lower than 5 ppm.  DTT 
was added to the enzyme solution at a final concentration of 10 mM and the resulting 
solution was incubated for 20 min.  Then, 5 molar equivalents of PMP, PLP, 
Fe(NH4)2(SO4)2, and Na2S, compared to the amount of SpnQ, were sequentially added to 
the enzyme solution with a 15 min incubation period between each addition.  The 
addition of Fe(NH4)2(SO4)2 and Na2S, and the 15 minute incubation intervals, were 
repeated until the final concentrations of Fe(NH4)2(SO4)2 and Na2S each reached 20 times 
that of SpnQ.  The extra salts were removed using an Econo-Pac 10 DG column as 
described previously.  The reconstituted protein was concentrated with Centricon YM-10 
by microcentrifugation. 
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Polyacrylamide Gel Electrophoresis.  The subunit molecular mass and the purity 
of the protein samples were assessed by SDS-PAGE as described in Chapter 2. 
Molecular Weight Determination.  The molecular weight of the native SpnQ was 
determined by gel filtration chromatography as described in Chapter 2.  
N-Terminal Amino Acid Analysis.  The purified native SpnQ protein were 
submitted to the Institute for Cellular and Molecular Biology at UT, Austin for N-
terminal amino acid analysis.  
UV-visible Scan of SpnQ Protein.  The absorbance of His6-tagged SpnQ, native 
SpnQ, and reconstituted SpnQ were scanned over the range of 250 nm to 750 nm on a 
Beckman DU-650 spectrophotometer. 
Iron Quantitation of SpnQ Protein.  Iron determination was accomplished by a 
well established method.329  A 1 mL solution containing either as-isolated or 
reconstituted SpnQ (1 mg) was treated with 0.5 mL of freshly prepared reagent A (2.25% 
w/v KMnO4 in 6 N HCl) at 60 °C for 2 h.  After the treatment was complete, 100 µL of 
freshly prepared reagent B (6.5 mM ferrozine, 13.1 mM neocuprine, 2 M ascorbic acid, 
and 5 M ammonium acetate in 25 mL ddH2O) was added, followed by vigorous mixing 
and incubation for 30 min at room temperature.  A number of standards made by different 
concentrations of Fe(NH4)2(SO4)2 solution in 0.01 M HCl, were treated in parallel with 
the protein sample, and the iron content of SpnQ was determined by comparing the 
absorbance of the SpnQ sample at A562 to the standard curve.  
The enzymatic activity of SpnQ was examined under three conditions: condition 
A, condition B, and condition C, were used to test whether the SpnQ-catalyzed C-3 
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deoxygenation follows mechanism A, mechanism B, or mechanism C, respectively.  
Briefly, mechanism A is a ColD-like mechanism, and condition A contained both PLP 
and L-glutamate and was carried out under an aerobic atmosphere.  Mechanism B is a 
DesI/DesII-like mechanism, and condition B was conducted in the presence of dithionite 
under an anaerobic atmosphere.  Mechanism C is an E1/E3-like mechanism, and condition 
C included an electron transfer intermediary and a reducing agent carried out in an 
aerobic atmosphere. 
Activity Assay for SpnQ - Condition A.  The assay was developed for assessing 
SpnQ activity by monitoring the disappearance of the SpnN product (24) and the 
concomitant formation of new peak(s) at 267 nm with a Dionex CarboPacTM PA1 
analytical column (4 x 250 mm) equipped with a CarboPacTM PA1 guard column (4 x 50 
mm).  A typical assay mixture of 100 µL contained 1.05 mM of the SpnN product, 0.25 
mM PLP, 3.0 mM L-glutamate, appropriate amounts of SpnQ, and 50 mM potassium 
phosphate (pH 7.5).  The reaction was initiated by the addition of the enzyme and was 
carried out at 37 °C.  A suitable amount of reaction mixture was withdrawn at appropriate 
time intervals.  The reaction was terminated by 10 fold dilution of the sample with water 
and flash freezing in liquid nitrogen.  After being redissolved at 4 °C, the enzyme was 
removed from the solution by filtering through Centricon YM-10 membrane by 
centrifugation and an appropriate amount of the filtrate was subjected to HPLC analysis.  
A linear gradient from 5 to 20% B over 15 min followed by another linear gradient from 
20 to 60% B over 20 min between Buffer A (water) and Buffer B (500 mM NH4OAc, pH 
7.0 adjusted with diluted NH3·H2O) gave baseline separation of the SpnN product 
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(retention time = 33.4 min) and a new SpnQ reaction product (retention time = 14.7 min).  
The elution gradient was followed by a final wash with 100% B for 5 min and a 
reequilibration with 5% B for 15 min.  The absolute rate was calculated as the number of 
nmols of product formation per min and percent conversion of the product was used 
directly for the relative rate.
Preparation and Characterization of the SpnQ Product - Condition A.  A 200 µL 
incubation contained 0.21 µmol of the SpnN product, 0.05 µmol of PLP, 0.6 µmol of L-
glutamate, 0.01 µmol of SpnQ in 50 mM potassium phosphate buffer (pH 7.5).  The 
reaction was conducted at 37 °C overnight.  The enzyme was removed by filtering 
through Centricon YM-10 by microcentrifugation.  Aliquots of 20 µL of the filtrate were 
repeatedly injected into HPLC and separated with the Dionex CarboPacTM PA1 analytical 
column.  The reaction product whose retention time was 14.7 min was manually 
collected.  After all the reaction filtrate was injected, the collected eluent from each 
individual run was combined and lyophilized.  The sample was then redissolved in 100 
µL of H2O and subjected to ESI-MS analysis. 
Determination of the Amino Donor for the SpnQ reaction - Condition A.  The 
efficiency of two amino acids, L-aspartate and L-glutamate as amino donors in the SpnQ 
catalyzed reaction were examined.  The amino acids were added to a final concentration 
of 3 mM in an SpnQ activity assay as previously described.  The relative efficiencies of 
these two amino acids as amino donors in the SpnQ reaction were determined by 
comparing the relative reaction rate with each co-substrate. 
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Determination of the Optimal Temperature for the SpnQ Reaction - Condition A.  
The optimal temperature for the reaction catalyzed by SpnQ was investigated using the 
previously described assay, but varying the temperature.  Temperatures of 37 °C, 29 °C, 
or 24 °C were used.  The relative efficiencies of the reaction at each temperature were 
determined by comparing the relative reaction rate at each temperature. 
Determination of the Optimal pH for the SpnQ Reaction – Condition A.  The 
optimal pH for the reaction catalyzed by SpnQ was examined using the previously 
described assay except that different buffers were used to obtain different pH values in 
the reaction mixture: a 50 mM MES buffer was used for the pH 5.5 reaction; a 50 mM 
Bis-Tris-propane buffer was used for the pH 6.5 reaction; a 50 mM potassium phosphate 
buffer was used for the pH 7.5 reaction; and a 50 mM Bis-Tris-propane buffer was used 
for the pH 8.5 and pH 9.5 reactions.  The relative reaction rates at each pH value were 
compared to determine the pH optimum.
The Effect of SAM on the SpnQ Reaction –Condition A.  To examine the 
possibility that SAM might play a role in the SpnQ-catalyzed reaction, SAM was 
included in an assay using the previously described conditions at a final concentration of 
200 µM.  The relative rates of the reactions in the presence versus absence of SAM were 
compared. 
The Effect of DTT on the SpnQ Reaction – Condition A.  DTT was included in an 
activity assay at a final concentration of 5 mM, and the relative reaction rate in the 
presence of DTT was compared with that in its absence. 
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The Effect of SpnQ Reconstitution on SpnQ Activity - Condition A.  The same 
amounts of reconstituted and as-isolated native SpnQ were used in activity assays 
performed in parallel, and the relative rates of the two reactions were compared.
The Effect of SpnQ His-tag on SpnQ Activity -Condition A.  His-tagged SpnQ, in 
stead of the native SpnQ, was included in the activity assays.  The relative rates of the 
reactions using His-tagged SpnQ and native SpnQ were compared.
Activity Assay for SpnQ - Condition B.  Reconstituted SpnQ obtained as described 
previously was treated with 20 equivalents of dithionite and was incubated at room 
temperature for 40 min in the anaerobic glove box in order to fully reduce the iron-sulfur 
clusters in preparation for the assay.  The resulting protein solution was used in the 
activity assay described below. 
An assay was developed for SpnQ by monitoring the disappearance of the SpnN 
product and the concomitant formation of new peak(s) at 267 nm with a Dionex 
CarboPacTM PA1 analytical column (4 x 250 mm) connected to a CarboPacTM PA1 guard 
column (4 x 50 mm).  A typical assay mixture of 100 µL contained 0.60 mM of SpnN 
product, 0.25 mM PMP, 0.60 mM dithionite, 30 µM SpnQ, and 50 mM potassium 
phosphate (pH 7.5).  The reaction was initiated by the addition of SpnQ and was carried 
out at room temperature (24 °C).  A suitable amount of the reaction mixture was 
withdrawn at appropriate time intervals.  The reaction was terminated by 10 fold dilution 
with water and flash freezing in liquid nitrogen.  After being redissolved at 4 °C, the 
enzyme was removed by filtering through Centricon YM-10 membrane by centrifugation 
and an appropriate amount of the filtrate was subjected to HPLC analysis.  A linear 
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gradient from 5 to 20% B over 15 min followed by another linear gradient from 20 to 
60% B over 20 min between Buffer A (water) and Buffer B (500 mM NH4OAc, pH 7.0 
adjusted with diluted NH3·H2O) gave base-line separation of the SpnN product (retention 
time = 33.4 min) and a new SpnQ reaction product (retention time = 35.8 min).  The 
elution gradient was followed by a final wash with 100% B for 5 min and a 
reequilibration with 5% B for 15 min.  The absolute rate was calculated as the number of 
nmols of product formed per min and percent conversion of the product was used to 
directly determine the relative rate.
The Effect of Na2S2O4 Concentration on SpnQ Activity - Condition B.  To examine 
whether the SpnQ reaction can sustain a high concentration of Na2S2O4, an assay was 
conducted using previously described conditions except that 2.5 mM Na2S2O4 was 
included.  The relative reaction rate was compared to that under standard condition B. 
The Effect of SAM on SpnQ Activity - Condition B.  SAM was included in the 
assays described previously at a concentration of 0.3 mM, which is equal to 5 molar 
equivalents of SpnQ used, or 1.2 mM, which is equal to 2 molar equivalents of substrate 
used.  The relative rates of the reactions were compared to that under standard condition 
B without SAM to determine the effect of SAM on the catalytic efficiency of SpnQ.  
Activity Assay for SpnQ – Condition C.  An as-isolated SpnQ was used in this 
assay.  The assay was developed for SpnQ by monitoring the disappearance of the SpnN 
product and the concomitant formation of new peak(s) at 267 nm with a Dionex 
CarboPacTM PA1 analytical column (4 x 250 mm) connected to a CarboPacTM PA1 guard 
column (4 x 50 mm).  A typical assay mixture of 50 µL contained 0.70 mM of SpnN 
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product, 0.15 mM PMP, 30 µM ferredoxin, 30 µM ferredoxin reductase, 4.0 mM 
NADPH, 30 µM SpnQ, and 50 mM potassium phosphate (pH 7.5).  The reaction was 
initiated by the addition of NADPH and was carried out at room temperature (24 °C).  A 
suitable amount of reaction mixture was withdrawn at appropriate time intervals.  The 
reaction was terminated by 10 fold dilution with water and flash freezing in liquid 
nitrogen.  After being dissolved at 4 °C, the enzyme was removed by filtering through 
Centricon YM-10 membrane by centrifugation and an appropriate amount of the filtrate 
was subjected to HPLC analysis.  A linear gradient from 5 to 20% B over 15 min 
followed by another linear gradient from 20 to 60% B over 20 min between Buffer A 
(water) and Buffer B (500 mM NH4OAc, pH 7.0 adjusted with diluted NH3·H2O) gave 
base-line separation of the SpnN product (retention time = 33.4 min), NADP (retention 
time = 39.2 min), and a new SpnQ reaction product (retention time = 35.8 min).  The 
elution gradient was followed by a final wash with 100% B for 5 min and a 
reequilibration with 5% B for 15 min.  The absolute rate was calculated as the number of 
nmols of product formed per min and percent conversion of the product was used to 
directly determine the relative rate.
Substrate Specificity of SpnQ – Condition C.  TDP-6-deoxy-4-keto-glucose (3) 
was examined as a possible substrate for SpnQ.  Using the HPLC assay described 
previously, 1.0 mM of TDP-6-deoxy-4-keto-glucose, instead of the SpnN product (24), 
was included in 50 µL of 50 mM potassium phosphate buffer (pH 7.5), along with 1.5 
mM NADPH, 0.15 mM PMP, 30 µM ferredoxin, 30 µM ferredoxin reductase, and 30 µM 
SpnQ.  At certain time intervals, an aliquot of 5 µL was withdrawn and analyzed for new 
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product formation.  After the reaction was allowed to proceed for 2 h at room 
temperature, all the enzymes were removed from the reaction mixture by filtering 
through Centricon YM-10 membrane by centrifugation.  To the supernatant was added 
1.0 mM NADPH, 30 µM SpnN and 20 µM SpnO.  After another two hours, the reaction 
was analyzed by HPLC following the procedures described for the SpnQ activity assay.  
Testing the Activity of the E1/E3 Pair Towards the SpnN Product.  In view of the 
significant sequence similarity between E1 and SpnQ, it would be interesting to examine 
whether the SpnQ substrate (24) can be converted to the C-3 deoxygenated product by 
the action of E1 and E3.  This possibility was tested by an assay similar to the SpnQ 
activity assay under condition C.  A typical assay mixture of 25 µL contained 1.05 mM of 
the SpnN product, 0.30 mM PMP, 60 µM E3, 2.0 mM NADH, 30 µM E1, and 50 mM 
potassium phosphate (pH 7.5).  It should be noted that in this reaction mixture, NADH, 
instead of NADPH, was used because NADH is the well-established reducing agent in 
the E1/E3 system.  The reaction was initiated by the addition of NADH and was carried 
out at 24 °C.  At appropriate time intervals, a suitable amount of the reaction mixture was 
subjected to HPLC analysis after removing the enzyme by Centricon YM-10.  The HPLC 
program used to separate the compounds was same as that used for the SpnQ activity 
assay (condition C).
Assay of E3 as the Electron Transfer Mediator in the SpnQ Catalyzed Reaction–
Condition C.  As has been explained previously, a gene encoding an E3 homologue was 
not found in the TDP-forosamine biosynthetic gene cluster.  However, this could be due 
to the inherent limitations of using gene sequence as an identification method.  To 
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examine whether the SpnQ catalyzed reaction needs an E3-like reductase, E3 was 
included in the assay mixture.  A typical reaction of 25 µL contained 1.05 mM of the 
SpnN product, 0.30 mM PMP, 60 µM E3, 2.0 mM NADH, 30 µM SpnQ, and 50 mM 
potassium phosphate (pH 7.5).  NADH is the reducing agent in the E1/E3 reaction, 
providing electrons to E3.  A suitable amount of reaction mixture was withdrawn at 
appropriate time intervals, was treated in the same way as in the SpnQ activity assay, and 
was subjected to HPLC analysis.  The same elution program as has been previously 
described for the SpnQ activity assay was used to separate the compounds. 
Testing the Possibility that SpnQ Uses NADH, FAD as the Electron Source -
Condition C.  An assay mixture of 25 µL contained 1.05 mM of SpnN product, 0.30 mM 
PMP, 600 µM FAD, 2.0 mM NADH, 30 µM SpnQ, and 50 mM potassium phosphate (pH 
7.5).  It should be noted that the reducing agent used is NADH.  A suitable amount of 
reaction mixture was withdrawn at appropriate time intervals, treated in the same way as 
in the SpnQ activity assay, and subjected to HPLC analysis.  The same elution program 
that was described for previous SpnQ assays was used to separate the compounds. 
Determining the Effect of Enzyme Reconstitution on the SpnQ/E3 (FAD) Reaction.
To examine the effect of reconstitution of SpnQ on the SpnQ/E3 (FAD) reaction, the as-
isolated native SpnQ was replaced with reconstituted SpnQ in the reactions.  The reaction 
contained the SpnN product, PMP, NADH, E3 (or FAD), and reconstituted SpnQ.  The 
concentration of each was the same as in the reaction containing the as-isolated native 
SpnQ described previously.  The reaction was analyzed in the same way as were the other 
SpnQ activity assays. 
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Determining the Effect of SAM on SpnQ/E3 Reaction.  A total amount of 150 µM 
SAM was included in the reactions with E3 or FAD as the potential electron transfer 
intermediary while maintaining the concentrations of other components unchanged.  The 
reaction was analyzed by HPLC using the same elution program as described for other 
SpnQ activity assays.  
Determining the Effect of the Electron Transfer Protein Pair Flavodoxin/Flavod-
oxin Reductase on SpnQ Activity - Condition C.  Flavodoxin (FLD) and flavodoxin 
reductase (FNR) are efficient electron transfer proteins that are involved in many 
biological reactions.  Therefore, the activity of FLD/FNR enzyme pair in the SpnQ 
catalyzed reaction was examined.  A typical assay mixture of 50 µL contained 0.70 mM 
of SpnN product, 0.15 mM PMP, 30 µM flavodoxin, 30 µM flavodoxin reductase, 2.0 
mM NADPH, 30 µM SpnQ, and 50 mM potassium phosphate (pH 7.5).  A suitable 
amount of reaction mixture was withdrawn at appropriate time intervals, treated in the 
same way as described for other SpnQ activity assays, and subjected to HPLC analysis.  
The same elution program as has been described for other SpnQ activity assays was used 
to separate the compounds in the reaction mixture.
Determining the Effect of Electron Transfer Protein Pair Swamping on SpnQ 
Activity – Condition C.  To examine the enzymatic activity of all possible combination of 
electron transfer enzymes, the two pairs of enzymes, ferredoxin/ferredoxin reductase and
flavodoxin/flavodoxin reductase were interchanged to produce two more enzyme pairs: 
ferredoxin/flavodoxin reductase and flavodoxin/ferredoxin reductase.  The two new 
enzyme pairs were individually included in the SpnQ activity assays as described 
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previously.  All the enzyme concentrations were maintained at 30 µM.  The electron 
transfer activities of FLD/FNR, ferredoxin/ferredoxin reductase, FLD/ferredoxin 
reductase, and ferredoxin/FNR in the SpnQ reaction were compared by their respective 
relative reaction rates.  
Determining the Effect of Including Only One Member of Each Electron Transfer 
Protein Pair on SpnQ Activity – Condition C.  In separate reactions, the enzymes 
flavodoxin, flavodoxin reductase, ferredoxin, and ferredoxin reductase were individually 
examined for their electron transfer capabilities.  Each enzyme was included separately in 
an assay mixture as was described for previous SpnQ activity assays.  The enzyme was 
removed by Centricon YM-10 and the filtrate was injected to HPLC to analyze substrate 
conversion.  The same elution program as described previously for other SpnQ activity 
assays was used. 
















Electron Transfer Route Using NADPH Regeneration System
Figure 3-4 .  Electrons are provided by isopropanol and transfered to the SpnQ reaction, 
passing alcohol dehydrogenase, ferredoxin reductase, ferredoxin and reaching SpnQ.  
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purification of the C-3 deoxygenation product from the reaction mixture, low 
concentrations of NADPH are desirable since NADPH and NADP+, the oxidized product 
of NADPH, are the major compounds that need to be removed.  To decrease the amount 
of NADPH used in the reaction, an NADPH regeneration system was employed.  A 
typical assay mixture of 50 µL contained 3.0 mM of SpnN product, 0.15 mM PMP, 30 
µM ferredoxin, 30 µM ferredoxin reductase, 60 mM of isopropanol, 0.25 mM of NADP+, 
20 µM of alcohol dehydrogenase, 30 µM of SpnQ, and 50 mM potassium phosphate (pH 
7.5).  The reaction was carried out at 37 °C.  A suitable amount of reaction mixture was 
withdrawn at appropriate time intervals, was treated in the same way as described in the 
SpnQ activity assay, and was subjected to HPLC analysis.  The same elution program as 
was described for the SpnQ activity assays was used to separate the compounds in the 
reaction mixture.  
SpnQ-Catalyzed Deprotonation from C-4’ of the PMP-Substrate Complex.  (4R)-
[4’-3H]PMP was prepared by Jenefer Alam of our laboratory.  The 50 µL reaction 
mixture contained 0.7 mM SpnN product, 0.15 mM (4R)-[4’-3H]PMP, 30 µM SpnQ and 
50 mM potassium phosphate buffer (pH 7.5).  The reaction was incubated at room 
temperature overnight before activated charcoal (10% solution, 200 µL) was added.  The 
resulting mixture was mixed vigorously on a vortex for 1 min and centrifuged for 10 min 
at 13,000 rpm to precipitate the charcoal.  A total amount of 100 µL of the supernatant 
was added to 5 mL of scintillation fluid and analyzed by scintillation counter.  Controls 
were run in parallel in which either the substrate, enzyme, or PMP was omitted in the 
reaction mixture.  
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NADPH Concentration Effect on Substrate Conversion – Condition C.  NADPH 
is the reducing cosubstrate in the SpnQ-catalyzed reaction.  To study the effect of 
NADPH concentration on substrate conversion, different concentrations of NADPH: 0.7 
mM, 0.84 mM, 1.04 mM, 1.4 mM, 1.76 mM, and 2.1 mM were used in the reactions 
while the concentration of the substrate was maintained at 0.7 mM.  Other components 
and their concentrations were the same as for the SpnQ activity assay.  The percent 
conversions of the substrate were calculated. 
Production and Characterization of the SpnQ Product – Condition C.  A 
preparative-scale reaction contained 15.2 µmol SpnN product, 0.75 µmol PMP, 0.94 
µmol NADP+, 0.3 mmol isopropanol, 8.5 mg NADP-dependent alcohol dehydrogenase, 
1.8 mg ferredoxin, 0.2 mg ferredoxin reductase, and 6.0 mg SpnQ in 3.6 mL 50 mM 
potassium phosphate buffer (pH 7.5).  The reaction was initiated by the addition of 
NADP+ and was incubated at 37 °C.  The progress of the reaction was monitored by 
HPLC analysis as described previously.  The reaction was almost complete in 2 h.  The 
enzymes in the reaction mixture were removed by filtering through Centricon YM-10 by 
microcentrifugation.  The filtrate was subjected to gel filtration chromatography (Bio-
Rad P2, extra fine, 2.5 x 150 cm) equilibrated with 25 mM NH4HCO3.  The column was 
eluted with the same buffer at a flow rate of 12 mL/h at 4 °C.  Fractions were assayed 
spectrophotometrically from 250 nm to 400 nm.  The fractions that displayed a single 
absorption maximum at 267 nm were lyophilized individually and analyzed by NMR.  
Spectra data for the SpnQ product: 1H NMR (D2O, mixture of keto and hydrated keto 
form): δ 0.87, 0.97 (3H, d, J = 6.5 Hz, 5-Me), 1.64 (3H, s, 5’’-Me), 1.54-2.44 (4H, m, 2-
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H, 3-H), 2.02-2.13 (2H, m, 2’-H), 3.84 (1H, q, J = 6.5 Hz, 5-H), 3.87-3.91 (3H, m, 4’-H, 
5’-H), 4.33-4.37 (1H, m, 3’-H), 5.28 (1H, d, J = 6.5 Hz, 1-H), 6.08 (1H, t, J = 7.0 Hz, 1’-
H), 7.50 (1H, s, 6’’-H); 13C NMR (D2O, hydrated form): δ 11.7, 11.8, 28.0, 30.3, 38.6, 
70.5, 71.0, 84.9, 85.3, 91.4, 93.7, 93.8, 111.8, 137.4, 151.8, 166.7; 31P NMR (D2O): δ –
10.7 (d, J = 21Hz), -12.5 (d, J = 21Hz).  High-resolution FAB- MS calc for 
C16H23N2O13P2 (M-H)
+ 513.0675, found 513.0692. 
GC/MS of SpnQ Product Derivative.  A 800 µL reaction contained 0.84 µmol of 
the SpnN product, 0.09 µmol PMP, 4.8 µmol NADPH, 0.12 mg ferredoxin, 0.03 mg 
ferredoxin reductase, 0.4 mg SpnQ in 50 mM potassium phosphate buffer (pH 7.5).  The 
reaction was allowed to proceed at 24 °C for 4 h and then was treated according to 
Scheme 3-1.  NaBH4 (0.38 mg, 0.01 mmol) was added to the reaction mixture.  The 




























Scheme 3-1.  SpnQ product derivatization for GC/MS analysis.
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being acidified to pH 2.0 with 5 M HCl.  The solution was boiled for 10 min and 
centrifuged to remove the enzyme precipitate.  The supernatant was then neutralized with 
5 M KOH to pH 7.0.  The solution was lyophilized to dryness and the solid was 
redissolved in 0.6 mL of 0.5 M NH4OH.  The sample was mixed with 1.0 mL of DMSO 
to which NaBH4 (21 mg, 0.55 mmol) had been added.  The reaction was stirred at 40 °C 
for 90 min before being slowly quenched with 0.1 mL of glacial acetic acid.  1-Methyl-
imidazole (2 mg, 25 µmol) and 6.0 mL of acetic anhydride were added, and the resulting 
mixture was stirred at room temperature for 1 h.  The reaction was then quenched with 
5.0 mL of methanol at 0 °C.  The products were extracted with chloroform and the 
combined organic extracts were washed twice with water, dried over anhydrous sodium 
sulfate, filtered, and concentrated.  The sample was then subjected to GC/MS analysis.  A 
control reaction was run in parallel in which the SpnQ protein was omitted from the 
reaction.
3.  RESULTS AND DISCUSSION
Cloning and Expression of SpnQ Protein.  Cloning of spnQ into pET24b(+) 
vector gave two constructs that produced either native SpnQ or C-terminal His-tagged 
SpnQ, respectively, depending on the presence or absence of the natural stop codon of the 
gene.  Both proteins were partially soluble in the expression cells and accounted for about 
10% of the total proteins in the crude extract.  
Purification and Characterization of His-tagged SpnQ Protein (Figure 3-5).  The 
His-tagged enzyme was purified to near homogeneity by a Ni-NTA chromatography 
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(Figure 3-5).  A total of 40 mg of homogeneous protein was obtained from a 6 L culture.  
The estimated subunit molecular weight of 51 kDa revealed by SDS-PAGE is consistent 
with the molecular weight 51446 Da, deduced from the translated amino acid sequence of 
SpnQ (including His6-tag).  
Purification and Characterization of Native SpnQ Protein (Figure 3-5).  Various 
types of chromatography were tried in the purification of native SpnQ.  The protein has 
poor binding affinity to phenyl-Sepharose resin and binds weakly to Mono Q resin.  The 
protein was finally purified to near homogeneity by sequential ammonium sulfate 
precipitation, DEAE chromatography, Hydroxyapatite chromatography, and S-200 
chromatography.  A total of 30 mg of light red-brown protein was obtained from a 6 L 
culture.  Including 15% glycerol was crucial in minimizing protein precipitation during 
the purification process.  Its subunit molecular weight of 50 kDa, as revealed by SDS-
PAGE, 







Figure 3-5.  SDS-polyacrylamide gel electrophoresis of proteins obtained in Chapter 3. 
Lanes 1 and 7, molecular markers; lane 2, native SpnQ protein; lane 3, C-terminal His-
tagged SpnQ; lane 4, E3 protein ; lane 5, flavodoxin ; lane 6, flavodoxin reductase.
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correlates well to the predicted value of 50381 Da based on the translated peptide 
sequence.  The molecular weight of native SpnQ was estimated to be 109.4 kDa by gel 
filtration chromatography, suggesting that the protein exists as a homodimer in solution.  
The sequence of the first 15 amino acid residues at the N-terminus of SpnQ was 
determined to be M-Q-S-R-K-T-R-A-L-G-K-G-R-A-R, which matches exactly with the 
translated spnQ sequence. 
Preparation of Apo-SpnQ.  The iron-sulfur center of the as-purified SpnQ was 
completely depleted within 1.5 h after the addition of dithionite and EDTA as judged by 
the complete loss of its light red-brown color.  The electronic absorption spectrum of 
Apo-SpnQ shows no absorbance above 300 nm.  
SpnQ Reconstitution.  Both apo-SpnQ and as-isolated native SpnQ were 
reconstituted in an anaerobic environment following the same protocol.  Both 
reconstituted proteins have dark green-black color which is common to many enzymes 
whose iron-sulfur centers are reconstituted.178,179  Interestingly, the enzyme reconstituted 
from Apo-SpnQ did not show any enzymatic activity in any of the three assay conditions: 
condition A, B or C.  This observation hints that SpnQ might undergo some irreversible 
conformational change when the iron-sulfur center is completely removed.  Subsequent 
repletion with iron and sulfur component cannot restore the correct enzyme 
conformation.  The enzymatic activity of the enzyme reconstituted from the as-isolated 
SpnQ will be discussed later. 
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UV-visible Spectrum of SpnQs.  As shown in Figure 3-6, the spectrum of native 
SpnQ has bands centered around 330 nm, and 460 nm with a broad shoulder centered 
around 550 nm.159,160  His6-tagged SpnQ has absorption maxima at the same wavelengths 
but the absorbance is less significant considering the protein concentration.  In view of 
the literature value of ε460 in the range of 6000-10000 M-1cm-1 for the [2Fe-2S] center and 
the enzyme concentrations measured by UV absorbance at 280 nm, the [2Fe-2S] content 
of His6-tagged SpnQ is between 0.25 and 0.42 clusters per subunit while that of native 
SpnQ is between 0.36 and 0.61 clusters per subunit.161  The anaerobically reconstituted 
SpnQ also has absorption maxima at 330 nm, 460 nm and 550 nm, but the absorbance at 








Figure 3-6 . UV-scan spectra of SpnQs. (I). the as-isolated native SpnQ protein. (II). C-
terminal His6-tagged SpnQ. (III). SpnQ reconstituted from the as-isolated native protein.
Iron Content of SpnQ Protein.  Compared to the iron content standard curve 
(Figure 3-7), native SpnQ contains 1.2 irons per polypeptide.  This value is relatively 
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consistent with 0.36~0.61 [2Fe-2S] clusters per subunit as judged by ε460.  The 
anaerobically reconstituted SpnQ contains 4.1 iron per polypeptide, suggesting that there 
are two [2Fe-2S] clusters per polypeptide in SpnQ.
Purification of E3, FLD and FNR (Figure 3-5).  Purification of E3 was done 
according to an established procedure.57,62  After ammonium sulfate precipitation, DEAE 
chromatography, and phenyl-Sepharose chromatography, 120 mg of nearly homogeneous 
E3 was obtained from a 6 L culture.  FLD and FNR were each purified to near 
homogeneity by a single Ni-NTA chromatography step.  About 15 mg of each FLD and 
FNR was obtained from 2 L of culture.  The electron transfer activity of E3 was 
demonstrated by the well-established DCPIP assay,180,181 while the enzymatic activity of 
FLD/FNR was demonstrated by the ferricyanide assay.182
µ
Figure 3- 7. Iron quantitation standard curve.
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Isolation and Characterization of the SpnQ Product-Condition A (Figure 3-8).  
When the SpnQ reaction (condition A) was analyzed by HPLC, the formation of a new 
compound was observed accompanied by the simultaneous consumption of the substrate.  
The new compound was originally thought to be the C-3 deoxygenated product, TDP-
2,3,6-trideoxy-4-keto-glucose (126).  However, instead of having a M.W. of 514 of TDP-
2,3,6-trideoxy-4-keto-glucose (126), the M.W. of this compound is 531 by ESI-MS 












Condition A: PLP, L-glutamate, aerobic.






2,4,6-trideoxy-glucose (153).  It has been mentioned previously that the sequence of 
SpnQ is similar to a number of aminotransferases.  In view of the components used in the 
assay mixture other than the SpnN product, PLP and L-glutamate, the only possible 
rationalization is that SpnQ under condition A catalyzes the C-4 aminotransfer reaction.  
For the TDP-hexoses that undergo transamination reactions, the substrate and the product 
are generally well separated by HPLC using a Dionex column.  Thus, it is not surprising 
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to observe that the retention time of the new compound from the SpnQ reaction under 
condition A is quite different from that of the SpnN product.  In the presence of PLP and 
L-glutamate, ColD catalyzes C-3 deoxygenation, while under the same conditions, SpnQ 
shows C-4 aminotransferase activity.  Thus, the mechanism of SpnQ-catalyzed C-3 
deoxygenation must be different from that of the ColD catalyzed reaction (mechanism 
A).  The aminotransfer reaction could be a side reaction that SpnQ catalyzes or it could 
be part of a complicated C-3 deoxygenation reaction.  It is interesting to note that this 
aminotransfer reaction is quite similar to DesI catalyzed reaction except that the substrate 
is TDP-2,6-dideoxy-4-keto-glucose (24) instead of TDP-6-deoxy-4-keto-glucose (3).
Amino Donors - Condition A.  In the SpnQ catalyzed C-4 aminotransfer reaction, 
L-glutamate was found to be an efficient amino donor while L-aspartate could hardly 
pH
 
Figure 3-9 . Effect of pH on the relative rate of SpnQ reaction under condition A.
function as an amino donor.  When L-aspartate was used, SpnQ displayed 5% of the 
activity observed with L-glutamate. 
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Optimal pH for SpnQ - Condition A.  As shown in Figure 3-9, SpnQ has an 
optimal aminotransferase activity at around pH 7.5.  Under acidic and alkaline 
conditions, the substrate, the SpnN product, was unstable and degraded.  The degradation 
was more severe under the alkaline conditions than under the acidic conditions. 
Temperature Effect for SpnQ - Condition A.  The optimal aminotransferase 
activity of SpnQ was at 37 °C.  With decreasing temperatures, a sharp reduction in
activity was observed.  At 24 °C, almost no substrate conversion was observed.
Effect of DTT.  Ornithine decarboxylase is a PLP-dependent enzyme.  The 
catalytic activity of ornithine decarboxylase was stimulated in the presence of DTT.162
The effect of DTT on the aminotransferase activity of SpnQ was examined.  At the level 
of 5 mM, which has significantly increased ornithine decarboxylase activity,162 DTT 
failed to show any enhancing effect on SpnQ activity. 
Effect of SAM.  Cystathionine β-synthase (CBS) catalyzes the PLP-dependent β-
replacement reaction in which the thiolate of L-homocysteine replaces the hydroxyl group 
of L-serine.  Human CBS has a complex domain structure, and its regulatory mechanism 
is complicated.  The N-terminal domain of CBS is a heme-binding domain.  The 
allosteric activator SAM increases CBS activity about 3-fold and likely binds to the C-
terminal regulatory domain.163,164  Since SpnQ is also a coenzyme B6-dependent enzyme 
and has an iron-sulfur center which might bind SAM, the possibility of SAM as an 
allosteric activator was examined.  The results show that the presence of SAM does not 
have any stimulatory or inhibitory effect on the aminotransferase activity of SpnQ.
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Effect of SpnQ Reconstitution on SpnQ Activity – Condition A.  The results from 
iron quantitation studies and UV analysis have shown that the iron-sulfur content of the 
reconstituted enzyme was increased significantly.  To examine any possible connection 
between the iron-sulfur content and the aminotransferase activity of SpnQ, the 
anaerobically reconstituted enzyme was used to conduct the activity assay.  The 
reconstituted enzyme did not show any change in the level of aminotransferase activity 
compared with the as-isolated enzyme.  It can thus be inferred that the iron-sulfur cluster 
does not participate in the aminotransfer reaction. 
Effect of SpnQ His6-tag on Aminotransferase Activity – Condition A.  
Interestingly, the His6-tagged enzyme did not show any aminotransferase activity.  The 
His6-tag probably prevents the correct folding of the enzyme.  Thus, His6-tagged enzyme 
was not used in further enzyme assays. 













Condition B: dithionite, anaerobic
Figure 3-10 .  SpnQ catalyzed reaction under condition B. 
reducing agent and is able to provide electrons to reduction reactions under anaerobic 
conditions.  When the reaction is exposed to air, because of the high oxidation potential 
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of O2, O2 becomes the direct electron acceptor preventing other oxidants from being 
reduced by dithionite.  Thus, the assays with dithionite as the only reducing agent were 
conducted anaerobically.  SpnQ was able to catalyze the C-3 deoxygenation to produce 
TDP-2,3,6-trideoxy-4-keto-glucose (126).  The conclusion that TDP-2,3,6-trideoxy-4-
keto-glucose was indeed being formed came from two pieces of evidence: first, an 1H-
NMR spectrum was obtained from a preparative scale reaction.  Although the spectrum 
was contaminated with peaks from impurities, the peaks of TDP-2,3,6-trideoxy-4-keto-
glucose were all present; second, a new compound formed accompanied by the decrease 
of the substrate as determined by HPLC analysis, and the new compound had the same 
retention time as TDP-2,3,6-trideoxy-4-keto-glucose analyzed by NMR.  Dithionite was 
also able to provide single electrons to PMP-∆3,4-glucoseen intermediate in the E1-
catalyzed C-3 deoxygenation in the biosynthesis of CDP-ascarylose when E3 and NADH 
were absent from the reaction mixture, as was seen in these assays of SpnQ. 
Concentration Effect of Dithionite - Condition B.  Interestingly, it was found that 
when the concentration of dithionite used in the reaction was comparable to that of the 
substrate, C-3 deoxygenation was inhibited.  When the concentration of dithionite was 
higher than 3.0 mM while the concentration of the substrate is 1.0 mM, the substrate 
conversion was lower than 10%.  The low conversion rate made product purification 
difficult and was the reason for the contaminated 1H-NMR spectrum mentioned above.  It 
is speculated that when the concentration of dithionite was increased, the reduction 
potential of dithionite was correspondingly enhanced.  This may cause damage to the 
integrity of the [2Fe-2S] center in SpnQ since iron-sulfur centers have multiple forms, 
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such as [4Fe-4S] and [3Fe-4S] and these forms can be interconverted.183,184  However, 
evidence for an explanation of this observed inhibition by high concentrations of 
dithionite must awaits more detailed studies.
Effect of SAM on SpnQ Activity - Condition B.  DesII, the C-4 deoxygenation 
enzyme in the TDP-desosamine biosynthesis, is SAM radical dependent.  The in vitro
enzymatic activity of DesII was demonstrated when dithionite was used as the reducing 
agent in the reaction.  As has been described previously, it is possible that the SpnQ-
catalyzed C-3 deoxygenation has a similar mechanism to the DesII-catalyzed C-4 
deoxygenation provided that there is a nonenzymatic tautomerization between TDP-2,6-
dideoxy-4-keto-glucose (24, Figure 3-2) and TDP-2,6-dideoxy-3-keto-glucose (136, 
Figure 3-2).  Although SAM was not included in the SpnQ reaction mixture (condition 
B), the possibility that there was already SAM present that was tightly bound to SpnQ 
and functioned in the C-3 deoxygenation, could not be eliminated since SAM was 
reported to bind close to the iron-sulfur center in SAM radical dependent enzymes.132,185
If that is the case, then increasing the concentration of SAM is expected to facilitate the 
reaction and increase the reaction rate.  Thus, a catalytic amount of SAM and an amount 
comparable to that of the substrate were each examined for their effects on the reaction 
rate.  At either concentration, SAM did not show any enhancing effect.  Moreover, in one 
SpnQ reconstitution experiment, after the addition of PLP and PMP, SAM of the same 
concentration as PLP and PMP was added to the incubation mixture before 
Fe(NH4)2(SO4)2 and Na2S were added.  Enzyme reconstituted in this way was used in the 
activity assays (condition B).  The relative reaction rate of C-3 deoxygenation exhibited 
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no change compared with the assays using as-isolated SpnQ or SpnQ reconstituted 
without SAM.  Combining all this information, it can be concluded that SAM does not 
play a role in the SpnQ catalyzed C-3 deoxygenation.  This eliminated the possibility that 
the SpnQ-catalyzed reaction is SAM radical dependent.
Isolation and Characterization of the SpnQ Product - Condition C (Figure 3-11).  
Isolation of the C-3 deoxygenation product, TDP-2,3,6-trideoxy-4-keto-glucose (126) , 
had been problematic mainly due to observed substrate inhibition.  One NADPH 
molecule provides two electrons both of which are used in the reduction of the PMP-
substrate complex.  Thus the ratio between NADPH and the substrate should be 1:1 for 













Condition C: NADPH,  ferredoxin, ferredoxin reductase, aerobic
Figure 3- 11.  SpnQ catalyzed reaction under condition C.
concentration of NADPH had to be correspondingly increased.  However, it was 
observed that substrate conversion became low (10%) when both the substrate and 
NADPH concentrations were high (3 mM).  In order to circumvent this problem, 
NADPH was regenerated in situ by the catalysis of alcohol dehydrogenase with 
isopropanol as the cosubstrate.  The amount of isopropanol added in the reaction mixture 
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was 20 times the amount of the SpnN product in order to drive the reaction to 
completion.  The amount of NADP in the reaction mixture was just enough to initiate the 
reaction and the by-product acetone was easily removed.  Clean NMR spectra of the 
SpnQ product were obtained from this method.  Spectroscopic analysis confirmed that 
the product was the expected C-3 deoxygenation product (Figure 3-12).  Due to the 
removal of the hydroxyl group at C-3, the chemical shift of the C-3 protons moved 
upfield.  As a result, the overlapping between the C-3 and C-5 protons was eliminated.  
The C-5 proton was left as a simple quartet.  Meanwhile, the spectrum around the C-2 
protons became complicated due to overlapping with the C-3 protons.  The enzymatic 
conversion was almost quantitative.  
Ferredoxin reductases are ubiquitous flavoenzymes that deliver electron 
equivalents from NADPH to low potential one-electron donors, such as ferredoxin, which 
are used in redox-based metabolism in plastids, mitochondria and bacteria.186,187
Ferredoxin reductases constitute a family of hydrophilic, monomeric enzymes that 
contain noncovalently bound FAD as a prosthetic group, while ferredoxins are [2Fe-2S] 
containing enzymes.188  When NADPH is the electron source, two electron equivalents 
are transferred to cofactor FAD of ferredoxin reductase.  The cofactor FAD, which is 
capable of transferring either a single electron or two electrons, functions as the 2e-/1e-
switch and delivers the electrons one at a time to the [2Fe-2S] center, an obligatory one-
electron redox coenzyme of ferredoxin.  Thus the combination of ferredoxin and 
ferredoxin reductase has both FAD and a [2Fe-2S] center, and functions in the same way
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as E3.  The successful isolation of the C-3 deoxygenation product TDP-2,3,6-trideoxy-4-
keto-glucose (126) in the presence of SpnQ, ferredoxin, and ferredoxin reductase, 
combined with the fact that the sequences of E1 and SpnQ are highly homologous to each 
other, points out that the SpnQ-catalyzed reaction has a similar mechanism as the reaction 
catalyzed by E1/E3.  Thus the mechanism C proposed previously is preferred (Figure 3-3).  
In the E1/E3 reaction, the enzyme that transfers electrons from the reducing agent NADH 
is E3 which is encoded by a gene physically close to the gene encoding E1 in the CDP-
ascarylose biosynthetic gene cluster.  In contrast, the SpnQ reaction does not employ a 
specific reductase enzyme encoded by a gene in the TDP-forosamine biosynthetic gene 
cluster.  As evidenced by the demonstrated dependence of the SpnQ reaction on the 
ferredoxin/ferredoxin reductase pair in vitro, and given the fact that these proteins are 
ubiquitous in the cell, this pair is a likely candidate for the electron source for SpnQ in 
vivo.  The E1/E3 reaction and the SpnQ reaction are also different in their use of reducing 
agents.  NADPH has been shown to be the favored electron source for 
ferredoxin/ferredoxin reductase, and thus is used in the SpnQ reactions.  Conversely, 
NADH is the established electron source for E3 and is used in the E1/E3 reaction. 
E1/E3 Reaction with the SpnN Product as Substrate – Condition C. The sequences 
of SpnQ and E1 are highly similar to each other (49% identity).  However, a gene 
encoding an E3 homolog has not been found in the biosynthetic gene cluster of TDP-
forosamine.  In order to examine whether the SpnQ-catalyzed reaction is similar to the 
E1/E3 catalyzed reaction, enzymes E1 and E3 were used in an assay containing the SpnN 
product as the substrate (condition C).  No turnover of the substrate was observed.  
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However, failure to observe the C-3 deoxygenation activity of E1/E3 may be because the 
structure of the SpnN product is different from the authentic substrate of E1/E3.  In E1/E3
catalyzed C-3 deoxygenation in CDP-ascarylose biosynthetic pathway, the substrate is 
CDP-6-deoxy-4-keto-D-glucose, while in this reaction, the substrate is TDP-2,6-dideoxy-
4-keto-D-glucose (24).  E1/E3 may not be able to recognize a TDP-sugar as a substrate.  
The lack of a hydroxyl group at C-2 may also prevent the SpnN product from being 
accepted by E1/E3.  
E3 and FAD as Possible Electron Transfer Intermediaries in SpnQ-Catalyzed 
Reaction – Condition C.  To examine whether an E3 homolog is required in the SpnQ 
catalyzed reaction, E3 was included in the assay mixture.  No turnover of the substrate 
was observed.  Thus the SpnQ/E3 pair could not carry out C-3 deoxygenation in spite of 
the sequence similarity between E1 and SpnQ.  It was next speculated that SpnQ may 
only need an electron transfer cofactor such as FAD instead of an enzyme to transfer 
electrons from NADH to the substrate complex.  Electron transfer from NADH to FAD 
has been documented in the catalysis of methane monooxygenase.157,158  However, when 
SpnQ was incubated with the SpnN product, NADH, and FAD, no substrate turnover was 
observed, thus disproving this possibility.   
Effect of SpnQ Reconstitution.  To provide compelling evidence that the SpnQ-
catalyzed C-3 deoxygenation reaction does not need an enzyme homologous to E3 or a 
cofactor, like FAD, as an electron intermediary, the SpnQ enzyme was anaerobically 
reconstituted to ensure that it contains all necessary cofactors.  With that done, failure to 
observe C-3 deoxygenation can be conclusively ascribed to the lack of a requirement for 
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FAD and present persuasive evidence that an E3 homolog is not required.  Thus, the 
SpnQ/E3 (FAD) reactions described previously were run again using reconstituted SpnQ, 
which was considered to be in its active form with all the cofactors present.  Even under 
these conditions, there was still no substrate conversion.  Therefore, the inability of 
SpnQ/E3 (FAD) to catalyze C-3 deoxygenation is not due to the incomplete iron-sulfur 
center and PMP or PLP contents in the as-isolated SpnQ.  Thus, both E3 and FAD have 
been eliminated as NADH-dependent electron transfer intermediaries in the SpnQ-
catalyzed reaction.  It can also be inferred from these results that it is unlikely that there is 
Scheme 3-2 . Between the two possilbe routes to obtain 126, Route B, 3-deoxyg-
















































an E3 homolog in the TDP-forosamine biosynthetic gene cluster which aids in C-3 
deoxygenation. 
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Substrate Specificity of SpnQ –Condition C (Scheme 3-2).  When TDP-6-deoxy-4-
keto-glucose (3), instead of the SpnN product, was used in the assay reactions, the peak 
of TDP-6-deoxy-4-keto-glucose remained unchanged in HPLC analysis.  However, this 
observation alone could not completely eliminate the possibility that there was a 
conversion.  If the retention time of the putative conversion product, TDP-3,6-dideoxy-4-
keto-glucose (130) , happened to be the same as that of TDP-6-deoxy-4-keto-glucose 
(3),no change would be observed in the HPLC trace even though conversion had 
occurred.  If this was the case, then adding SpnO, SpnN and more NADPH would have 
converted TDP-3,6-dideoxy-4-keto-glucose (130) to TDP-2,3,6-trideoxy-4-keto-glucose 
(126) which had been shown to have a different retention time from that of TDP-6-
deoxy-4-keto-glucose (3) under the HPLC conditions used.  No peak corresponding to 
TDP-2,3,6-trideoxy-4-keto-glucose was observed while the peak of TDP-6-deoxy-4-keto-
glucose remained largely unchanged in HPLC analysis.  The tiny amount of the SpnN 
product, TDP-2,6-dideoxy-4-keto-glucose (24), formed by the action of SpnO and SpnN 
towards 3, was likely to be too little to be observed.  As was explained in Chapter 2, 
SpnO shows every low activity in vitro.  In the UV-absorbance activity assay for SpnO, 
the decrease of A340 corresponding to the formation of the SpnN product was very small.  
There had been doubt whether the C-2 deoxygenation or the C-3 deoxygenation occurs 
first in the TDP-forosamine biosynthetic pathway.  The result from this experiment 
clearly indicated that SpnQ could not recognize TDP-6-deoxy-4-keto-glucose as a 
substrate.  So the RfbB product can only be the substrate of the SpnO/SpnN catalyzed C-
2 deoxygenation, while the product thus formed becomes the substrate of the SpnQ-
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catalyzed C-3 deoxygenation.  Thus, C-2 deoxygenation occurs prior to C-3 
deoxygenation.  This observation will likely hold true in the biosynthesis of any NDP-
2,3-dideoxy-hexoses in whose biosynthetic gene cluster proteins homologous to SpnQ 
and TylX3/SpnO are identified. 
Effect of SAM – Condition C.  Addition of SAM in either a catalytic amount or in 
an amount comparable to the substrate did not show any effect on substrate conversion.  
In the enzyme assays under all three conditions (condition A, B or C), SAM did not show 
any effect on catalysis, nor did it participate in the reactions by acting as cosubstrate.  It 
can now be concluded that neither the SpnQ-catalyzed C-4 transamination nor the C-3 
deoxygenation requires SAM.  Thus, the C-3 deoxygenation mechanism must be 
completely different from the SAM radical dependent mechanism of the DesII-catalyzed 
C-4 deoxygenation.  Therefore, mechanism B proposed earlier was conclusively 
eliminated.  
Electron Transfer Proteins in the SpnQ-Catalyzed Reaction - Condition C (Figure
3-13).  The enzyme pair of ferredoxin/ferredoxin reductase has been shown to transfer 
electrons from NADPH to SpnQ in the SpnQ-catalyzed C-3 deoxygenation.  The 
ubiquitous presence of this enzyme pair in vivo implicates that the reductase required in 
the SpnQ reaction may come from the general cellular pool.  However, ferredoxin and 
ferredoxin reductase are not the only electron transfer proteins in the cell.  Flavodoxin 















Figure 3-13. Catalytic activities demonstrated by different enzyme pairs.
electron transfers in the same way as ferredoxin and ferredoxin reductase.  When the 
enzyme pair of ferredoxin/ferredoxin reductase in the SpnQ activity assay was replaced 
with flavodoxin/flavodoxin reductase, the latter enzyme pair showed reductase 
competency comparable to the former enzyme pair as judged by the substrate conversion 
rate.  The components of ferredoxin/ferredoxin reductase and flavodoxin/flavodoxin 
reductase were interchanged to make two new enzymes pairs, ferredoxin/flavodoxin 
reductase and flavodoxin/ferredoxin reductase.  The enzyme pair flavodoxin/ferredoxin 
reductase was almost as competent as the natural enzyme pairs, while 
ferredoxin/flavodoxin reductase has slightly lower catalytic activity (about 80% of the 
other three pairs).  Any single component, ferredoxin, flavodoxin, ferredoxin reductase or 
flavodoxin reductase did not show any electron transfer activity, as evidenced by the 
absence of substrate conversion.  Interestingly, the enzyme pair flavodoxin/flavodoxin 
reductase completely lost its electron transfer activity after several freeze-thaw cycles, 
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while the enzyme pair ferredoxin/ferredoxin reductase maintained full activity for 
months.  Moreover, the enzyme pair ferredoxin/flavodoxin reductase maintained 40% of 
its activity while the enzyme pair flavodoxin/ferredoxin reductase maintained 20% of its 
activity after several freeze-thaw cycles.  Thus, flavodoxin and flavodoxin reductase each 
individually lost some activity by the freeze-thaw treatment.  They were still partially 
active but completely lost the ability to act as a functional pair after degradation.  
Regeneration of NADPH.  The NADPH regeneration system made of alcohol 
dehydrogenase, isopropanol, and a catalytic amount of NADP+, is capable of supplying in 
situ generated electron equivalents from NADPH to the electron transfer chain in the 
SpnQ reaction.  The reaction was efficient at 37 °C but did not occur at all at 24 °C.  The 
temperature dependence of the reaction is not due to SpnQ, but rather to the purchased 
alcohol dehydrogenase which is recommended to be used at 37° C.  Both the substrate 
and product of the SpnQ reaction were shown to be relatively stable for 2 h at 37 °C. 
Stereochemistry of SpnQ-Catalyzed Deprotonation of the PMP-substrate Comp-
lex (Figure 3-14).  In the E1/E3 reaction, the reaction steps from the Schiff base formation  
(67, Scheme 1-10, Chapter 1) to the CDP-6-deoxy-∆3,4-glucoseen formation (69, Scheme 
1-10, Chapter 1) are reversible and it is the pro-S proton of C-4’ of PMP that is removed 
and reinstalled.53,63,64  Since the SpnQ/ferredoxin/ferredoxin reductase reaction is
mechanistically similar to the E1/E3 reaction, the reaction steps from the Schiff base 










































Figure 3-14. Stereospecificity of SpnQ catalyzed deprotonation of PMP-substrate complex.
pro-R
 
reversible in the presence of SpnQ.  When (4’R)-[4’-3H] PMP was incubated with the 
substrate and SpnQ, twice the amount of radioactivity was released into the reaction 
buffer compared with control reactions in which either the substrate, the enzyme or both 
the substrate and the enzyme was/were omitted from the incubation mixture.  This result 
proves that the deprotonation and reprotonation of the pro-R C-4’ proton of PMP are 
indeed reversible in the SpnQ reaction.  However, the evidence obtained so far indicates 
that the stereochemistry of the deprotonation of PMP is different from that in the E1/E3
reaction.
Effect of NADPH Concentration – Condition C.  When the concentration of the 
substrate was 0.7 mM, one equivalent of NADPH could efficiently drive the reaction to 
completion within 3 h.  The conversion of the substrate was also complete at 
concentration of NADPH as high as 3-fold molar excess relative to the concentration of 
the substrate.  Thus, NADPH did not show any inhibitory effect.  However, when the 
concentrations of both the substrate and NADPH were increased to 3.0 mM, the reaction 
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rate significantly decreased and only 10% of the substrate was converted to product at 
equilibrium.  In addition, by using the NADPH regeneration system described previously, 
the substrate present at a concentration of 3.0 mM could be quantitatively converted to 
product in the presence of a catalytic amount of NADPH.  The reason why the SpnQ 
reaction was inhibited when the concentrations of both the substrate and NADPH were 
high is still not clear and must await detailed studies. 
GC/MS of the SpnQ Product Derivative – Condition C.  GC/MS analysis of the 
SpnQ reaction clearly showed the presence of a compound of m/z 260 which is the 
expected mass of the derivatized SpnQ product.  The m/z 260 peak was absent from the 
GC trace of the reaction without SpnQ.  
4.  CONCLUSIONS (Figure 3-15)
Extensive studies of the SpnQ protein were described in this chapter.  Both the 
His6-tagged and the native protein were expressed and purified.  Anaerobic reconstitution 
was conducted on both the as-isolated enzyme and the apo-enzyme.  SpnQ was shown to 
be an aminotransferase when only PLP and L-glutamate were included in the assay 
mixture.  The product of this reaction is TDP-2,6-dideoxy-4-amino-glucose (153).  SpnQ 
was also shown to function as an enzyme catalyzing the C-3 deoxygenation of TDP-2,6-
dideoxy-4-keto-glucose (24) in the presence of NADPH and ferredoxin/ferredoxin 
reductase.  Flavodoxin/flavodoxin reductase was also shown to function effectively as the 
electron source of the SpnQ reaction in vitro.  Both enzyme pairs are ubiquitous in the 
cell, indicating that either pair may be the electron source of the SpnQ reaction in vivo.  
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SpnQ could also catalyze C-3 deoxygenation under anaerobic conditions with dithionite 
as the electron source.  
Mechanistically, SpnQ catalyzes a radical reaction similar to that of E1/E3.  
But unlike E1/E3, SpnQ does not use a dedicated NADH-dependent reductase.  This 
explains well why a gene encoding an E3 homolog has not been identified in the TDP-
forosamine biosynthetic gene cluster.  These results have unambiguously demonstrated 
that the mechanism of the SpnQ catalyzed C-3 deoxygenation is completely different 
from that of the ColD catalyzed C-3 deoxygenation and the DesII catalyzed C-4 
deoxygenation.  
The fact that SpnQ uses the SpnN product (24) as its substrate, but does not 
recognize the RfbB product (3) clearly established that C-3 deoxygenation occurs after 
the SpnO/SpnN catalyzed C-2 deoxygenation, thus providing an unequivocal proof for 
the sequence of the early reactions in TDP-forosamine biosynthesis.  SpnQ has homologs 
in many NDP-2,3-dideoxy-hexose biosynthetic gene clusters.  Evidence for the 
mechanism of the SpnQ catalyzed reaction and the explicit demonstration of the substrate 
specificity of SpnQ not only provides significant mechanistic insights into the formation 












































































Figure 3-15.  Proposed mechanisms of SpnQ catalyzed reactions. (a). SpnQ  catalyzes C-4 aminotransfer 
reaction in the presence of L-glutamate and PLP. (b). SpnQ catalyzes C-3 deoxygenation. The electron
















































Chapter 4.  Characterization of SpnR, the TDP-2,3,6-trideoxy-4- keto-D-
glucose 4-aminotransferase and SpnS, the TDP-4-amino-2,3,4,6-
tetradeoxy-D-glucose 4-N,N-dimethyltransferase
1.  INTRODUCTION
Deoxyaminosugars comprise an important class of deoxysuagr moieties 
synthesized by a variety of organisms, including plants, fungi, and bacterial.75
Deoxyaminosugars are usually formed via transamination reaction, which results in the 
substitution of a keto group with an amino group.  The latter can be ionized under 
physiological pH, and therefore might be engaged in both electrostatic interactions with 
other ionizable groups and in the formation of hydrogen bonds with certain chemical 
groups on the target molecule.  For example, certain macrolide antibiotics containing 
deoxyaminosugars bind to the peptidyl exit site of the ribosome and block the tunnel that 
channels nascent peptides away from the peptidel bond formation center.40  For the 14-
membered-ring macrolide erythromycin, it has been demonstrated that the 
deoxyaminosugar desosamine mediates hydrogen bonding interactions that are essential 
for binding of the antibiotic to the ribosome.41  Alternatively, the amino group might be 
important for interactions between antibiotic molecules, as in the case of polyene 
macrolides.  Such interactions appear to play an important role in the mechanism of 
action of this class of antibiotics, which is based on the ability of several antibiotic 
molecules to organize themselves into a channel spanning the cellular membrane of the 
target organism.111  These features of deoxyaminosugars make studies of their synthesis 
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important in efforts to produce antibiotics with new deoxysugar appendages by 
reengineering biosynthetic pathways either in vivo or in vitro. 
Several aminotransferases that catalyze the installation of an amino group on a 
sugar have been studied.  TylB in the biosynthetic pathway of TDP-D-mycaminose, a 
sugar component of the antibiotic tylosin, produced by Streptomyces fradiae, has been 
shown to act as a C-3 aminotransferase by in vitro biochemical studies conducted in our 
laboratory.129  DesI in the biosynthetic pathway of the D-desosamine portion of the 
antibiotics methymycin and neomethymycin (87) produced by Streptomyces venezuelae, 
is a C-4 aminotransferase catalyzing the conversion of TDP-6-deoxy-4-keto-glucose (3) 
to TDP-4-amino-4,6-dideoxy-glucose (57).  The function of DesI has been assigned by 
both in vitro and in vivo studies (Scheme 4-1).72 135 DesV, also in the biosynthetic 
















































Scheme 4-1. Macrolides generated by wide type Streptomyces venezuelae, desI mutant and 
desV mutant.
desV mutant
R1 = OH, R2=H : methymycin
R1 = H, R2=OH : neomethymycin
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successful isolation of the product, TDP-3-amino-3,4,6-trideoxy-glucose (59) from an 
enzymatic reaction of TDP-4,6-dideoxy-3-keto-glucose (58) and DesV.189 Interestingly, 
the presence of both a C-3 aminotransferase and a C-4 aminotransferase in the same 
biosynthetic pathway clearly demonstrated the substrate regiospecificities of these 
enzymes.  A desI knockout mutant of Streptomyces venezuelae failed to produce 
methymycin and neomethymycin (87).  Instead, a methymycin analogue carrying D-
quinovose was generated (85).  The fact that desV did not complement the missing desI
gene indicates that the C-3 aminotransferase, DesV, could not catalyze the C-4 
transamination reaction, and thus, the biosynthesis of TDP-D-desosamine was stalled.51,72
On the other hand, another S. venezuelae mutant in which desV gene was replaced by a 
thiostrepton resistance gene produced two macrolide compounds analogous to 
methymycin and neomethymycin (87), respectively, but both carrying a 4,6-dideoxy-
glucose (154) instead of D-desosamine.49  The fact that desI did not complement the 
missing desV gene means that the C-4 aminotransferase could not take a C-3 ketosugar as 
substrate, and the biosynthesis of D-desosamine was interrupted after the formation of the 
DesII product.  A ketoreductase in the general cellular pool probably catalyzes the C-3 
ketoreduction to form the C-3 hydroxyl group observed in the compounds isolated from 
the desV knockout mutant.  It is likely that the substrate specificities demonstrated by 
DesI and DesV are general characteristics of aminotransferases.  Sequence analysis 
revealed that all the assigned aminotransferases in the deoxysugar biosynthetic pathways 
could be divided into two groups (Figure 4-1): the C-3 aminotransferases of which DesV 


























Figure 4-1 .  Phylogenetic tree of aminotransferases involved in deoxysugar biosynthesis.
DesI is an example.  The C-3 aminotransferases could be further divided into two 
subgroups: enzymes having 2-deoxy sugars as substrates and enzymes having 2-hydroxy 
sugars as substrates.  The C-4 aminotransferases which are predicted to take 2-deoxy 
sugars as substrates and those that are predicted to take 2-hydroxy sugars do not fall into 
clear phylogenetic subclasses as do the C-3 aminotransferases.  Within each group or 
subgroup, the sequences are very well conserved while the sequences of members of 
different groups have less similarity.  The C-3 aminotransferases predicted to use 2-
deoxy sugars as substrates are somewhat distantly related to other C-3 aminotransferases.  
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In the TDP-D-forosamine biosynthetic gene cluster, spnR is proposed to encode 
an aminotransferase catalyzing the conversion of TDP-2,3,6-trideoxy-4-keto-glucose 











































Schem 4-2.  (a). SpnR and SpnS catalyzed reactions in the TDP-forosamine biosynthetic pathway. 





functional assignment solely based on sequence analysis can be misleading.  For 
example, E1 has significant sequence similarity to many aminotransferases, but its 
authentic function is to catalyze C-3 deoxygenation in the biosynthesis of CDP-
ascarylose.  SpnQ also shows considerable sequence similarity to a number of 
aminotransferases.  However, conversion of TDP-2,6-dideoxy-4-keto-glucose (24) to 
TDP-4-amino-2,4,6-trideoxy-glucose (153, Figure 3-8) was shown to be only a secondary 
function of SpnQ.  The C-4 transamination reaction catalyzed by SpnQ was kinetically 
less efficient than those catalyzed by typical aminotransferases.  The major function of 
SpnQ was shown to be the C-3 deoxygenation of TDP-2,6-dideoxy-4-keto-glucose (24) 
in the biosynthetic pathway of TDP-D-forosamine.  Thus, the least ambiguous and most 
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reliable way to assign an enzyme as an aminotransferase is by characterizing either gene 
knockout products or enzymatic reaction products. 
Much information about C-3 aminotransferases has been obtained from the 
thorough biochemical studies conducted on TylB.  In contrast, our knowledge on C-4 
aminotransferases is still limited.  Although the function of DesI has been confirmed by 
in vivo deletion experiments and in vitro enzymatic reactions, a detailed biochemical 
characterization was not carried out.  
In this chapter, the aminotransferase function of SpnR is studied by in vitro
enzymatic reactions, and a detailed biochemical characterization is described.  The work 
done in Chapter 2 and Chapter 3 has clearly established the order of the C-2 and C-3 
deoxygenation.  Since both the C-2 and C-3 deoxygenations are activated by the presence 
of the C-4 keto group, it can be inferred that the C-4 transamination reaction should occur 
after the two deoxygenation reactions.  The SpnR substrate, which is also the product of 
the SpnQ reaction, is TDP-2,3,6-trideoxy-4-keto-glucose (126).  The compound has been 
isolated from a preparative SpnQ enzymatic reaction, but is unstable, and can easily 
decompose by losing TDP.  In view of the instability of this compound and the 
reversibility of the transamination reaction, the SpnR catalyzed reaction was analyzed in 
the reverse direction using α-ketoglutarate and a chemically synthesized compound 155
as substrates (Scheme 4-2).  Compound 155 is structurally similar to TDP-4-amino-
2,3,4,6-tetradeoxy-glucose (127) except that the oxygen bridging the anomeric carbon 
and the β-phosphor of TDP in TDP-4-amino-2,3,4,6-tetradeoxy-glucose (127) is replaced 
with a methylene group.  
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Methylation reactions occur widely in nature.  The substrates of methylations 
represent a broad range of biomaterials including DNA, tRNA, proteins, polysaccharides 
and small molecules.  DNA methylation has been recognized for its prominent role in 
controlling diverse immune processes, tumor genesis, and age-related changes.168,169  The 
cytosine residues in CG dinucleotides are the main sites for DNA methylation.170,171
Studies have shown that DNA methylation precedes and directs histone modification to 
effect changes in chromatin structure.  Histone methylation is chemically stable and may 
be reversible.172,173  Histone methylation mainly occurs on lysine residues although 
arginine methylation has also been documented.174,175  The specific function of histone 
methylation is largely decided by the location of the substrate residue.171  Compared with 
the extensive studies on macromolecule methylation, methylations of macrolide 
antibiotics are less well studied although it has been documented that methylation of 
macrolide antibiotics plays an important role in macrolide antibiotic recognition 
specificities.176
Most methylation reactions are enzyme-catalyzed and SAM dependent.  
However, in some cases, the methyl donor can be coenzyme B12, such as in methylation 
reactions catalyzed by one type of methionine synthases.190,191  In this reaction, the 
methyl group of 5-methyltetrahydrofolate is passed to a reactive form of vitamin B12 to 
form methylcobalamin which can transfer the methyl group to the thiol side chain of 
homocysteine to form methionine.  Macrolide antibiotic methylation can occur either on 
the sugar appendages or on the aglycone, and the methylation sites are usually 
nucleophilic NH2-, (NHR-), OH-, and CHR2-.  Correspondingly, the methyltransferases 
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can be subclassified as N-methyltransferases, O-methyltransferases, and C-
methyltransferases.  Sequence analysis supports and illustrates these subclassifications.  
The proteins from different subclasses are only distantly related, while those within a 
given subclass are more closely related.  N-methyltransferases can be further divided into 
two subgroups (Figure 4-2): 4-amino-N-methyltransferases of which SpnS from the TDP-
D-forosamine biosynthetic way and VinG from the TDP-vicenisamine biosynthetic 
pathway are the representatives,156 and 3-amino-N-methyltransferases, of which TylM1, 

















Figure 4- 2. Phylogenetic tree of 3-N-methyltransferases and 4-N-methyltransferases that are involved 
in deoxysugar biosynthesis.  
Like other enzymes in the deoxysugar biosynthetic pathways, most 
methyltransferases are assigned based on sequence analysis since few of them have been 
biochemically characterized.  TylM1, the 3-amino-N,N-dimethyltransferase in the 
biosynthetic pathway of TDP-D-mycaminose in antibiotic tylosin produced by 
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Streptomyces fradiae, has been studied in detail by our laboratory.195  It has been 
demonstrated that the N,N-dimethylation is a stepwise nucleophilic process.  The function 
of 3-N,N-dimethyltransferase DesVI has also been confirmed by enzymatic assays.195
Among C-methyltransferases, TylC3 in the biosynthetic pathway of TDP-L-mycarose has 
been proved to be the enzyme catalyzing the conversion of TDP-2,6-dideoxy-4-keto-
glucose (28, Scheme 1-2) to TDP-2,6-dideoxy-4-keto-3-C-methyl-glucose (30, Scheme 
1-2).167  The presence of the 4-keto group activates the α carbon and facilitates the proton 
abstraction on C-3.  The resulting carbanion can serve as a good nucleophile in the C-
methylation reaction.  SAM has been shown to be the methyl donor in all of the 
characterized sugar methylation reactions. 
In the biosynthetic pathway of TDP-D-forosamine, SpnS is suggested to catalyze 
4-amino-N,N-dimethylation reaction (Scheme 4-2).  Thus, the SpnS catalyzed reaction 
must occur later than the SpnR catalyzed transamination reaction.  Since the SpnR 
reaction must be after the C-2 and C-3 deoxygenations, SpnS must be the last step in 
TDP-D-forosamine biosynthetic pathway.  In this chapter, in vitro enzymatic activity 
studies and biochemical characterization on SpnS will be presented.  The functional 
analysis of SpnR and SpnS described in this chapter has led to the complete 
establishment of the biosynthetic pathway of TDP-D-forosamine.  
2.  EXPERINETAL PROCEDURES
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Materials.  Most materials used in these experiments were identical to those 
described in Chapter 2.  Other reagents, such as SAM, pyruvate, and α-ketoglutarate, 
were purchased from Sigma-Aldrich. All the chemicals used in the chemical synthesis of 
155 were analytical grade or the highest quality commercially available.  
General Equipment.  The equipment and other experimental apparati were 
identical to those described in Chapter 2. 
Bacterial Strains.  Various E. coli host cells used were identical to those 
described in Chapter 2.  
Synthesis of 155.  Chemical synthesis of 155, an analog of TDP-4-amino- 2,3,4,6-
tetradeoxy-glucose (127) was performed by Dr. Kent Zhao following the scheme 
delineated in Scheme 4-3.
PCR Amplification of the spnR Gene.  The cloning of spnR gene was completed 
by Dr. Kent Zhao.  Two oligonucleotide primers complementary to the sequence at each 
end of the spnR gene were designed to amplify the gene for cloning into the pET24b(+) 
vector.  The start primer (KZR-1), 5’-GGGGCCTCCATATGTGATCAACCTGCA-
CCAG-3’, contains an NdeI restriction site (in bold) and the first 18 nucleotides of the 
spnR gene.  The halt primer (KZR-2) 5’-ATCCGCTCGAGCTTTCGGAGTGGTGA-
TCTTTG-3’, was designed to introduce an XhoI restriction site (in bold) immediately 
downstream of the coding sequence.  The natural stop codon of spnR was not included in 
the sequence of KZR-2 in order to produce a C-terminal His6-tagged fusion protein upon 
cloning into pET24b(+).  Polymerase mediated amplification was carried out in a 0.5 mL 
microcentrifuge tube.  To the reaction mixture was added 37.5 µL of double-deionized 
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H2O, 5.0 µL of pfu polymerase buffer (10 x), 4.0 µL of deoxyribonucleotidyl-
triphosphate mix (2.5 mM each), 1.0 µL of start primer KZR-1 (10 µM), 1.0 µL of halt 
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spinosa as the amplification template, and 1.0 µL of cloned pfu polymerase (2.5 units).  
The reaction mixture was then overlaid with a layer of mineral oil and subjected to the 
following thermal cycles: (1) 1 denaturation cycle of incubation at 95 °C for 3 min; (2) 
30 amplification cycles of incubation at 95 °C for 30 s, 60 °C for 30 s and 72 °C for 2.5 
min; and (3) 1 extension cycle of incubation at 72 °C for 10 min.  The tube was held at 4 
°C prior to being removed from the thermal cycler. 
PCR Amplification of the spnS Gene.  The cloning of spnS gene was completed by 
Dr. Kent Zhao.  Two oligonucleotide primers complementary to the sequence at each end 
of the spnS gene were designed to amplify the gene for cloning into the pET24b(+) 
vector.  The start primer (KZS-1), 5’-GGGAATTCCATATGTCGCGCGTGAGCGA-
CAC-3’, contains an NdeI restriction site (in bold) and the first 20 nucleotides of the spnS
gene.  The halt primer (KZS-2) 5’-ATCCGCTCGAGGTTGCGGATTCCGACGAAC-3’, 
was designed to introduce an XhoI restriction site (in bold) immediately downstream of 
the coding sequence.  The natural stop codon of spnS was not included in the sequence of 
KZS-2 in order to produce a C-terminal His6-tagged fusion protein when cloned into 
pET24b(+).  Polymerase mediated amplification was carried out in a 0.5 mL 
microcentrifuge tube.  To the reaction mixture was added 37.5 µL of double-deionized 
H2O, 5.0 µL of pfu polymerase buffer (10 x), 4.0 µL of deoxyribonucleotidyltriphosphate 
mix (2.5 mM each), 1.0 µL of start primer KZS-1 (10 µM), 1.0 µL of halt primer KZS-2 
(10 µM), 0.5 µL of genomic DNA (about 0.1 µg) from Saccharopolyspora spinosa as the 
amplification template, and 1.0 µL of cloned pfu polymerase (2.5 units).  The reaction 
mixture was then overlaid with a layer of mineral oil and subjected to the following 
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thermal cycles: (1) 1 denaturation cycle of incubation at 95 °C for 3 min; (2) 30 
amplification cycles of incubation at 95 °C for 30 s, 60 °C for 30 s and 72 °C for 2.5 min; 
and (3) 1 extension cycle of incubation at 72 °C for 10 min.  The tube was held at 4 °C 
prior to being removed from the thermal cycler.  
Cloning of the spnR and spnS genes.  After PCR amplification, standard 
recombinant DNA techniques were used to clone the genes into an appropriate expression 
vector.  Typically, 5 µL of the reaction mixture was withdrawn and electrophoresed on a 
0.7% agarose gel to check the size and the yield of the product.  The PCR product 
mixture was separated from the oil and subjected to DNA purification using QIAquick
spin kit.  After digestion with appropriate restriction enzymes, the entire mixture was 
loaded onto a 0.7% agarose gel for electrophoresis.  The desired DNA band with 
expected size was excised and purified by the QIAquick spin kit.  Ligation of the target
gene with predigested pET24b(+) was achieved by the action of high concentration T4 
DNA ligase.  Typically, a ligation reaction of 20 µL including 5.0 unit of ligase was 
carried out for 2 h at room temperature. 
Transformation of 20 µL E.coli DH5α host cells was carried out with 20 ng of the 
ligation product.  The resulting cells were incubated on ice for 30 min followed by a heat 
shock at 42 °C for 90 s.  The cells were then cooled down by incubation on ice for 
another 2 min before 800 µL of LB medium was added.  After incubating at 37 °C with 
shaking (200 rpm) for 45 min, the culture was briefly centrifuged (13,000 rpm, 1 min).  
An aliquot of 700 µL of the supernatant was removed.  The small cell pellet was 
resuspended in the remaining medium and then plated out on LB plates supplemented 
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with 30 µg/mL kanamycin.  The plates were incubated for 20 h at 37 °C before six 
clonies were picked to inoculate 5 mL of liquid medium, which was incubated at 37 °C 
overnight.  The plasmid DNAs were isolated from each of the cultures using QIAprep 
spin Miniprep kit.  The plasmid DNA (40 ng) from each miniprep was digested with 
appropriate restriction enzymes.  Positive clones were identified by the presence of the 
fragment with the expected size on the agarose gel after electrophoresis and were further 
confirmed by DNA sequencing.  The plasmid DNA of the positive clones, pKZR and 
pKZS for spnR and spnS, respectively, were used to transform the E. coli BL21 (DE3) 
competent cells.  
Purification of the SpnR Protein.  All purification steps were carried out at 4 °C.
Step 1:  Growth E. coli BL21 (DE3)-pKZR cells.  An overnight culture of E. coli
BL21 (DE3)-pKZR, grown in LB medium supplemented with kanamycin (30 µg/mL) at 
37 °C, was diluted 250-fold by addition of 4 mL of the overnight culture to each of three 
1 L flasks of the same medium and incubated at 37 °C until the OD600 reached 0.3.  The 
incubation temperature was adjusted to 24 °C and the incubation was continued for one 
more hour before the OD600 reached 0.4.  The culture was then induced with IPTG to a 
final concentration of 0.2 mM and allowed to grow for an additional 15 h at 24 °C.  The 
cells were harvested by centrifugation at 5,000 g for 10 min at 4 °C and stored at –80 °C.  
The typical yield of wet cells was about 6 g per liter.
Step 2:  Crude Extract Preparation.  The cells were resuspended in 80 mL of lysis 
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, 5 mM 
2-mercapto-ethanol, pH 8.0), and disrupted with five 1 min sonication bursts, with 1 min 
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cooling intervals between bursts.  Cellular debris was removed by centrifugation at 
35,000 g for 20 min.  The supernatant was transferred into a large centrifuge bottle for 
incubation with Ni-NTA resin.  
Step 3:  Ni-NTA Affinity Chromatography.  An 8 mL of Ni-NTA slurry (4 mL of 
resin) was added to the crude extract, and the resulting mixture was incubated for 2 h 
with gentle shaking at 4 °C.  The majority of the supernatant was decanted after the resin 
was spun down to the bottom of the centrifuge bottle with brief centrifugation at low 
speed (1,000 g).  The remaining resin slurry was mixed well and loaded into an empty 
glass column (1 x 25 cm).  The column was washed with 30 mL of the lysis buffer 
followed by various amounts of wash buffers.  The wash buffers and elution buffer used 
contained the same ingredients as the lysis buffer except that the concentrations of 
imidazole were altered.  The column was washed sequentially with 30 mL of wash buffer 
containing 20 mM imidazole, 30 mL of wash buffer containing 40 mM imidazole, and 15 
mL of wash buffer containing 60 mM imidazole.  No peristaltic pump was used.  The 
buffers passed through the column by gravity at a flow rate of 0.5 mL/min.  After 
washing, the SpnR protein was eluted with 15 mL of elution buffer containing 100 mM 
imidazole.  Eluted protein was concentrated to about 3 mL by ultrafiltration in an Amicon 
concentrator using a YM- 10 membrane (Amicon).
Step 4: Sephacryl S-200 HR Chromatography.  The protein from step 3 was 
applied to a Sephacryl S-200 HR column (2.5 x 100 cm) preequalibrated with buffer A 
(25 mM Tris·HCl, 1 mM 2-mercapto-ethanol, 15% glycerol, pH 7.5).  The column was 
eluted with the same buffer at a flow rate of 0.8 mL/min.  The fraction size of the eluent 
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was set at 8 mL.  Pure fractions were identified by SDS-PAGE, and concentrated to 3.0 
mL by ultrafiltration in an Amicon concentrator using a YM-10 membrane (Amicon).  
The purified SpnR protein was stored at –80 °C.  
Purification of the SpnS protein.  All purification steps were carried out at 4 °C.
Step 1:  Growth E. coli BL21 (DE3)-pKZS cells.  An overnight culture of E. coli
BL21 (DE3)-pKZS, grown in LB medium supplemented with kanamycin (30 µg/mL) at 
37 °C, was diluted 250-fold by addition of 4 mL of the overnight culture to each of six 1 
L flasks of the same medium and incubated at 37 °C until the OD600 reached 0.4.  The 
incubation temperature was adjusted to 30 °C and the incubation was continued for 
another half an hour before the OD600 of the culture reached 0.5.  The culture was then 
induced with IPTG to a final concentration of 0.2 mM and allowed to grow for an 
additional 7 h at 30 °C.  The cells were then harvested by centrifugation at 5,000 g for 10 
min at 4 °C and stored at –80 °C.  The typical yield of wet cells was about 6 g per liter.
Step 2:  Crude Extract Preparation.  The cells were resuspended in 80 mL of lysis
buffer (50 mM sodium phosphate, 300 mM NaCl, 5 mM imidazole, 15% glycerol, 5 mM 
2-mercapto-ethanol, pH 8.0), and disrupted with five 1 min sonication bursts, with 1 min 
cooling intervals between bursts.  Cellular debris was removed by centrifugation at 
35,000 g for 20 min.  The supernatant was transferred into a large centrifuge bottle for 
incubation with Ni-NTA resin.  
Step 3:  Ni-NTA Affinity Chromatography.  To the crude extract, was added 8 mL 
of Ni-NTA slurry (4 mL of resin) and the resulting mixture was incubated for 2 h with 
gentle shaking at 4 °C.  The majority of the supernatant was decanted after the resin was 
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spun down to the bottom of the centrifuge bottle with brief centrifugation at low speed 
(1,000 g).  The remaining resin slurry was mixed well and loaded into an empty glass 
column (1 x 25 cm).  The column was washed with 30 mL of lysis buffer followed by 
various amounts of wash buffers.  The wash buffers and elution buffer used contained the 
same ingredients as the lysis buffer except that the concentrations of imidazole were 
altered.  The column was washed sequentially with 30 mL of wash buffer containing 20 
mM imidazole, 30 mL of wash buffer containing 40 mM imidazole, and 15 mL of wash 
buffer containing 60 mM imidazole.  No peristaltic pump was used.  The buffer passed 
through the column by gravity at a flow rate of 0.5 mL/min.  After washing, the SpnS 
protein was eluted with 15 mL of elution buffer containing 100 mM imidazole.  Eluted 
protein was concentrated to about 3 mL by ultrafiltration in an Amicon concentrator 
using a YM-10 membrane (Amicon).
Step 4:  Sephacryl S-200 HR Chromatography.  The protein from the previous 
step was applied to a Sephacryl S-200 HR column (2.5 x 100 cm) preequalibrated with 
buffer A (25 mM Tris·HCl, 1 mM 2-mercapto-ethanol, 15% glycerol, pH 7.5).  The 
column was eluted with the same buffer at a flow rate of 0.8 mL/min.  The fraction size 
was set at 8 mL.  Pure fractions were identified by SDS-PAGE, and concentrated to 3.0 
mL by ultrafiltration in an Amicon concentrator using a YM-10 membrane (Amicon).  
The purified SpnS protein was stored at –80 °C.  
Polyacrylamide Gel Electrophoresis.  The subunit molecular mass and the purity 
of the protein samples were assessed by SDS-PAGE as described in Chapter 2.
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Molecular Weight Determination.  The native molecular weights of the purified 
protein samples were determined by gel filtration chromatography following the 
procedure described in Chapter 2. 
Activity Assay for SpnR.  An HPLC-based assay was developed for SpnR with a 
Dionex CarboPacTM PA1 analytical column (4 x 250 mm) connected to a CarboPacTM 
PA1 guard column (4 x 50 mm) by monitoring the consumption of the substrate and the 
formation of a new compound at 267 nm.  A typical assay mixture of 80 µL contained 0.5 
mM of the substrate 155, 30 mM of α-ketoglutarate, 2.0 mM of DTT, 2.0 mM of MgCl2, 
0.2 mM of PLP, 10 µM of SpnR, and 50 mM potassium phosphate buffer (pH 7.5).  The 
reaction was initiated by the addition of SpnR and was carried out at room temperature 
(24 °C).  A suitable amount of reaction mixture was withdrawn at appropriate time 
intervals.  The reaction was terminated by dilution with a 10-fold excess of water and 
flash freezing in liquid nitrogen.  The enzyme was removed by filtering through a 
Centricon YM-10 microconcentrator by centrifugation.  An appropriate amount of the 
filtrate was subjected to HPLC analysis.  A linear gradient from 5 to 20% B over 15 min 
followed by another linear gradient from 20 to 60% B over 20 min was used to resolve 
the substrate 155 (retention time = 6.5 min) and the SpnR product (retention time = 31.3 
min).  Buffer A was water and Buffer B was 500 mM NH4OAc, pH 7.0, adjusted with 
diluted NH3·H2O.  The elution gradient was followed by a final wash with 100% B for 5 
min and reequilibration with 5% B for 15 min.  The absolute rate of SpnR product 
formation was calculated as the number of nmols of product formation per min, and 
percent conversion of the substrate was used directly to determine the relative rate.
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Reconstitution of SpnR with PLP under Native Conditions.  A 200 µL solution 
containing 120 µM SpnR, 2.0 mM PLP, 1 mM DTT, and 50 mM potassium phosphate 
(pH 7.5) was incubated at room temperature for 6 h.  The entire solution was then loaded 
onto an Econo-Pac 10 DG column (Bio-Rad).  The reconstituted protein was eluted with 
50 mM potassium phosphate buffer (pH 7.5).  Fractions containing the SpnR protein 
were pooled and concentrated.  Any residual unbound PLP was removed by repeated 
dilution and concentration using Centricon YM-10 microconcentrator.  The presence of 
the enzyme bound PLP was determined by UV-visible spectroscopy.
Reconstitution of SpnR with all Necessary Substrates Present.  A 200 µL solution 
containing 120 µM SpnR, 2.0 mM PLP, 1 mM DTT, 0.5 mM of the substrate 155, 5.0 
mM α-ketoglutarate, and 50 mM potassium phosphate buffer (pH 7.5) was incubated at 
room temperature for 6 h.  The entire solution was then loaded onto Econo-Pac 10 DG 
column (Bio-Rad).  The reconstituted protein was eluted with 50 mM potassium 
phosphate buffer (pH 7.5).  Fractions containing the SpnR protein were pooled and 
concentrated.  Any residual unbound PLP was removed by repeated dilution and 
concentration using Centricon YM-10 microconcentrator.  The presence of enzyme 
bound PLP was determined by UV-visible spectroscopy.
UV-visible Spectrum of the SpnR Protein.  The absorbance of the as-isolated 
SpnR protein and the reconstituted SpnR protein (reconstituted either in the presence or 
in the absence of the substrates) was measured from 250 nm to 750 nm on a Beckman 
DU-650 spectrophotometer. 
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Effect of Reconstitution on SpnR Catalytic Activity.  PLP was omitted from the 
SpnR activity assay mixture while the concentrations of other reagents were held constant 
and the as-isolated SpnR was replaced with the reconstituted SpnR (reconstituted either 
in the presence or in the absence of the substrates).  The substrate conversion was 
compared with that of the reaction catalyzed by the as-isolated SpnR. 
Mg2+ Requirement in SpnR Catalysis.  The Mg2+ ion was omitted from the SpnR 
activity assay mixture and the relative reaction rate was compared with that of a reaction 
containing Mg2+. 
PLP Concentration Effect.  While the concentrations of other reagents were held 
constant, the concentration of PLP in the SpnR activity assay mixture was set at either 0, 
10 µM, 20 µM, 40 µM, or 80 µM.  The relative reaction rates were compared to 
determine the PLP concentration effect. 
PMP as the Cofactor.  PLP was replaced with PMP in the SpnR activity assay.  
The competence of PMP as cofactor in the transamination reaction was evaluated with 
that of PLP by comparison of the substrate conversions of each reaction.   
Determination of the Optimal Amino Acceptor.  Two α-keto acids, pyruvate and 
α-ketoglutarate were examined for their efficiency as the amino acceptor in the SpnR 
catalyzed reaction.  The α-keto acids were added to a final concentration of 3.0 mM in 
assays described previously.  The efficiency of these two α-keto acids as amino acceptors 
was examined by comparing the relative reaction rates when using each in the reaction.
Optimal pH for SpnR Catalysis.  The optimal pH for the reaction catalyzed by 
SpnR was examined in buffers with different pHs.  The concentrations of the reaction 
194
reagents were held constant, while the pH was varied over a range of 5.5 to 9.5.  A 50 
mM MES buffer was used in the reaction at pH 5.5; a 50 mM Bis-Tris-Propane buffer 
was used in the reaction at pH 6.5; a 50 mM potassium phosphate buffer was used in the 
reaction at pH 7.5; and a 50 mM Bis-Tris-propane buffer was used for the reactions at pH 
8.5 and 9.5.  The relative reaction rates at different pHs were compared to determine the 
optimal pH of the SpnR reaction. 
Isolation and Characterization of the SpnR Product.  The reaction was carried out 
in the reverse direction, from aminosugar to ketosugar, and the substrate used was 155, 
an analog of TDP-4-amino-2,3,4,6-tetradeoxy-glucose.  A preparative scale incubation 
was carried out in which 7.8 mM 155, 143 mM α-ketoglutarate, 0.3 mM PLP, and 0.23 
mM SpnR were incubated in 3 mL of 50 mM potassium phosphate buffer (pH 7.5).  The 
reaction was initiated by the addition of SpnR and was carried out at 24 °C.  The progress 
of the incubation was monitored by HPLC as described previously for the SpnR activity 
assay.  The reaction was almost complete (97%, based on peak area integration) after 15 
h.  The enzyme was removed using a Centricon YM-10 and the filtrate was applied onto 
a gel filtration column (Bio-Rad P2, extra fine, 2.5 x 150 cm) preequalibrated with 25 
mM NH4HCO3.  The compounds were eluted with the same buffer at a flow rate of 12 
mL/h at 4 °C.  Fractions were assayed spectrophotometrically by scanning from 250 nm 
to 400 nm.  The fractions that displayed a single absorption maximum at 267 nm were 
lyophilized as individual fractions and analyzed by NMR.  Spectra data for the SpnR 
reverse reaction product: 1H NMR (D2O, 4-keto and 4-keto hydrated form): δ 1.11 (d, J = 
4.2 Hz, 5-Me), 1.21 (d, J = 4.2 Hz, 5-Me), 1.84 (3H, m, 5’’-Me), 1.57-2.58 (6H, m, 2-H, 
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3-H, CH2-P), 2.28 (2H, m, 2’-H), 3.64 (1H, q, J = 3.9 Hz, 5-H), 4.20 (1H, q, J = 3.9 Hz, 
5-H), 4.03-4.35 (4H, m, 4’-H, 5’-H, 1-H), 4.52 (1H, ddd, 3’-H), 6.26 (1H, t, J = 4.2 Hz, 
1’-H), 7.66 (s, 6’’-H), 7.67 (s, 6’’-H). 13C NMR (D2O, hydrated form): 12.0, 15.2, 27.8, 
29.2, 33.6 (d, J = 138.2), 38.8, 65.2, 67.6, 71.4, 75.2, 85.2, 85.6, 92.8, 112.0, 139.8, 
152.0, 167.5. 31P NMR (D2O, hydrated form): 14.8 (d, J = 26 Hz), 13.9, (d, J = 26 Hz), -
10.6 (d, J = 26 Hz). High resolution FAB-MS calculated for C17H26N2O12P2 (M-H)
- was 
511.0883, and a mass of 511.0880 was found. 
Assay of SpnR in the Forward Direction.  After the SpnR reverse reaction product 
was isolated, it became possible to assay SpnR in the forward direction.  The substrate is 
an analog (156) of TDP-2,3,6-trideoxy-4-keto-glucose (126).  An assay mixture of 50 µL 
contained 0.6 mM 156, 12.0 mM L-glutamate, 1.0 mM MgCl2, 1.0 mM DTT, 50.0 µM 
PLP and 10 µM SpnR.  After the reaction was incubated at 24 °C for 3 h, the enzyme was 
removed using a Centricon YM-10 microconcentrator and the filtrate was subjected to 
HPLC analysis.  The elution program was the same as that used for the SpnR activity 
assays. 
Assay of SpnR in the Forward Direction with Authentic Substrate.  The highly 
deoxygenated and unstable SpnQ product (126) was generated immediately prior to use.  
A typical assay mixture of 80 µL contained 0.70 mM SpnN product (24), 0.15 mM PMP, 
30 µM ferredoxin, 30 µM ferredoxin reductase, 2.0 mM NADPH, 30 µM SpnQ, and 50 
mM potassium phosphate buffer (pH 7.5).  After the incubation was carried out at room 
temperature for 3 h, all the enzymes in the reaction mixture were removed using a 
Centricon YM-10 concentrator.  To the filtrate (80 µL) were added 0.025 µmol of PLP, 
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1.0 µmol of L-glutamate and 0.1 µmol of MgCl2.  The reaction mixture was incubated at 
room temperature for 2 h.  The enzyme SpnR was then removed using a Centricon YM-
10 microconcentrator and the final reaction filtrate was subjected to HPLC analysis.  The 
separation program was the same as the one used for the SpnR activity assays.
Substrate Specificity of SpnR.  The SpnN product (24) was examined as a possible 
substrate for SpnR.  A typical assay mixture of 25 µL contained 1.05 mM SpnN product 
(24), 0.25 mM PLP, 10.0 mM L-glutamate, 30 µM SpnR and 50 mM potassium 
phosphate buffer (pH 7.5).  After the assay mixture was incubated at 37 °C for 18 h, the 
enzyme was removed by filtering through a Centricon YM-10 microconcentrator by 
centrifugation and the filtrate was subjected to HPLC analysis.  In another incubation, 
26.2 nmol of the SpnN product was incubated with 12.5 nmol of PLP, 15 nmol of L-
glutamate and 0.74 nmol of SpnQ in 25 µL of 50 mM potassium phosphate buffer (pH 
7.5).  SpnQ, under these conditions, was previously shown to act as a 4-aminotransferase, 
as described in Chapter 3.  After the reaction mixture was incubated at 37 °C for 10 h, the 
enzyme was removed using a Centricon YM-10 microconcentrator.  Under these 
conditions, the SpnQ-catalyzed 4-aminotransfer did not proceed to completion, and thus, 
there was still some SpnN product present in the reaction mixture after removal of SpnQ.  
To the filtrate were added 7.5 nmol of PLP, 0.25 µmol of L-glutamate and 1.5 nmol of 
SpnR and the incubation was carried out at either room temperature or 37 °C for 4 h.  
After the enzyme was removed using a Centricon YM-10 microconcentrator, the filtrate 
was analyzed by HPLC.  The elution program was the same as the one used for the SpnR 
activity assays.  This incubation with SpnR was performed to test whether SpnQ and 
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SpnR were both catalyzing the identical reaction under the conditions used.  If so, this 
would provide further evidence supporting the identification of the product as TDP-4-
amino-2,4,6-trideoxy-glucose (153). 
Determination of the Equilibrium Constant of the SpnR Reaction.  A 50 µL of 
reaction mixture contained 0.6 mM 155, 0.6 mM α-ketoglutarate, 50 µM PLP, 10 µM 
SpnR and 50 mM potassium phosphate buffer (pH 7.5).  After the reaction was carried 
out at room temperature for 12 h, the enzyme was removed using Centricon YM-10
microconcentrator, and the filtrates were subjected to HPLC analysis.  The elution 
program was the same as the one used for the SpnR activity assays.  The concentrations 
of the keto- and aminosugar were calculated based on the integrals of the corresponding 
peaks.  The equilibrium constant Keq was defined as in Equation 4-1, where [α-KG]0 is 
the initial concentration of α-KG.  
Activity Assay for SpnS.  An HPLC-based assay was developed for SpnS with a 
Dionex CarboPacTM PA1 analytical column (4 x 250 mm) connected to a CarboPacTM 








formation of new compounds at 267 nm.  A typical assay mixture of 60 µL contained 
1.05 mM 155, 2.0 mM SAM, 2.0 mM MgCl2, 2.0 mM DTT, 10 µM SpnS, and 50 mM 
potassium phosphate (pH 7.5).  The reaction was initiated by the addition of SpnS and 
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was carried out at 37 °C.  A suitable amount of the reaction mixture was withdrawn at 
appropriate time intervals and the reaction was terminated by denaturing the protein at 90 
°C for 4 min.  The enzyme was removed by filtering through a Centricon YM-10 
microconcentrator with centrifugation and the filtrate was subjected to HPLC analysis.  A 
linear gradient from 5 to 20% B over 15 min followed by another linear gradient from 20 
to 60% B over 20 min while Buffer A is H2O and Buffer B is 500 mM NH4OAc (pH 7.0, 
adjusted with diluted NH3·H2O), was able to separate 155 (retention time = 6.5 min) and 
by-product S-adenosylhomocysteine (retention time = 3.0 min).  However, SAM 
degradation product and the SpnS product overlapped with each other and could not be 
resolved.  The elution gradient was followed by a final wash with 100% B for 5 min and 
a reequilibration with 5% B for 15 min.  
Preparation and Characterization of the SpnS Product.  A preparative scale 
incubation was carried out in which 16.5 µmol of 155, 41.2 µmol of SAM, 4 µmol of 
MgCl2, 4 µmol of DTT and 0.16 µmol of SpnS were incubated in 2 ml of 50 mM 
potassium phosphate buffer (pH 7.5).  The reaction was initiated by the addition of SpnS 
and was carried out at 37 °C.  The progress of the reaction was monitored by the HPLC 
assay described previously.  After 15 h, about 50% of the substrate was converted to the 
methylation product as judged by peak area integration.  The enzyme was then removed 
by filtering through a Centricon YM-10 membrane by centrifugation and the filtrate was 
applied to a gel filtration column (Bio-Rad P2, extra fine, 2.5 x 120 cm) preequalibrated 
with 25 mM NH4HCO3.  The column was eluted with the same buffer at a flow rate of 12 
mL/h at 4 °C.  Fractions were assayed spectrophotometrically by scanning from 250 nm 
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to 400 nm.  The fractions that displayed a single absorption maximum at 267 nm were 
lyophilized as individual fractions and analyzed by NMR.  Spectra data for the SpnS 
reaction product: 1H NMR (D2O): δ 1.32 (3H, d, J = 4.2 Hz, 5-Me), 1.85 (3H, s, 5’’-Me), 
1.44-2.16 (6H, m, 2-H, 3-H, CH2-P), 2.24-2.34 (2H, m, 2’-H), 2.66 (3H, s, NH-Me), 3.02 
(1H, q, J =1.5 Hz, 4-H), 4.05-4.16 (5H, m, 4’-H, 5’-H, 1-H, 5-H), 4.54 (1H, ddd, 3’-H), 
6.27 (1H, t, J = 3.9 Hz, 1’-H), 7.67 (1H, s, 6’’-H). 13C NMR (D2O): δ 11.9, 15.4, 19.2, 
26.0, 30.9, 34.2 (d, J = 138.2), 38.8, 57.7, 65.4, 66.1, 68.9, 71.1, 85.2, 85.6, 112.2, 138.0, 
152.0, 167.2. 31P NMR (D2O): δ 14.1 (d, J = 27 Hz), -10.7 (d, J = 27 Hz). High-
resolution FAB-MS calculated for C18H31N3O11P2 (M+H)
+ was 528.1212, and a mass of 
528.1502 was found.
Effects of Metals on SpnS Catalysis.  Solutions of 2.0 mM of a variety of metals 
ions were tested for their effects on SpnS catalysis by including the appropriate salt of 
each individual ion Al3+, Fe3+, Zn2+, Mg2+, Fe2+, Co2+, and Ca2+ in the SpnS activity assay 
while maintaining the concentrations of other reagents unchanged.  The elution program 
was the same as the one used for the SpnR activity assays.
Effect of Mg2+ Concentration on SpnS Catalysis.  Solutions of 100 µM, 200 µM, 
400 µM, 800 µM, 2.0 mM, and 10 mM of MgCl2 were individually included in the SpnS 
activity assays.  The relative reaction rates were compared by HPLC analysis.  The 
elution program was the same as the one used for the SpnR activity assays.
Optimal pH for SpnS Catalysis.  The optimal pH for the reaction catalyzed by 
SpnR was examined in buffers with different pHs.  The concentrations of the reaction 
reagents were held constant, while the pH was varied over a range of 5.5 to 9.5.  A 50 
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mM MES buffer was used in the reaction at pH 5.5; a 50 mM Bis-Tris-Propane buffer 
was used in the reaction at pH 6.5; a 50 mM potassium phosphate buffer was used in the 
reaction at pH 7.5; and a 50 mM Bis-Tris-propane buffer was used for the reactions at pH 
8.5 and 9.5.  The relative reaction rates at different pHs were compared to determine the 
optimal pH for the SpnS catalysis. 
The Time Courses of Methylation.  The time courses of mono-and di-methylation 
of 155 were determined by HPLC following the consumption of substrate and formation 
of monomethylated and dimethylated products.  A typical assay mixture consisted of 1.0 
mM 155, 2.0 mM SAM, 2.0 mM MgCl2, 2.0 mM DTT and 10.0 µM SpnS in 50 µL of 50 
mM potassium phosphate buffer (pH 7.5).  Aliquots were withdrawn at appropriate time 
intervals, diluted 20 fold, filtered through Centricon YM-10 by centrifugation to remove 
proteins, and injected to an Adsorbosphere SAX column (5µ, 4.6 x 250 mm) monitored at 
267 nm.  A linear gradient from 0 to 20% B between buffer A (50 mM potassium 
phosphate, pH 3.5) and buffer B (500 mM potassium phosphate, pH 3.5) over 20 min 
gave base line separation between 155 (retention time = 11.2 min) and the 
monomethylated product (retention time = 20.2 min).  The peak of the dimethylated 
product still overlapped with those of SAM and its degradation products and therefore 
could not be directly observed.  The elution gradient was followed by a final wash with 
100% B for 5 min, and a reequilibration with 0%B for 15 min.  The amounts of 155 and 
the monomethylated product were calculated from the integrals of the corresponding 
peaks.  The amount of the dimethylated product was calculated by subtracting the
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integrals of both the remaining substrate and the monomethylated product from that of 
the initial substrate.
Dimethylation Assay for SpnS.  The monomethylated product (158) of SpnS 
isolated from the preparative scale reaction was used as the substrate to examine the 
dimethylation reaction catalyzed by SpnS.  A typical assay mixture of 50 µL contained 
1.0 mM of the monomethylation product (158), 2.0 mM SAM, 2.0 mM MgCl2, 2.0 mM 
DTT, 20 µM SpnS and 50 mM of potassium phosphate (pH 7.5).  The reaction was 
initiated by the addition of SpnS and was carried out at 37 °C for 12 h.  The enzyme was 
removed by filtering through a Centricon YM-10 microconcentrator by centrifugation 
and the filtrate was subject to HPLC analysis (Dionex column).  The elution program was 
the same as the one used for SpnR activity assay.  As has been mentioned before, neither 
the monomethylation product nor the dimethylation product, could not be separated from 
SAM degradation products under the condition used.  Thus the whole overlapped peaks 
were collected.  The compounds were dried by lyophilization and redissolved in 100 µL 
of H2O.  The solution was submitted to MS analysis.
3.  RESULTS AND DISCUSSION
Synthesis of an Analog of TDP-4-amino-2,3,4,6-tetradeoxy-glucose.  The 
chemical synthesis of compound 155 was completed by Dr. Kent Zhao.  In 155, the 
oxygen atom that connects the hexose ring and TDP in the case of TDP-4-amino-2,3,4,6-
tetradeoxy-glucose (127) is replaced with a methylene group.  Compound 155 was useful 
in both the SpnR and SpnS enzymatic reactions, serving as the substrate of both the 
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methylation reaction and the reverse transamination reaction.  The compound was stable 
even being heated at 90 °C.  The overall chemical synthesis took 11 steps.  Spectra data 
for 155: 1H NMR (D2O): δ 1.20 (3H, d, J = 6.9 Hz, 5-Me), 1.79 (3H, s, 5’’-Me), 1.50-
2.05 (4H, m, 2-H, 3-H), 1.90-2.02 (2H, m, CH2-P), 2.12 (2H, m, 2’-H), 3.44 (1H, m, 4-
H), 3.85 (1H, m, 5-H), 4.02 (4H, m, 4’-H, 5’-H, 1-H), 4.48 (1H, ddd, 3’-H), 6.21 (1H, t, J
= 6.6 Hz, 1’-H), 7.67 (1H, s, 6’’-H).  31P NMR (D2O): δ 14.3 (d, J = 27 Hz), -10.6 (d, J = 
27 Hz). High-resolution FAB-MS calculated for C17H28N3O11P2 (M-H)
– was 512.1199, 
and a mass of 512.1189 was found.  
Cloning and Expression of the SpnR and SpnS Proteins.  In the biosynthetic gene 
cluster of TDP-D-forosamine, functions of spnO, spnN and spnQ encoded enzymes have 
been characterized in detail.  The spnR and spnS genes are physically adjacent to these 
three genes.  The proteins encoded by spnR and spnS were proposed based on sequence 
analysis to be an aminotransferase and a methyltransferase, respectively, catalyzing the 
last two steps in the biosynthetic pathway of TDP-D-forosamine.  We decided to clone 
spnR and spnS to complete the characterization of the TDP-D-forosamine biosynthetic 
pathway.  Cloning of spnR into the pET24b(+) vector gave a construct that was highly 
efficient in producing soluble SpnR, accounting for more than 20% of the total proteins 
in the crude extract.  The spnS gene could also be well expressed when cloned into 
pET24b(+) vector, although a portion of the expressed proteins formed inclusion bodies.  
As judged by SDS-PAGE of the crude extracts of the host cells, SpnS was not a major 
soluble protein. 
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Purification and Characterization of the SpnR Protein (Figure 4-3).  The protein 
was purified to homogeneity after Ni-NTA and Sephacryl S-200 chromatography.  The 
typical yield was about 80 mg of pure SpnR from a 3 L culture.  The protein had a light 
yellow color characteristic of PLP-containing enzymes.  Its subunit molecular weight of 
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Figure 4-3. SDS-polyacrylamide gel electrophoresis of proteins obtained in Chapter 4.
Lanes 1 and 4, molecular markers; lane 2, C-terminal His-tagged SpnR protein; lane 3, 
C-terminal His-tagged SpnS.
calculated from the deduced amino acid sequence (including the C-terminal His6-tag).  A 
Mr of 85.9 kDa, as judged by gel filtration chromatography, indicates that the native 
SpnR exists as a homodimer.  The concentrated SpnR protein is stable and can endure 
repeated freeze/thaw cycles without losing noticeable activity.  
Effect of Mg2+ on the SpnR Catalysis.  Mg2+ is a divalent cation commonly used 
in the reactions in which the substrate and/or product have a diphosphate functional 
group.  The cation is supposed to stabilize the negatively charged phosphate groups and 
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thus facilitates the reaction.  Therefore, Mg2+ was initially included in the SpnR activity 
assays.  However, it was found that the relative reaction rate was not affected when Mg2+
was omitted from the reaction mixture.  Thus, Mg2+ was not required in the SpnR 
reaction.
Effect of Different Concentrations of Exogenous PLP.  PLP is the commonly used 
coenzyme in the transamination reactions.  When different amounts of PLP were 
included in SpnR assay reactions, it was found that the relative reaction rate was greatly 
increased by the presence of PLP in a concentration-dependant manner.  As shown in 
Figure 4-4, the reaction rate increased when the concentration of PLP was raised from 0 
µM to 40 µM.  Beyond this point, additional exogenous PLP could not further improve 
the reaction rate.
µ
Figure 4-4. Effect of PLP concentration on SpnR reaction with 155 as the substrate.
Effect of Exogenous PMP.  PMP is another commonly used coenzyme of 
aminotransferases.  When PMP was included in the SpnR assay mixture, PMP 
demonstrated its capability to increase the reaction rate.  The same amount of 155 was 
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converted to its 4-keto product as that in the reaction using PLP after the reaction reached 
equilibrium.  
Reconstitution of SpnR with PLP under Native Conditions.  The reconstituted 
protein had a stronger yellow color compared with the as-isolated SpnR indicating the 
presence of an increased amount of enzyme-bound cofactor.  
Reconstitution of SpnR with all Necessary Substrates Present.  In this 
reconstitution process, SpnR was incubated with PLP in the presence of 155 and α-
ketoglutarate.  The reconstituted protein showed a stronger yellow color compared with 
the as-isolated SpnR indicating the presence of an increased amount of enzyme-bound 
cofactor.  
UV Scan of the as-Isolated SpnR and Reconstituted SpnR.  The as-isolated protein 
showed little absorbance at 410 nm.  The protein was estimated to contain 0.07 PLP per 
monomer calculated from the extinction coefficient of PLP ε410 = 6000 M-1cm-1.192-194  In 
the UV-visible spectrum (Figure 4-5), the absorbance at 410 nm of the reconstituted 
enzymes, which were reconstituted either in the presence or absence of the substrates, 
was significantly enhanced compared with that of the as-isolated enzyme.  The two 
methods of reconstitution did not show a difference at the level of PLP incorporation in 
reconstituted SpnR as judged by similar A410/A280 values (0.12).  The PLP content, 0.85 
per monomer, is the same for the reconstituted enzymes obtained either way.  Such 









Figure 4-5. UV scan spectra of SpnRs. (I). the as-isolated SpnR. (II). SpnR reconsituted with
PLP in the presence of 155 and -ketoglutarate. (III). SpnR reconstituted with PLP in the
absence of 155 and   -ketoglutarate.  
aminotransferase in the biosynthetic pathway of TDP-mycaminose.  The as-isolated TylB 
showed no absorbance above 300 nm in its UV-vis spectrum and was evidently devoid of 
any PLP coenzyme.  The enzyme was not active in amino transfer reactions.  
Reconstitution of TylB in the absence of its substrates was not successful whether it was 
under the native condition or denaturing condition since the reconstituted enzyme still did 
not show any enzymatic activity.  The active reconstituted enzyme was obtained in the 
presence of all the necessary substrates.  Thus, SpnR was different from TylB in its 
coenzyme binding ability.  This difference can be rationalized by the fact that TylB is a 
C-3 aminotransferase, while SpnR is a C-4 aminotransferase.  The sequences of these two 
enzymes only have 26.9 % identity.
Effect of SpnR Reconstitution on its Catalytic Activity.  It has been demonstrated 
that the as-isolated SpnR was capable of catalyzing the reverse transamination reaction 
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(from amino sugar to keto sugar) in the absence of exogenous PLP at a slow rate and that 
addition of exogenous PLP accelerated the reaction.  When the reconstituted enzymes 
were used in reactions without exogenous PLP, 34% of the substrate 155 was converted 
to the product 156 in 10 min while only 5% of 155 was converted in the reaction using 
the as-isolated enzyme in the same time period.  In comparison, 19% of 155 was 
converted in the SpnR reaction with 50 µM of exogenous PLP in 10 min.  The 
reconstituted enzymes obtained by two reconstitution methods (in the presence or 
absence of the substrates) did not show a difference in their catalytic efficiency.  This 
correlates well with their similar PLP content. 
Isolation and Characterization of the SpnR Product (Figure 4-6).  The SpnR 
reverse reaction product was isolated as a pure compound by gel filtration 
















Scheme 4-4. Compound 156 was isolated from the large scale SpnR reaction.
keto group at C-4 of the product made it possible that the compound coexisted with its 4-
keto hydrated form.  This is consistent with the two sets of 5-Me doublet at 1.1 and 1.2 
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ppm, respectively, and two sets of 5-H quartet at 3.6 and 4.2 ppm, respectively in the 1H 
NMR spectrum.  Moreover, in the 31P NMR spectrum, there are two sets of β-P doublets 
at 13.9 ppm and 14.8 ppm, respectively.  The 4-H signal which appeared at 3.05 ppm in 
the substrate 1H NMR spectrum disappeared in the product spectrum, consistent with the 
transformation of the 4-amino group in the substrate to the 4-keto group in the product.  
In the 13C NMR spectrum, only the hydrated 4-C could be observed at 92.2 ppm while 
the signal of the C-4 in the carbonyl form could not be seen.  This is probably because 
keto signals in 13C NMR spectra are usually weak, and the amount of the compound used 
to obtain the spectrum was small, making the keto signal undetectable.  In summary, 
successful isolation and characterization of the SpnR reaction product provided 
unambiguous evidence that SpnR is an aminotransferase in TDP-D-forosamine 
biosynthesis, catalyzing conversion of 155 to 156. 
Optimal pH for SpnR.  As shown in Figure 4-7, SpnR has an optimal activity 
around pH 8.5.  This enzyme exhibited a sharp reduction of activity in more alkaline 
conditions.  The enzyme can tolerate slightly acidic conditions and has comparable 
activity as that in neutral conditions.  
Amino Acceptors.  α-Ketoglutarate was shown to be a better amino acceptor than 
pyruvate, although pyruvate was a competent alternative (about 50% reaction efficiency 
of pyruvate compared to α-KG) when the reactions were analyzed in the reverse 
direction.  Since the SpnR catalyzed transamination reaction is a reversible process, it can 
be inferred that both L-glutamate and L-alanine can be used as amino donors by SpnR.
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Activity Assay of SpnR in the Forward Direction.  In the presence of L-glutamate 
and a catalytic amount of PLP, SpnR was able to convert 156 to 155.  HPLC analysis 
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Figure 4-7. pH Effect on the SpnR reaction using 155 as substrate.
showed almost complete conversion from the 4-keto sugar to the 4-amino sugar in 4 h at 
room temperature.  This, again, provided unambiguous evidence that SpnR is indeed the 
desired aminotransferase that catalyzes the C-4 transamination step in the biosynthesis of 
TDP-D-forosamine.  
SpnR Reaction with the SpnQ Product as the Substrate.  After removing all the 
enzymes in the SpnQ assay mixture, consumption of the SpnQ product accompanied by 
the concomitant accumulation of a new compound was observed after the addition of 
SpnR, L-glutamate and PLP in the HPLC analysis.  The retention time of the new 
compound is 9.2 min, which is typical of an amino sugar under the same elution 
conditions.  Since the 4-keto group is the only functional group of the SpnQ product, 
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TDP-2,3,6-trideoxy-4-keto-glucose (126), that is capable of undergoing transamination, 
this result confirmed that SpnR catalyzes the C-4 transamination of the SpnQ product.  
Substrate Specificity of SpnR (Scheme 4-5).  In the first reaction, when the SpnN 











Scheme 4-5.  SpnR catalyzed reaction with the SpnN product as the substrate.
Conditios: PLP, L-glutamate,
with a retention time of 14.7 min according to HPLC analysis.  In the second reaction, 
before the SpnQ reaction (condition A including SpnQ, L-glutamate, and PLP) was 
completed, SpnQ was removed from the reaction mixture, and SpnR and more of L-
glutamate and PLP were added.  The consumption of the SpnN product continued, and 
was accompanied by the concomitant continued accumulation of the SpnQ product peak.  
There were no other peaks formed in the HPLC traces.  Thus, the SpnR product formed 
in the first reaction is same as the SpnQ product formed in the second reaction.  The 
product was identified as TDP-4-amino-2,4,6-trideoxy-glucose (153) considering several 
lines of evidence.  First, based on sequence analysis of SpnQ and SpnR, both enzymes 
contain coenzyme B6.  The common reaction that the two enzymes catalyze in the 
presence of L-glutamate and PLP should be a transamination reaction.  Second, SpnR has 
been shown to be an efficient aminotransferase in activity assays.  The only functional 
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group of the SpnN product (24) capable of undergoing an aminotransfer reaction is the 4-
keto group.  Third, the MS of the isolated compound is 531, which is the same as the 
calculated mass of TDP-4-amino-2,4,6-trideoxy-glucose (153).  This result not only 
provided more supporting evidence that SpnQ is an enzyme that behaves like an 
aminotransferase under condition A, but also demonstrated the substrate flexibility of 
SpnR.  The enzyme can take both the SpnQ product and the SpnN product as substrates.  
The presence of the 3-hydroxyl group in the SpnN product does not prevent the 
compound from being recognized by SpnR.  Nonetheless, it should be noted that when 
the SpnN product was used as the substrate, it took 12 h to achieve 80% substrate 
conversion even at 37 °C while more than 90% of the SpnQ product could be converted 
by SpnR in 2 h at room temperature.  It is reasonable to speculate that the SpnR catalyzed 
reaction with the SpnN product (24) as substrate is kinetically inefficient because the
SpnR active site has evolved to bind the SpnQ 3-deoxygenation product preferentially.  If 
this were not the case, then TDP-D-forosamine could not be obtained since SpnQ requires 
the 4-keto group to activate the C-3 position for deoxygenation. 
Equilibrium Constant.  The transamination reaction catalyzed by SpnR is a 
reversible process.  Using 155 and α-KG as substrates, a Keq of 2.6 was obtained from the 
reaction carried out in 50 mM potassium phosphate buffer (pH 7.5) at 24 °C.  The 
equilibrium slightly favors the direction towards the aminosugar side.  This result is 
consistent with the observation that an excess of α-ketoglutarate was required in order to 
drive the reverse reaction, from the aminosugar to ketosugar, to completion.  
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Purification and Characterization of the SpnS Protein (Figure 4-3).  The protein 
was purified to homogeneity after Ni-NTA and Sephacryl S-200 chromatography.  
Although most of expressed SpnS formed inclusion bodies in the host cells, 50 mg of 
pure SpnS was nonetheless obtained from a 6 L culture.  The absorption spectrum of the 
purified protein showed no absorbance above 300 nm.  Its subunit molecular weight of 28
kDa as revealed by SDS-PAGE correlates well with the predicted value of 28660 Da
calculated from the deduced amino acid sequence (including the C-terminal His6-tag).  A 
Mr of 62.1 kDa, as judged by gel filtration chromatography, indicates that the native 
SpnS exists as a homodimer.  The protein was not stable and precipitated easily, 
especially after several freeze/thaw cycles.  TylM1, the 3-amino-N,N-dimethyltransferase 
in the TDP-mycaminose biosynthetic pathway, was reported to be extremely unstable, 
even requiring the presence of 0.1 mM of exogenous SAM to stabilize the protein during 
purification.  Compared with TylM1, SpnS appears to be a more robust enzyme.  No 
exogenous SAM was included in any buffers used during the purification.  
Isolation and Characterization of the SpnS Product (Figure 4-8).  The authentic 
SpnS substrate, TDP-4-amino-2,3,4,6-tetradeoxy-glucose (127), was difficult to obtain.  
Extensive effort was made to chemically synthesize the compound.  However, it turned 
out that the compound is extremely unstable, the TDP part being easily cleaved.  The 
instability of the compound also made its synthesis through enzyme catalyzed 
biochemical reactions impractical.  Thus, 155 was used in all the SpnS assays as well as 
the preparative reaction.  The preparative reaction product was purified by gel filtration 
chromatography.  Spectroscopic analyses confirmed that it is the monomethylated 
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product 158 (Scheme 4-6) .  The N-methyl group appears at 2.66 ppm as a sharp singlet 
in the 1H NMR spectrum.  Integration of the singlet indicated that it consisted of 3 
protons.  The N-methyl group has a chemical shift of 30.9 ppm in the 13C NMR spectrum.  
About half of 155 was converted to the monomethylated product (158), and there was no 

















Scheme 4-6.  Compound 158 was isolated from the large scale SpnS reaction.
did not continue to completion to form 157 under the conditions used.  However, these 
results provided direct evidence that the N-methylation catalyzed by SpnS is a stepwise 
process with the monomethylated product as an intermediate.  The TylM1 catalyzed 
dimethylation has been shown to be stepwise, with the monomethylated product also 
formed as an intermediate.129,195  But unlike SpnS, TylM1 could quantitatively convert its 
substrate to the N,N-dimethylated product.  
Reaction Time Course of Methylations.  The progress of the reaction as monitored 
by consumption of the substrate and formation of the monomethylated product was
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recorded over 6 h (Figure 4-9).  The incubation was conducted using a saturating 
concentration of SAM.  Consumption of the substrate and concomitant formation of the 
monomethylated product were observed.  The monomethylated product reached a steady 
state one hour after the reaction was initiated and did not accumulate to a significant 
extent throughout the entire process.  On the other hand, the dimethylated product could
not be directly observed by HPLC due to peak overlapping.  The amount of the 
Figure 4-9.  Time courses of the SpnS catalyzed N-methyltransfer reactions.
dimethylated product formed was deduced from the difference between the amount of the 
initial substrate and that of the sum of the remaining substrate and generated 
monomethylated product.  Over time, the amount of the dimethylated product 
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continuously increased, eventually becoming the major product.  Interestingly, only 
monomethylated product was isolated from the preparative reaction containing the 
substrate 155, MgCl2, SAM and SpnS.  High concentrations of the substrate and SAM in 
the preparative reaction might have had an inhibitory effect on SpnS preventing the 
reaction from proceeding to formation of the dimethylated product.  Correspondingly, 
about half of the amount of the substrate (155) that was added initially was recovered 
even after the reaction had been carried out at 37 °C overnight.  
Optimal pH for SpnS.  Since neither the monomethylated nor the dimethylated 
product could be explicitly observed by HPLC using the Dionex column, the pH 
preference of SpnS was analyzed by the overall consumption of the substrate 155.  SpnS 
showed an optimal activity around pH 8.5.
Metal Effects.  Different di-, and tri-valent cations were examined for their effects 
on the SpnS reaction rate.  When trivalent cations were included in the reaction mixture, 
no substrate conversion was observed.  Among the divalent cations examined, the 
reaction with Fe2+ was most efficient while that with Mg2+ was secondary to it.  
Reactions in the presence of Co2+, Ca2+, and Zn2+ did not occur.  Considering the fact that 
Fe2+ is easily oxidized by air and Mg2+ is the common divalent cation used in NDP 
containing reactions, Mg2+ was included in all subsequent SpnS activity assays and 
preparative reactions.  
Mg2+ Concentration Effect.  Mg2+ is required in the SpnS reaction.  In the absence 
of Mg2+, no substrate consumption was observed.  As shown in Figure 4-10, the presence 
of 2.0 mM of Mg2+ increased the reaction rate to its maximum. 
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Dimethylation of the Monomethylated Product.  The isolated monomethylated 
product, 158, was incubated with SpnS along with other necessary components.  In this 
reaction, the competition for SAM between the monomethylation and dimethylation 
reactions was removed.  From the MS analysis of the product mixture, the presence of 
m/z of 540 in ESI-MS (M-H)- and m/z of 542 in ESI-MS (M+H)+ was observed.  The 
dimethylated product has a molecular weight of 541.  The MS results indicate that SpnS 
is able to catalyze the methyltransfer reaction using the monomethylated product as the 
substrate, confirming the stepwise mechanism of the SpnS reaction.  
0.1 0.2 0.4 0.8 2.0 10.0
 
Figure 4-10.  Effect of Mg2+ concentration on the relative rate of the SpnS reaction. 
4.  CONCLUSIONS
The results from this chapter provide unambiguous evidence that SpnR and SpnS 
are the aminotransferase and methyltransferase in the biosynthetic pathway of TDP-D-
forosamine, catalyzing conversion of TDP-2,3,6-trideoxy-4-keto-glucose (126) to TDP-4-
amino-2,3,4,6-tetradeoxy-glucose (127) and TDP-4-amino-2,3,4,6-tetradeoxy-glucose 
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(127) to TDP-D-forosamine (128), respectively.  The detailed study carried out on the 
PLP-containing SpnR will enrich our understanding of the C-4 aminotransferases that 
occur in several other deoxysugar biosynthetic pathways, and will also pave the way to a 
better understanding of the evolutionary differences between C-3 aminotransferases and 
C-4 aminotransferases.  The SpnS catalyzed reaction is another example of a SAM-
dependent methylation reaction.  The aerobic reaction conditions used eliminate the 
possibility of SAM radical involvement.  So far, all the methylation reactions that occur 
on the sugar components of antibiotics that have been characterized use SAM as the 
methyl donor.  More importantly, the investigation in this chapter concludes the 
biosynthetic studies of TDP-D-forosamine.  The biosynthetic pathway of TDP-D-
forosamine has been unequivocally established as a series of reactions catalyzed by 
SpnO, SpnN, SpnQ, SpnR and SpnS in sequence.  
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